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General introduction
Chapter 1
The immune system
Our body is constantly challenged by pathogens, such as bacteria,
viruses and fungi. Therefore, it has developed several defense sys-
tems, such as the skin and mucosal surfaces that form a difficult to
cross barrier for pathogens. If pathogens succeed in entering the
body they are detected and attacked by the immune system. In addi-
tion to protecting against infections, the immune system is also
important for proper clearance of dead cells. Moreover, the immune
system can detect and eradicate cells with aberrant properties to pre-
vent cancer. Consequently, a disregulated immune system can lead
to life threatening infections or the formation of cancer, but also
autoimmunity and allergy. Under these pathological conditions, mod-
ulation of the immune response can be beneficial. For instance,
immune responses can be dampened in allergy, autoimmunity or
transplantation settings, while immune responses can be enhanced
to combat infections or cancer. 
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Figure 1. Cells of the innate and adaptive immune system 
The innate immune system consists of mast cells, NK cells, granulocytes and antigen
presenting cells. Antigen presenting cells form the link between innate and adaptive
immunity. Cells of the adaptive immune system are T cells and B cells. NK cell; natural
killer cell, neutr; neutrophil, eosin; eosinophil, baso; basophil, Mφ ; macrophage, mono;
monocyte, myDC; myeloid dendritic cell, pDC; plasmacytoid dendritic cell, act T cell;
activated T cell and *; phagocytes. 
In vertebrates, the immune system consists of two branches with dif-
ferent characteristics, known as innate and adaptive immunity
(Figure 1). Innate immunity is the first line of defense and regulated
by natural killer cells, mast cells, granulocytes and phagocytes [1-5].
If this first line of defense is not sufficient, the adaptive immune sys-
tem comes into action. Antigen presenting cells (APCs), which
include monocytes, macrophages and dendritic cells (DCs), form the
link between the innate and adaptive immune system. APCs express
specific cell surface receptors that recognize molecules common to
pathogens. These so-called pathogen recognition receptors (PRRs)
include Toll-like receptors (TLRs), lectins and nucleotide-binding
oligomerization domain containing (NOD)-like receptors [6-9].
Activation of PRRs leads to internalization of pathogens and signal-
ing events resulting in activation of nuclear factor κB (NF-κB), which
controls the expression of an array of inflammatory cytokines. Upon
internalization, pathogens are degraded which leads to the genera-
tion of peptides that are presented on the surface of APCs in the con-
text of major histocompatibility complex (MHC) molecules [10].
Peptides generated from proteins derived from internalized material
are presented in the context of MHC class II molecules, which are
predominantly expressed on APCs [11]. Peptides presented in MHC
class II molecules are recognized by T cells expressing CD4, called
helper T cells. These helper T cells activate cells of the innate
immune system and stimulate antibody production by B cells [12].
However, in APCs some exogenous antigens derived via endocytic
uptake are presented on MHC class I molecules, instead of MHC
class II molecules. This process is known as cross-presentation [13].
Peptides derived from cytoplasmic proteins, either endogenous pro-
teins or intracellular pathogens, are presented in the context of MHC
class I molecules by all cells [14]. Peptides presented in MHC class
I molecules are recognized by T cells expressing CD8, cytotoxic T
cells [15]. APCs as well as their target (B and T) cells express a set
of auxiliary receptor-ligand pairs, known as costimulatory molecules
which are needed for proper activation of the adaptive immune
response. Only simultaneous activation of costimulatory molecules
and specific receptors for the peptide-MHC complexes on T cells and
B cells leads to sufficient activation of these lymphocytes and con-
sequently the induction of adaptive immune responses. 
Dendritic cells 
As mentioned earlier, all antigen presenting cells use PRRs to rec-
ognize pathogens and respond by the production of cytokines.
However, of all APCs, DCs are most potent in modulating T cell
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responses and thus play a central role in linking innate and adaptive
immunity [16-19]. As the most effective antigen presenting cells of
the body, DCs are being explored in the clinic for boosting immuno-
logical responses against various cancers including melanoma,
myeloma and prostate cancer [20-23]. In these studies, monocytes
or DC-precursors are isolated from cancer patients and differentiated
to DCs in vitro. Upon loading with tumor-specific antigens or a tumor
lysate the DCs are given back to the patient to trigger specific T cell
responses against the tumor cells [24, 25]. Although DCs are used in
clinical trials world-wide, fundamental knowledge about the complex
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Figure 2. Different stages in the life of DCs
DC precursors (preDC) move from the blood into the tissues. In the tissues, immature
DCs (iDC) scan for antigens. Upon encountering pathogens or other antigens under
inflammatory situations the iDCs undergo maturation and migrate through the lymph
vessels to the lymph nodes. In the lymph nodes, mature DCs (mDC) stimulate B cells
and T cells, leading to the initiation of an adaptive immune response. After fulfilling their
function the DCs undergo programmed cell death (apoptosis) (DCapop).
biology of these cells is lagging behind.
DCs can originate from lymphoid or myeloid precursors giving rise to
plasmacytoid DCs (pDCs) and myeloid DCs, respectively. The more
recently identified pDCs are interferon (IFN)-producing cells found in
blood and they are important mediators in immune responses
against viruses [26, 27]. Myeloid DCs are found in the blood and in
peripheral tissues and these cells can initiate immune responses
against diverse antigens in various situations. To study myeloid DCs,
monocyte-derived DCs are often used as a model. For this purpose,
monocytes are cultured in the presence of IL-4 and GM-CSF for 6-7
days to obtain DCs [28, 29]. Alternatively DCs can be differentiated
from CD34-positive cells (hematopoietic progenitors). Currently, no
good DC-model cell lines are available, which hampers cell biologi-
cal studies [30].
PRRs
During their development (myeloid) DC-precursors move from the
blood into the peripheral tissues, where these cells reside in an
immature state (Figure 2). These immature DCs (iDCs), are
equipped with a plethora of PRRs [31, 32], such as TLRs, C-type
lectins and NOD-like receptors, that allow them to efficiently recog-
nize pathogen-associated molecules on pathogens (Table 1). TLRs
are the vertebrate counterparts of the Drosophila melanogaster
receptor Toll [32]. To date, 13 members of this family of transmem-
brane receptors have been identified and they can operate both as
homo- and heterodimers that can recognize a large variety of
pathogen components. For instance, TLR4 recognizes lipopolysac-
charide (LPS) from Gram-negative bacteria and TLR5 recognizes fla-
gellin [33, 34]. TLR2 can form heterodimers with TLR1 and TLR6
which recognize peptidoglycans, lipoteichoic acid (LTA) and lipopro-
teins, components of Gram-positive bacteria [35]. TLR2 and TLR4
are also involved in recognizing fungi [36]. On the other hand, TLR3,
7 and 8 can recognize viral components, such as double stranded
and single stranded RNA [37, 38]. TLRs are signaling receptors and
activation most often leads to NF-κB mediated gene expression.
Most TLRs make use of the adaptor protein myeloid differentiation
primary response gene 88 (MyD88) [39]. In contrast, TLR3 uses the
TIR domain-containing adaptor-inducing IFNβ (TRIF) adaptor, which
signals to increase expression of type I IFNs [40]. TLR4 is unique
since until now it is the only TLR that can activate the MyD88 as well
as the TRIF dependent signaling pathway. In addition to transmem-
brane PRRs, DCs also express recently identified intracellular recep-
tors for microbes, like NOD-like receptors and RIG-like helicases
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TLR1
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7 and 8
TLR10
Combines with TLR2
Peptidoglycan, lipoproteins, lipoarabino-
mannan, zymosan
polyI:C, viral double stranded RNA
LPS, heat shock protein 60
Flagellin
Combines with TLR2
Imidazoquinolines, viral single 
stranded RNA
?
[112]
[36, 113-116]
[37]
[33, 117, 118]
[34]
[6]
[38, 119, 120]
C-type lectins
PRRs on myeloid and
monocyte-derived DCs
Ligand binding References
TLRs
Mannose receptor
DEC-205
DC-SIGN
DCIR
Dectin-1
Dectin-2
CLEC-1
CLEC-2
Endo-180
MGL
DLEC
DCAL-1
DCAR
MICL
Mannose, fucose, sLewisX
HIV1
Complex mannose residues, LewisX,
viruses, fungi, ICAM-2, -3
?
β-glucan
High mannose, fungi
?
?
Mannose, fucose, N-acetylglycosamine,
collagen
Terminal N-acetyl galactosamines
?
CD4 T cells
?
? 
[121]
[122, 123]
[124-130]
[131]
[132, 133]
[134, 135]
[42, 136]
[136]
[137, 138]
[139, 140]
[141]
[142]
[143]
[144]
Intracellular PRRs
NOD1 and 2
RIG-I and MDA-5
Muropeptides derived from peptidogly-
cans
Viral double stranded RNA
[9, 145-148]
[41, 149-151]
Table 1. Pathogen recognition receptors (PRRs) in human DCs.
[41]. In addition, DCs express several C-type lectins including DC-
SIGN, dectin-1 and the mannose receptor [31]. C-type lectins are
calcium dependent transmembrane receptors that bind carbohydrate
structures on pathogens as well as on endogenous ligands. Binding
of pathogens to C-type lectins leads to internalization of the recep-
tor/ligand complex, however recent findings indicate that C-type
lectins are also capable of activating intracellular signaling pathways
[42, 43]. Pathogens often activate multiple PRRs and these PRRs
can affect each others function. Therefore, the resulting response is
determined by the specific combination of receptors present on the
APC. 
DC maturation
When iDCs are exposed to pathogens, antigens and/or pro-inflam-
matory signals, they undergo a dramatic phenotypic conversion
known as DC maturation (Figure 2). This process transforms iDCs,
specialized in antigen recognition and internalization, into antigen
presenting mDCs, which are very efficient in stimulating T cells.
During maturation, molecules needed for antigen recognition and
uptake are downregulated, while molecules required for antigen pro-
cessing and presentation, such as MHC and costimulatory mole-
cules, are upregulated [44-46]. Moreover, in response to maturating
signals, DCs start to secrete cytokines that further induce and acti-
vate T cells. In addition to upregulating MHC molecules, DCs are
able to regulate the fate of MHC molecules. In iDCs the majority of
the MHC molecules is maintained in an intracellular lysosomal com-
partment known as the MHC class II compartment. Upon maturation,
MHC molecules, loaded with peptides derived from internalized anti-
gens, are transported from the MHC class II compartment to the cell
membrane [18]. DCs are more potent than other APC in stimulating
T cells, in part because they are able to efficiently cross-present anti-
gens [13].
During maturation, tissue resident iDCs have to acquire the ability to
travel out of the tissue and into the lymph nodes [47] (Figure 2).
Therefore, strongly adherent iDCs transform into highly migratory
mDCs. Migration to the lymph nodes is mediated by the chemokines
CCL19 and CCL21. In order to respond to these chemokines mDCs
have to express the active chemokine receptor CCR7 [47-49]. PGE2,
a prostaglandin produced from arachidonic acid by the cyclooxyge-
nase (COX) enzymes [50-52], is important for the induction of migra-
tion during maturation [53-57], in part because it induces expression
and activation of CCR7 [58, 59]. The development of migration also
involves extensive changes in the cytoskeletal organization of the
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DCs [60, 61] (this thesis). During maturation DCs lose adhesion
structures and develop the characteristic dendritic extensions, after
which they are named. These dendritic extensions enhance contact
with T cells and B cells once the DCs reach the lymph nodes. 
Adhesive interactions in the immune system
Regulation of adhesive and migratory properties plays a prominent
role in immune regulation. The ability of immune cells to enter lymph
nodes or tissues relies on sets of adhesion molecules, such as inte-
grins. The latter are composed of an α chain and a β chain. Distinct
conformations determine the ability to bind ligand, where a closed,
bended conformation is unable to bind ligand and the open, extend-
ed conformation can bind ligand [62-65]. In addition, there are inter-
mediate activation states resulting in intermediate affinities [66]. The
activity of integrins can be further regulated by receptor cluster-
ing.[67-70]. In addition to β2- and β7-integrins, which are selectively
expressed in the immune system, β1- and β3-integrins are important
for proper functioning of the immune system. Integrins play important
roles during various phases of the immune response and defective
integrin function lead to severe diseases, such as blistering disorder,
leukocyte adhesion deficiencies and bleeding disorders [71]. The
αMβ2- and αXβ2-integrins are complement receptors and αMβ2-,
αLβ2- and α5β1-integrins are receptors for several pathogens [72-
75]. In addition to cell-pathogen interactions, integrins are important
14
Figure 3. Adhesion structures, FAs and podosomes, in DCs
In the upper panel a DC displaying FAs is depicted. In the lower panel a DC displaying
podosomes can be seen. Staining for the cytoskeletal plaque protein vinculin (green)
reveals FAs and the rings of the podosomes. Phalloidin-TexasRed staining of F-actin
(red) reveals actin stress fibers connected to the FAs as well as the cores of the
podosomes.
for cell-cell interactions, such as the rolling of leukocytes on the
endothelium and formation of the immunological synapse between
DCs and T cells [76, 77]. Furthermore, integrins, especially the β1-
integrins, mediate cell-extracellular matrix (ECM) interactions [78-
80]. The interactions with other cells and with the ECM and the reg-
ulation thereof are essential for adhesion and migration of leuko-
cytes. Constitutive active integrins result in defective cell migration,
showing that the activity of integrins has to be tightly regulated and is
important for the initiation of immune responses [81]. 
In addition to sensing and binding to their surroundings, cells have to
control their shape and move to coordinate adhesion and migration.
This is controlled by the cytoskeleton, a framework of filaments that
coordinates cell division and intracellular traffic, supports the plasma
membrane, provides stability and controls cell shape. The cytoskele-
ton consists of three types of filaments, actin filaments, microtubules
and intermediate filaments. For cells to move forward they have to
undergo cycles of protrusion, attachment to the substrate, forward
translocation of the cell body, release of adhesions and retraction at
the cell rear [82]. The forces needed for these processes are gener-
ated either by polymerization of actin leading to protrusion of the
plasma membrane [83], or by motor proteins, which use the energy
derived from repeated cycles of ATP hydrolysis to move along fila-
ments [84]. Nonmuscle myosin II is the actin-binding motor protein
that is essential to generate contractility. Light-chain phosphorylation
allows the myosin molecules to assemble into short, bipolar, thick fil-
aments, which leads to contraction [85].
The ECM is linked to the actomyosin cytoskeleton through integrins,
which can organize into specific "higher order" adhesion sites.
Dependent on organization and composition, these adhesion sites
are known as focal adhesions (FAs), focal complexes, fibrillar adhe-
sions, invadopodia and podosomes [82, 86, 87]. FAs, focal complex-
es and fibrillar adhesions are related (integrin containing) adhesion
plaques found in many cell types which connect the cell to the sur-
rounding ECM. Focal complexes are smaller nascent adhesion struc-
General introduction
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Cell type Putative function References
Endothelial cells
Macrophage/monocyte/DC
Osteoclast
Smooth muscle cell
Transformed fibroblast
matrix degradation, arterial remodeling
adhesion, migration, diapedesis
sealing zone formation, bone resorption
matrix degradation, migration
adhesion, migration
[152, 153]
[95, 101, 154]
[96, 155]
[97, 156]
[103]
Table 2. Putative podosome functions in different cells.
Chapter 1
tures found at the periphery of spreading or migrating cells, which
can further mature into FAs [88]. The latter are relatively stable struc-
tures connected to stress fibers, bundles of actin filaments
crosslinked by α-actinin (Figure 3). FAs can further mature into fibril-
lar adhesions, which are mostly located to the center of the cell [82,
88, 89]. 
Podosomes
In contrast to these adhesion plaques, podosomes and invadopodia
have a very different morphology. Podosomes have a very charac-
teristic organization consisting of a core of actin surrounded by a ring
containing integrins and structural proteins, such as vinculin [90, 91]
(Figure 3). Podosomes are very dynamic structures that can merge,
split and display high actin turnover in the core [92]. The appearance
of podosomes and of the related invadopodia is restricted to particu-
lar cell types (Table 2). Invadopodia are a feature of invasive (tumor)
cells [90] whereas podosomes can be found in endothelial cells, Src-
transformed fibroblasts and cells of the myeloid lineage, such as
monocytes, macrophages, osteoclasts and DCs [93]. In contrast to
the adhesion plaques, podosomes are active sites of matrix degra-
dation which allow the cells to invade into tissues or cross tissue
boundaries [94, 95]. In addition, podosomes play an important role
during osteoclast-mediated bone resorption [96, 97]. Podosomes are
regulated by the small Rho GTPases, Rho, Rac and Cdc42, and reg-
ulators thereof [94, 98-100]. Actin regulatory pathways affect the for-
mation and turnover of podosomes, which is not surprising since the
actin core is a prominent part of podosomes. The absence of proteins
regulating actin turnover, such as Wiskott-Aldrich Syndrome protein
(WASP) or the actin nucleating Arp2/3 complex, results in podosome
disruption [99, 101]. In addition, podosomes are regulated by tyro-
sine phosphorylation, which is underscored by the finding that cells
transformed with the tyrosine kinase Src can form podosomes [102,
103]. In addition to the actin cytoskeleton, podosomes are regulated
by microtubules [104, 105] and their interactions with the cell sub-
strate [106]. However, the precise mechanisms behind this regulation
remain largely unknown.
Adhesion and migration in DCs
Although iDCs also display FAs, podosomes are the most prominent
adhesions found in these cells [99] (this thesis). In contrast, migrato-
ry mDCs completely lack podosomes and FAs but instead display
numerous dendritic extensions, which serve to enhance the cells sur-
face and hence facilitate the interactions with T cells [107]. These
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findings indicate that both the DC cytoskeleton and the organization
of DC adhesion change dramatically during the process of DC matu-
ration. 
Aim of this thesis
DCs link innate and adaptive immunity and are key players in the
induction of efficient immune responses. Functional maturation of
DCs is critical for the induction of efficient immune responses [108].
For instance, the induction of migration during DC maturation was
shown to be essential for the induction of T cell responses both in
mice and in human cancer patients receiving DC-vaccination [109-
111]. However, the cytoskeletal changes that occur during DC matu-
ration and its consequences for cell adhesion or the induction of
migration remain poorly understood. More insight into these process-
es will help improve our understanding of the function of DCs in
inflammation, infection and autoimmunity and may improve DC-vac-
cination strategies in cancer patients. Therefore, the aim of this the-
sis is to investigate the cytoskeletal changes that occur in human
monocyte-derived DCs in response to maturation signals, and study
its consequences for adhesive and migratory behavior. 
In chapter 2 we compare different APC cell lines as models to study
DC-biology. DCs are post-mitotic cells that have to be isolated and
differentiated from blood, spleen or buffy-coat material. The produc-
tion of DCs involves the use of expensive cytokines and is rather time
consuming. Moreover, donor-to-donor variations often can give rise
to variable results. Hence, a good model cell line would circumvent
some of these problems. Although no cell line can fulfill all require-
ments for a DC-model, we describe a number of cell lines that can be
used to investigate different aspects of DC-biology. 
In chapter 3 the loss of cell adhesion structures and the acquisition
of migration during DC-maturation are investigated in detail.
Podosome dissolution in response to maturation stimuli is mediated
by prostaglandins produced by the DCs, and the prostaglandin PGE2
induces very rapid podosome loss. Podosome loss as well as inacti-
vation of α5β1-integrin are needed to acquire migration.
In chapter 4 the effects of different classes of bacteria on adhesive
and migratory properties and other aspects of DC-maturation are
investigated. Gram-negative bacteria are superior to Gram-positive
bacteria in inducing podosome loss, migration and inducing expres-
sion of costimulatory molecules, CCR7 and cytokines. This is medi-
ated by activation of TLR4 and predominantly TRIF-dependent.
Moreover, these effects involve the production of prostaglandins
(possibly PGE2) by DCs. 
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In chapter 5, we investigate the signal transduction pathways
involved in PGE2 mediated podosome dissolution. PGE2 activates
the EP2 and EP4 receptors on DCs, which raises cAMP levels. This
results in activation of the small GTPase RhoA and inactivation of
Rac1 and Cdc42. Active RhoA activates its downstream effector Rho
kinase. Activation of the RhoA-Rho kinase axis leads to actomyosin
contraction, which is necessary for podosome loss and leads to the
(transient) formation of FAs. A model linking actomyosin contractility
to podosome loss is put forward.
In chapter 6, we explore the regulation of podosome formation on
different kinds and shapes of substrates. DCs can adhere to and
form adhesion structures on a broad range of substrates. FA-forma-
tion, but not DC-adhesion or podosome-formation, is affected by the
hydrophobicity of the substrate. Interestingly, when DCs are seeded
on substrates with varying topology, podosomes specifically form in
those areas where height differences occur. These changes in sub-
strate topology most probably induce a curvature of the cell mem-
brane triggering local podosome formation. We postulate that
podosomes are mechanosensitive structures regulated by mechani-
cal stress on the outside (chapter 6) and cytoskeletal tension on the
inside of the cell (chapter 5).
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Human and murine model cell lines for
dendritic cell biology evaluated
Chapter 2
Abstract
Dendritic cells (DCs) are specialized antigen presenting cells that link
innate and adaptive immune responses. As key mediators of T cell
dependent immunity, DCs are considered primary targets for initiat-
ing immune responses in infectious diseases and cancer.
Conversely, DCs can also play an important role in the induction of
tolerance in organ transplantation, autoimmune disorders and aller-
gy. While DCs have been used in clinical trials worldwide during the
past decade, many of the highly specialized cell biological character-
istics of DCs remain poorly understood. Small numbers of DCs can
be isolated as terminally differentiated, post-mitotic cells from either
blood or spleen. Alternatively, DC-precursors, such as monocytes or
bone marrow-derived stem cells, can be isolated and differentiated
into DCs in vitro. The relative low numbers of cells that can thus be
obtained, combined with difficulties manipulating these terminally dif-
ferentiated primary cells in vitro and in vivo, have seriously hampered
studies aimed at exploring the cell biology of DCs. Good model cell
lines therefore provide invaluable tools to study DC biology. So far
most DC models are myeloid leukemia-derived cell lines that can be
differentiated in vitro towards a DC phenotype. Here, we compared
the phenotypical and functional characteristics of frequently used
mouse and human DC-model cell lines. We conclude that, although
none of these cell lines fully recapitulates all cell biological or
immunological features of primary DCs, some of these cell lines pro-
vide valuable tools to study specific aspects of DC biology. 
Introduction
Antigen presenting cells, such as B cells, macrophages and dendrit-
ic cells (DCs), are responsible for the induction of cellular immune
responses, by internalizing and processing antigens for presentation
to T cells. Of all antigen presenting cells, DCs are by far the most
effective inducers of T cell-based immunity [1]. As DCs are also rap-
idly activated in response to bacterial or viral antigens, these cells
play an essential role in linking innate and adaptive immune
responses. DCs originate from myeloid precursors that during their
development move from the blood into the (peripheral) tissues.
These tissue-resident DCs, generally known as immature DCs
(iDCs), are equipped with specialized receptors, such as Toll-like
receptors that allow them to efficiently recognize and respond to
pathogens through pathogen-associated molecules. In addition, C-
type lectins and Fc receptors present on these cells facilitate inter-
nalization and processing of pathogens or other foreign antigens.
When iDCs are exposed to pathogens, antigens and/or pro-inflam-
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matory signals, they undergo a dramatic conversion known as matu-
ration. During maturation DCs upregulate major histocompatibility
complex (MHC) and costimulatory molecules, activate their antigen
processing machinery and become highly migratory, which enables
these cells to travel to the lymph nodes were they interact with B and
T cells to initiate an adaptive immune response. Since DCs are so
well equipped to initiate adaptive immune responses, they are con-
sidered prime targets for modulating immune responses against can-
cer, but also vehicles that can be used to dampen responses in case
of autoimmunity, allergy or transplantation. Although laboratories
worldwide are exploring therapeutic applications of DCs, many
aspects of DC-biology are still poorly understood. This is to a large
part due to the fact that studying DC-biology in vitro is difficult for a
number of reasons. First of all, the most commonly used DCs are iso-
lated from either spleen [2] or blood [3, 4] and post-mitotic, limiting
the amount of cells that can be obtained. For instance, myeloid DCs,
which can be isolated directly from peripheral blood [5], make up less
than 1 % of all mononuclear cells. Consequently, isolation of these
myeloid DCs by flow cytometry or magnetic bead sorting is rather
inefficient and expensive, while relatively small numbers of cells can
be obtained. Moreover, the life span of such cultures is limited since
DCs are terminally differentiated and cannot divide. Larger numbers
of DCs can be derived by in vitro differentiation of bone marrow stem
cells [6], peripheral blood mononuclear cells [7] or monocytes [8].
Isolation of these DC-precursors from the bone marrow, whole blood
or buffy-coat material is laborious while their subsequent differentia-
tion towards DCs is time consuming, requiring six to nine days.
Moreover, transfection or electroporation of recombinant DNA or
short hairpin RNAs into DCs is generally very ineffective and associ-
ated with significant cell death. Finally, experiments using these pri-
mary cells are often complicated by donor to donor variations in
cytokine expression levels, cell surface molecule expression levels
and the ability to stimulate T cells. Hence, there is a significant need
for model cell lines that accurately replicate cell biological aspects of
DC biology such as antigen uptake, processing and presentation and
that can be induced to undergo maturation in response to pathogens
or cytokine stimulation. 
Here we compare a number of cell lines of either mouse or human
origin, for their use as DC models. As mouse models, we evaluated
Raw264.7, J774 and D1 cells, while the cell lines THP-1, HL60 and
MUTZ-3 cells were compared for their ability to serve as human DC
equivalents. We examined the presence of DC-specific molecules
and describe the ability of each of these cell lines to respond to mat-
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uration stimuli. Moreover, we have compared the ability of these cells
to take-up and present antigens as well as examined adhesive and
migratory properties either in unstimulated cells or after receiving a
differentiation signal. Finally, we evaluated ease of culture and trans-
fectability of these different DC models.
Expression of MHC, costimulatory and DC-spe-
cific molecules
DC maturation, induced by exposure to pathogens or inflammatory
stimuli, is characterized by upregulation of MHC and costimulatory
molecules and accompanied by extensive changes in the cytoskele-
tal organization [9-13]. Raw264.7 and J774 cells are widely used
murine cell lines with macrophage properties derived from tumors in
Balb/c mice [14, 15]. Although not as efficient in antigen presentation
as DCs, significant similarities exist between DC and macrophages
regarding their response after exposure to pathogens or foreign anti-
gens. When compared to DCs, these macrophage cell lines express
costimulatory molecules and MHC class I and II ([16, 17] and our
own observations). Moreover, Raw264.7 cells efficiently upregulate
surface expression of CD80, CD86, CD40 and MHC class II mole-
cules in response to lipopolysaccharide (LPS) [16, 17]. In addition,
we observed that Raw264.7, differentiated by exposure to IL-4 and
GM-CSF for 7 days upregulated surface expression of CD11c, a DC-
specific marker in mice (Table 1). When these IL-4 and GM-CSF
treated cells are further stimulated with LPS for 24 h, upregulation of
the costimulatory molecule CD40 is observed. J774 cells also
express MHC class II and costimulatory molecules [18] and respond
to LPS by upregulating CD86 expression [19]. We similarly stimulat-
ed J774 cells with IL-4 and GM-CSF with or without LPS but
observed no change in the expression pattern of MHC and costimu-
latory molecules and no expression of CD11c (Table 1). The third
mouse cell line that we evaluated is D1, a growth factor dependent
cell line derived from spleen cells of C57BL/6 mice [20]. Even with-
out cytokine stimulation, these cells closely resemble mouse iDCs,
based on expression of DC-specific markers as well as MHC- and
costimulatory molecules. Moreover, D1 cells acquire a mature phe-
notype upon exposure to inflammatory stimuli [20]. D1 cells express
MHC class I and II molecules, the costimulatory molecules CD80,
CD86 and CD40, as well as CD11c [20]. After maturation MHC class
II, CD86 and CD40 are further upregulated [20] (Table 1). In addition
to MHC, costimulatory and DC-specific molecules, Raw264.7, J774
and D1 cells express receptors for recognition and up-take of
pathogens [19-25]. Of these three murine cell lines examined, the
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receptor repertoire in D1 cells most closely resembles that found in
DCs. Taken together, these data suggest that although all three cell
lines express, or can be stimulated to express, MHC molecules and
costimulatory molecules, only Raw264.7 and D1 cells can be stimu-
lated to express DC-specific molecules. We conclude that of these
mouse models, D1 cells most closely resemble primary DCs. It
should be noted however that D1 cells are more difficult to grow
when compared to the other cell lines.
THP-1, HL-60 and MUTZ-3 cells are all human leukemia cell lines
with monocyte-like properties, which makes them potentially good
surrogates for human DCs. THP-1 is a monoblastic leukemia cell line
established from a 1-year-old male [26]. While lacking expression of
costimulatory and MHC class II molecules ([27] and our own obser-
vations), THP-1 cells express MHC class I molecules [28] and can be
induced to express the costimulatory molecule CD86 in response to
LPS [29]. Moreover, combined stimulation of THP-1 cells with IL-4
and protein kinase C activators such as bryostatin or phorbol 12-
myristate 13-acetate (PMA) leads to expression of CD80, CD86,
CD40 and the DC-specific C-type lectin Dendritic Cell-Specific
ICAM3 Grabbing Non-integrin (DC-SIGN) ([30] and our own obser-
vations) (Table 2). A second myeloid leukemia cell line, HL-60, estab-
lished from a 35-year-old female is arrested at the myeloblast differ-
entiation stage and can be differentiated to monocytes or granulo-
cytes [31-34]. HL-60 cells, express MHC class I molecules [35], but
lack expression of MHC class II and costimulatory molecules [27].
Stimulation with the calcium ionophore ionomycin was shown to
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Table 1. Expression of MHC and costimulatory molecules and CD11c in D1, Raw264.7
and J774 cells. Immature (iD1) and mature D1 (mD1) cells, unstimulated Raw264.7
(Raw) cells or J774 cells were compared. In addition, Raw264.7 cells and J774 cells
were cultured with IL-4 and GM-CSF (both 20 ng/ml) for 7 days (Raw+IL-4/GM-CSF and
J774+IL-4/GM-CSF). These stimulated cells were further stimulated with LPS for 24 h
(Raw+IL-4/GM-CSF+LPS and J774+IL-4/GM-CSF+LPS). +; expressed, low; low
expression and -; not expressed, m; membrane, i; intracellular
MHC class II
MHC class I
CD80
CD86
CD40
CD11c
+
+
-
low 
low 
-
+
+
-
low
low 
-
+
+
-
low 
low
-
+
+
low 
low 
+
+
+
+
low 
low 
low 
+
+
+
low
low
low
low
+ i
+
+
+
+
+
+ m
+
+
low
+
+
J774
IL-4
GM-CSF
LPS
J774
IL-4
GM-CSF
J774Raw
IL-4
GM-CSF
LPS
Raw 
IL-4
GM-CSF
RawmD1iD1
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induce expression of CD80, CD86 and CD83 [36], which indicates
that this stimulation results in a more mature phenotype. No
(enhanced) expression of costimulatory molecules or MHC mole-
cules was induced by treatment with the phorbol-ester PMA (Table
2). 
MUTZ-3 is a human myeloid leukemia cell line established from a 29-
year-old male [37]. Similar to primary monocytes, MUTZ-3 cells can
be differentiated in six or seven days using GM-CSF and IL-4 to
acquire an iDC-phenotype (iMUTZ-DCs) [38]. Moreover, maturation
can be induced by treatment with LPS or cytokines to acquire a phe-
notype (mMUTZ-DCs) closely resembling that of mature primary
DCs [38]. Undifferentiated MUTZ-3 cells express CD34, CD14,
CD86, CD40 and MHC class I an II molecules ([38] and our own
observations). Upon differentiation with IL-4 and GM-CSF, CD14 and
CD34 are downregulated, while the cells start to express CD80 and
DC-SIGN, and upregulate CD86, CD40 and MHC class II molecules
([38] and our own observations) (Table 2). Upon further stimulation
with LPS or cytokine combinations CD80, CD86, CD40 and MHC
class II molecules are further upregulated and the cells start to
express the maturation marker CD83 and the chemokine receptor
CCR7 [38, 39]. All three human cell lines express receptors for
recognition and up-take of pathogens [29, 30, 38, 40-42]. The
30
Table 2. Expression of MHC and costimulatory molecules, monocyte marker CD14, DC-
maturation marker CD83 and DC-specific molecule DC-SIGN in HL-60, MUTZ-3 and
THP-1 cells. Unstimulated HL-60, MUTZ-3 or THP-1 cells were compared. In addition,
HL-60 cells were stimulated with 0.1 µM PMA for 24h and THP-1 cells were stimulated
with 0.1µM PMA and 500 U/ml IL-4 for 24h. MUTZ-3 cells were differentiated with GM-
CSF (100 ng/ml) and IL-4 (1000 U/ml) for 7 days to obtain iMUTZ-DCs and further
matured with MCM, TNFα and PGE2 for 2 days to obtain mMUTZ-DCs. +; expressed,
low; low expression, -; not expressed and nd; not determined.
MHC class I
MHC class II
CD80
CD86
CD40
CD14
CD83
DC-SIGN
+
-
+
+
+
-
-
+
+
-
-
-
+
low
-
-
+
+
+
+
+
-
+
+
+
+
+
+
+
-
-
+
+
+
low
+
+
+
-
-
+
-
-
-
nd
-
-
-
+
-
-
-
nd
-
-
-
THP-1
PMA
IL-4
THP-1mMUTZ-DCiMUTZ-DCMUTZ-3HL-60
PMA
HL-60
expression pattern of these receptors in (stimulated) THP-1 cells
more closely resembles that of DCs when compared to HL-60 cells,
however the receptor profile of MUTZ-3 cells most closely approach-
es that of primary DCs. Taken together we conclude that HL-60 cells
express MHC class I but lack expression of MHC class II, costimula-
tory and DC-specific molecules, and do not significantly respond to
signals reported to enhance differentiation/maturation. THP-1 cells
express costimulatory, MHC class I and II molecules and can be
induced to acquire some DC like features, such as expression of cos-
timulatory molecules and DC-SIGN. However, in comparison to
these two cell lines, differentiation and maturation of MUTZ-3 cells
most accurately mirrors normal DC development. On the negative
side, MUTZ-3 cells are heterogeneous and more difficult to propa-
gate when compared to HL-60 and THP-1.
Antigen uptake and presentation
iDCs are strongly endocytotic cells that use phagocytosis and
pinocytosis to take up antigens and sample their environment. In
response to maturation, internalized antigens are processed and pre-
sented to T cell as peptides in the context of MHC class I/II mole-
cules. Both Raw264.7 and J774 cells efficiently take up antigen by
phagocytosis [23, 43] and pinocytosis [44, 45]. Consequently, these
cells are widely used model cell lines to study phagocytosis. In addi-
tion, release of cytokines such as IL-6, TNFα, IL-1β [46, 47] and IL-
12 [48, 49] , in response to LPS, occurs efficiently in both cell lines.
However, while LPS and/or phosphatidic acid-activated Raw264.7
cells can stimulate alloreactive T cells [17], J774 cells cannot. 
Similar to these two macrophage cell lines, (immature) D1 cells effi-
ciently take up antigens by fluid phase-, as well as receptor-mediat-
ed endocytosis, while after maturation the endocytotic capacity
decreases [20, 50]. Furthermore, maturation of D1 cells leads to the
redistribution of MHC class II molecules from intracellular vesicles to
the plasma membrane [20]. Similar to primary mature DCs, mature
D1 cells produce IL-12p75 in response to TNF [20] and efficiently
stimulate T cells [20]. In addition, D1 cells can present peptides
derived from exogenous antigens in the context of MHC class I mol-
ecules [51-53], a mechanism known as crosspresentation, which is
considered to be essential for the induction of cytotoxic T cell (CTL)
responses. To summarize, Raw264.7, J774 as well as D1 cells can
take up antigen, however only the Raw264.7 and D1 cells have the
capacity to process and present antigen to T cells. While Raw264.7
provide and excellent model for studying phagocytosis, D1 cells are
superior to the Raw264.7 cells in their ability to stimulate T cells and
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therefore more closely resemble primary mouse DCs. Hence, D1
cells are the model of choice for studying antigen presentation. 
The human cell line THP-1 [54] as well as differentiated MUTZ-3 [40]
or HL-60 cells [55] are capable of taking up antigen by endocytosis.
THP-1 cells secrete T cell recruiting and differentiating cytokines,
such as IL-6 and IL-8 [56], leading to moderate stimulation of T cells
[57, 58]. HL-60 cells produce IL-6 [59] and IL-8 [60] and can also
stimulate T cells upon activation, albeit moderately [61, 62]. The rel-
ative low T cell stimulating capacity of THP1 and HL 60 cells is
reflected by the absence of MHC class II molecules. Unstimulated
MUTZ-3 cells are also weak inducers of T cell stimulation, while
iMUTZ-DCs, and even more so mMUTZ-DCs, produce IL-12 and are
efficient T cell stimulators [38, 63]. Upon external loading with MHC
class I-specific peptides MUTZ-DCs can induce potent CTL respons-
es [63]. THP-1 cell are able to crosspresent antigens in MHC class I
molecules and this is enhanced upon differentiation [64]. MUTZ-3
cells are likely to be suitable to study crosspresentation, since these
cells are much more efficient in stimulating T cells than THP-1 cells. 
In conclusion, all three human cell lines compared here are able to
take up antigens, however the MUTZ-DCs are by far the most effi-
cient in stimulating T cells [40, 65]. 
Adhesion and migration
In addition to endocytotic capacity, cytokine production and antigen
presenting capabilities, regulation of adhesive and migratory proper-
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Fig. 1. Morphology of J774 and Raw264.7 cells upon stimulation with cytokines and
LPS.
J774 or Raw264.7 cells adhere on fibronectin-coated coverslips and upon stimulation
with mouse GM-CSF and IL-4 (both 20 ng/ml) for 7 days these cells spread and become
more adhesive as visualized by an actin staining. Additional stimulation with LPS for 24
h results in even further spreading. Note, how particularly the Raw264.7 cells develop
elaborate filopodium-like protrusions after stimulation. 
ties is an important aspect of DC-behavior. Immature DCs are strong-
ly adherent cells that spread and form podosomes [13, 66]. These
specialized adhesion structures are found in Src transformed cells,
as well as myeloid cells, such as osteoclasts, monocytes, DCs and
macrophages. Podosomes consist of an actin-dense core surround-
ed by a ring containing structural proteins, such as vinculin, paxillin
and myosin II [67]. Podosomes are thought to play a role in crossing
tissue boundaries. During maturation DCs loose podosomes and
transform from slowly migrating cells into cells capable of high-speed
migration [13]. Raw264.7 and J774 cells are strongly adherent cells
and after exposure to IL-4/GM-CSF and LPS these cells undergo
extensive spreading and become even more adherent (Figure 1),
making these cells extremely suitable for microscopy studies. This
response is most pronounced in the Raw264.7 cells. Under normal
culture conditions, neither Raw264.7 nor J774 cells form
podosomes, and neither can such structures be induced in response
to IL-4/GM-CSF and LPS. However, at least in Raw264.7 cells,
podosome formation can be induced by the addition of RANK ligand,
an osteogenic factor that promotes differentiation of these cells
towards osteoclasts [68]. In spite of their phenotypic resemblance to
mouse DCs, iD1 cells are less adherent than primary mouse DCs
and podosomes cannot be found ([20] and our own observations)
suggesting that iD1 are not suitable to study this aspect of DC-biolo-
gy. However, by similarity to mouse-derived DCs, iD1 cells are slow-
ly migrating cells that switch to high-speed migration in response to
maturation [20]. Hence, to study podosomes turnover in a mouse
model, Raw264.7 cells differentiated towards osteoclasts can be
used. However, D1 cells more strongly resemble primary mouse
DCs, as these cells can be induced to acquire a highly migratory phe-
notype in response to maturation stimuli. 
The human cell lines, THP-1, HL-60 and MUTZ-3 are suspension
cells and thus unable to form podosomes. Upon differentiation into
iMUTZ-DCs podosomes can be observed in a very small portion of
these cells (our own observations) (Figure 2). However, when THP-
1 cells are stimulated with a combination of IL-4 and PMA or when
HL-60 cells are stimulated with PMA alone, most of these cells
adhere and form podosomes ([69] and our own observations) (Fig 2).
Similar to podosomes observed in primary human DCs, PMA-
induced podosomes in THP1 and HL-60 cells dissolve within minutes
after the addition of the inflammatory mediator prostaglandin E2
(PGE2), a potent migratory stimulus for these cells [13]. Moreover,
THP-1 show directed migration towards several chemokines impor-
tant for DC migration, while HL-60 cells can only do so when differ-
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entiated towards monocytes [70]. In contrast to primary DCs, how-
ever, neither of these two cell types switch to a high-speed migration
mode in response to maturation [71]. Relative to primary DCs,
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Fig. 2. Morphology of different human cell lines compared to monocyte-derived DCs.
A. Comparison of adhesive behavior and podosome formation between human mono-
cyte-derived DCs and various DC model cell lines, seeded on fibronectin.
Monocytes were isolated from buffy-coat material and plastic adherent monocytes were
cultures with GM-CSF (800 U/ml) and IL-4 (500 U/ml) for 6 days to obtain iDCs. To
induce maturation iDCs were stimulated with monocyte-conditioned medium (MCM,
50% v/v), TNFα (10 ng/ml) and PGE2 (10 µg/ml) for 2 days. MUTZ-3 cells were differ-
entiated with GM-CSF (100 ng/ml) and IL-4 (1000 U/ml) for 7 days to obtain iMUTZ-DCs
and further matured with MCM, TNFα and PGE2 for 2 days to obtain mMUTZ-DCs. HL-
60 cells were left untreated or stimulated with 0.1 µM PMA for 24 h and THP-1 cells
were left untreated or stimulated with 0.1 µM PMA and 500 U/ml IL-4 for 24 h. Cells
were seeded on fibronectin-coated coverslips and stained for vinculin (green) and actin
(red). HL-60, THP-1, MUTZ-3 and iMUTZ-DCs are poorly adherent cells that do not
develop specific adhesion structures. Monocytes, iDCs, but also stimulated HL-60 and
THP-1 cells are strongly adherent and develop podosomes that can be seen as vinculin
rings (green) surrounding actin dots (red). mDCs and mMUTZ-DCs show reduced
adherence accompanied by a loss of podosomes.
B. Podosome dissolution induced by PGE2. iDCs, HL-60 stimulated with PMA for 24 h
and THP-1 cells stimulated with PMA/IL-4 for 24 h were seeded on fibronectin and stim-
ulated with 10 µg/ml PGE2 for 5 min and stained for vinculin (green) and actin (red).
Podosomes that were present in these cells (panel A) rapidly dissolve in response to
stimulation, while the cells remain attached. This response is somewhat less pro-
nounced in the THP-1 cells.
MUTZ-DCs are poorly adhesive, even in the immature state, but sim-
ilar to DCs, MUTZ-DCs acquire a more migratory phenotype in
response to maturation (our own observations). Taken together these
results demonstrate, that THP-1 and HL-60 cells are useful models
to study podosome biogenesis and turnover, while MUTZ-3 cells
more accurately reflect the induction of high-speed migration that
occurs during DC maturation.
Culture and manipulation
In addition to closely resembling DCs, a good model cell line should
be easy to culture and readily transfectable. J774 and Raw264.7
cells are easy to culture cell lines, which can either be subjected to
retroviral transduction [72] or transfected with calcium phosphate [73,
74], DEAE dextran [24] or other transfection reagents such as lipo-
fectamine [75, 76]. D1 cells are dependent on conditioned medium
[20] and need to be maintained under carefully controlled conditions
in order to prevent loss of their specific DC-like features. Although
retroviral transduction of D1 cells has been reported [77], to date,
successful transfection of these cells has not been established. 
As for human DC models, MUTZ-3 cells are dependent on the addi-
tion of conditioned medium and these cells need to be cultured and
differentiated towards MUTZ-DCs under carefully defined culture
conditions. The differentiation of MUTZ-3 cells is as time consuming
and expensive as differentiation of DCs from peripheral blood
mononuclear cells or monocytes. By contrast, THP-1 and HL-60 cells
are easy to culture suspension cells. Furthermore, induction of a DC-
morphology in THP-1 or HL-60 cells is less time consuming and does
not require the use of expensive cytokines. All three human cell lines
can be efficiently tranduced with retroviral vectors [38, 78]. There are
some reports were THP-1 or HL-60 cells are transfected by electro-
poration [79], however the transfection efficiency is low. MUTZ-3
cells can be transfected with low efficiency using Amaxa nucleofec-
tion but this is associated with significant cell death (our own obser-
vations). 
Conclusions and perspectives
It can be concluded that we have yet to find the perfect DC-model,
as none of the cell lines described here completely mirrors all cell
biological/immunological aspects of DCs. Strengths and weaknesses
of each of the particular model cell lines are summarized in Table 3.
In the mouse setting, D1 cells most closely resemble primary DCs,
however culture conditions and poor transfectability of these cells
stand in the way of large-scale biochemical experiments. For those
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types of experiments, Raw 264.7 cells may be a more suitable
model.
In the human setting THP-1 and HL-60 cells are robust cell lines that
can be used when large numbers of cells are needed, or when the
focus is on studying podosome formation or turnover. However, while
both THP-1 and HL-60 cells mimic some aspects of iDC-biology,
MUTZ-3 cells are the only model cell line suitable for investigating
mDC-function, although the need to carefully control culture condi-
tions is a complicating factor. With the exception of strong adhesion
and podosome formation in the immature state, MUTZ-3 derived
DCs most closely resemble primary DCs. Particularly when it comes
to immunological experiments involving antigen presentation and T
cell stimulation, these cells are the system of choice. 
In spite of their limitations, a number of DC model cell lines can be
successfully used to study important aspects of DC biology in vitro.
We believe that such in vitro approaches will continue to be impor-
tant, as poor transfectability and donor to donor variations preclude
the use of primary cells in some experiments. We expect that the
proper use of DC model cell lines may help reveal important new
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Table 3. Overview of DC-functions displayed by D1, J774, Raw264.7, HL-60, MUTZ-3
and THP-1 cells. 1; upon PMA stimulation, 2; upon PMA/IL-4 stimulation, 3; upon
Me2SO stimulation, 4; upon RANKL stimulation, 5; upon IL4/GM-CSF stimulation (and
maturation) and 6; upon LPS or phosphatidic acid stimulation. ++; very good, +; good
and -; poor. Sup R1: supernatant of R1 cells needed, sup 5637: supernatant of 5637
cells needed
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+
+
+
+
+
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migration
antigen presen-
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transfectable
easy to culture
THP-1HL-60Raw264.7 MUTZ-3J774D1
HumanMouse
insights into DC biology that can subsequently be applied to improve
application of DCs in the clinic.
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Abstract
Dendritic cells (DCs) are professional antigen presenting cells of the
immune system that play a key role in regulating T cell-based immu-
nity. The capacity of DCs to activate T cells depends on their matu-
ration state as well as their ability to migrate to the T cell areas of
draining lymph nodes. Here we investigated the effects of DC matu-
ration stimuli on the actin cytoskeleton and β1-integrin-dependent
adhesion and migration. Podosomes, specialized adhesion struc-
tures found in immature DCs, rapidly dissolve in response to matu-
ration stimuli such as TNFα and PGE2, whereas the TLR agonist
LPS induce podosome dissolution only after a long lag time. We
demonstrate that LPS-mediated podosome disassembly as well as
the onset of high-speed DC migration is dependent on the production
of prostaglandins by the DCs. Moreover, both of these processes are
inhibited by Ab-induced activation of β1-integrins. Together, these
results show that maturation-induced podosome dissolution and loss
of α5β1-integrin activity allow human DCs to undergo the transition
from an adhesive to a highly migratory phenotype.
Introduction
Dendritic cells (DCs) are the most potent antigen presenting cells of
the immune system [1]. Upon antigen uptake and exposure to
inflammatory stimuli these cells undergo a remarkable transition from
a tissue resident, endocytic cell type to a highly migratory antigen
presenting cell type, a process known as DC maturation [1, 2]. This
phenotypical conversion not only involves up-regulation of MHC and
costimulatory molecules, but is also accompanied by extensive
changes in cytoskeletal organization and cell adhesion [3-6]. 
The ability of DCs to migrate is essential for the induction of immune
responses. Upon antigen recognition and exposure to inflammatory
signals, DCs migrate out of the tissues, via the blood or lymph ves-
sels into the lymph nodes, were they activate T cells. We recently
demonstrated both in preclinical mouse-models [7] and in human
cancer patients [3], that DC-vaccine efficacy directly correlates with
DC maturation and the capacity of these cells to migrate into the
lymph nodes. The migration of mature DCs (mDCs) can be defined
as high-speed migration [8], comparable to the migration of T cells
[9]. This type of migration is characterized by short lived and low
affinity interactions with the substrate. Immature DCs (iDCs), on the
other hand, show an adhesive and low-speed migratory behavior
which is dependent on strong interactions with the extracellular
matrix (ECM), similar to fibroblasts [8]. β1-integrins are the main
adhesion molecules responsible for these DC-ECM interactions [10,
42
11]. Although the fibronectin binding integrins α4β1 and α5β1 are
both expressed by DCs, we and others have shown that adhesion of
DCs to fibronectin is predominantly α5β1 mediated [3, 12, 13]. In
their high affinity state, integrins form multimeric complexes in the
plasma membrane that enhance binding to the ECM. The integrin
cytoplasmic domains in turn recruit a large number of structural and
signaling proteins into higher order complexes that connect integrins
to the actomyosin cytoskeleton. In most cells, such adhesive con-
tacts are known as focal adhesions [14]. However, cells of myeloid
origin, such as macrophages, osteoclasts and DCs, form adhesion
complexes distinct from focal adhesions, known as podosomes [15].
Unlike focal adhesions, podosomes are not linked to contractile actin
stress fibers but rather consist of an actin-dense core surrounded by
a ring of cytoskeletal proteins [16, 17]. 
Although a large variety of stimuli, including cytokines, CD40 ligation
or TLR ligands induce DC maturation [18-20], these stimuli not
always bring out all the characteristics mDCs need to fulfill their func-
tion [21]. Particularly migration appears to be insufficiently developed
in response to some stimuli. In order to effectively manipulate DC
migration in clinical applications, a more detailed knowledge of how
maturation factors mobilize DCs is needed. Here we investigated the
effects of different maturation stimuli on cell adhesion and migration
in DCs. We find that high-speed DC migration, induced by maturation
signals, requires dissolution of podosomes as well as loss of β1-inte-
grin activity. In the presence of a β1-activating Ab, both podosome
dissolution and cell migration are effectively inhibited. Moreover, we
demonstrate that prostaglandins such as PGE2, produced by DCs
during maturation, mediate podosome disassembly as well as the
onset of high-speed migration.
Results
Induction of high-speed migration in response to DC matura-
tion stimuli
The ability of DCs to migrate is essential for the efficient induction of
T cell responses.
In earlier work, we have shown that the capacity of DCs to migrate
on fibronectin in vitro, correlates well with their migratory behavior in
vivo [3]. Consistent with these previous findings, the majority of the
iDCs were slowly migrating with a mean speed of 0.5 ± 0.1 µm/min
(Figure 1A). In contrast, DCs matured with a maturation cocktail
(MCM, PGE2, TNFα), routinely used in clinical applications [3, 22],
were highly migratory, showing random migration at a mean speed of
PGE2 in DC maturation
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5 ± 0.5 µm/min (Figure 1B). The effects of maturation on cell migra-
tion were noticeable after 16 h of stimulation whereas a full migrato-
ry capacity was obtained after 24 h of stimulation (Figure 1C). 
The activity of α5β1-integrin is down-regulated during DC mat-
uration
DC maturation is associated with a significant loss in adhesion to
fibronectin [3]. The expression of active β1, as determined by an Ab
(12G10) which exclusively recognizes the active conformation of this
integrin [23], was almost completely absent on mDCs. At the same
time, expression levels of β1-integrins were unaffected during matu-
ration (Fig 2A). These data suggest that the regulation of β1-integrin
activity, rather than expression, controls DC adhesion. More impor-
tantly, adhesion of mDCs to fibronectin could be completely restored
using a β1-activating Ab (TS2/16), while the adhesion of iDCs could
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Figure 1: mDCs migrate on fibronectin and migration is initiated after 16 to 24 h. (A/B)
Immature and mature DCs were added to fibronectin-coated plates and monitored for
60 min. Plots of 50 individual tracks, aligned at their starting positions, are shown. The
mean speed ±SEM (µm/min) is depicted in the upper right corner as well as the per-
centage of migrating cells ±SD. (C) DCs were incubated for different time periods (0, 5,
16, 24, 41, and 48 h) with a combination of MCM, PGE2 and TNFα, added to fibronectin-
coated plates and migration was monitored for 60 min. The percentage of migrating
cells ±SD is depicted. Significant differences (p<0.05) compared to the percentage of
migrating DCs after 48 h of maturation are indicated by an asterisk.
not be further enhanced (Fig 2B). Ab-induced adhesion was still
α5β1 mediated, since an α5-blocking Ab (SAM-1) effectively inter-
fered with this interaction (Fig 2B). These data demonstrate that,
while the α5β1-integrin expressed on mDCs is still capable of medi-
ating adhesion to fibronectin, its activity is specifically down-regulat-
ed during DC maturation. 
Immature DCs display podosomes enriched in active β1-inte-
grin
The dramatic changes in cell adhesion and migration, as they occur
during DC maturation, are also reflected in the morphology and
cytoskeletal organization of these cells. When plated on fibronectin,
iDCs exhibit extensive cell spreading accompanied by the formation
of numerous podosomes (Fig 3A, upper panel). In sharp contrast,
mDCs were much less spread and no longer carry podosomes (Fig
3A, lower panel). Importantly, both the β1- and α5-chain of the
fibronectin-binding α5β1-integrin were present in podosomes and the
active form of the β1-integrin, as detected with the 12G10 Ab, was
PGE2 in DC maturation
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Figure 2: Active β1-integrin is down-regulat-
ed upon maturation. 
(A) Active β1-integrin expression on DCs
decreases upon maturation. Immature DCs
and mDCs were stained using monoclonal
antibodies recognizing β1-integrin (AIIB2) or
a specific activation epitope of the β1-inte-
grin (12G10). Expression was determined
by flow cytometry. Open graphs represent
isotype controls. (B) Adhesion of mDCs to
fibronectin can be enhanced by Ab-induced
activation of β1-integrins. Calcein-AM-
labeled iDCs and mDCs were added with or
without preincubation with a blocking Ab
against α5-integrin (SAM-1) to fibronectin-
coated plates, and incubated in the pres-
ence or absence of an anti-β1-integrin acti-
vating Ab (TS2/16). Cells were lysed and the
fluorescence was quantified using a cytoflu-
ometer. Results are depicted as the mean
percentage of adhesion of triplicate wells
SD. Adhesion of iDCs and mDCs incubated
with SAM-1 before and after activation with
TS2/16 is significantly decreased in compar-
ison to non-treated control cells. Adhesion of
mDCs using TS2/16 is significantly
increased in comparison to adhesion of
mDCs without a β1-integrin activating Ab
(p<0.05). 
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highly enriched in podosomes (Figure 3B). These results indicate
that adhesion of iDCs to fibronectin is mediated by active α5β1-inte-
grin molecules present in these podosomes.
DC maturation signals induce rapid disassembly of
podosomes 
Since DC maturation leads to dramatic changes in adhesive behav-
ior and migration, we explored the effect of maturation-inducing fac-
tors on the actin cytoskeleton. In the immature state most DCs dis-
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Figure 3: Immature DCs form podosomes enriched in active α5β1-integrin. 
(A) Immature DCs form podosomes on fibronectin. Immature and mature DCs were
plated on fibronectin-coated coverslips and stained with an anti-vinculin Ab (green) and
phalloidin-Texas Red (red) to detect F-actin. In the lower right corner of the overlay of
iDCs a higher magnification of part of the image is shown. (B) Active β1-integrin is
enriched in podosomes in iDCs. Immature DCs seeded on fibronectin-coated coverslips
were stained with monoclonal antibodies against α5- (SAM-1), β1- (AIIB2), and active
β 1-integrin (12G10) (green). F-actin was detected using phalloidin-Texas Red (Red).
played podosomes. However, in most cells, podosomes were lost
within 5-10 min in response to either the maturation cocktail or PGE2
alone, while stimulation with TNFα induced podosome dissolution in
PGE2 in DC maturation
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Figure 4: Rapid dissolution of podosomes in DCs in response to maturation stimuli.
Immature DCs were seeded on fibronectin-coated coverslips and stimulated for differ-
ent periods with maturation stimuli. Subsequently, the cells were stained with an anti-
vinculin Ab (green) and phalloidin-Texas Red to stain F-actin (red). (A) Immature DCs
were left untreated or stimulated for 5 min or 16 h with a combination of MCM, PGE2
and TNFα. Representative images are depicted. (B) Immature DCs were either left
untreated or stimulated for 5 min or 16 h with a combination of MCM, PGE2 and TNFα
, MCM alone, TNFα alone, PGE2 alone or LPS. The number of cells containing
podosomes was counted in 7 images per condition per experiment. The percentage of
cells expressing podosomes ±SEM is depicted. An average of 3 experiments is shown.
Conditions that are significantly different from the control situation (p<0.05) are indicat-
ed with an asterisk. (C) Immature DCs were transfected with βactinGFP, seeded on
fibronectin and imaged for 60 min prior to and 20 min after the addition of TNFα with a
30 second interval or for 20 min with a 20 second interval without PGE2 and 17 min with
a 10 second interval with PGE2.  Fluorescent images were taken at different time points
after TNFα addition (upper panel) and after PGE2 addition (lower panel)(see also
Supplementary video 1 and Supplementary video 2). 
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a subset of the DCs (Figure 4A and 4B). Prolonged stimulation did
not further affect the number of cells displaying podosomes (Figure
4B). A moderate effect of MCM on podosome dissolution was
observed after prolonged stimulation (16 h). These results identify
PGE2 as the most active component in the maturation cocktail. A
concentration of 10 µg/ml PGE2, which is routinely used in the matu-
ration cocktail, was the lowest concentration to induce efficient
podosome dissolution (Figure 5). Surprisingly, LPS, a TLR ligand and
potent DC maturation factor, failed to induce podosome dissolution
after 5-10 min, while prolonged stimulation resulted in a nearly com-
plete loss of podosomes (Figure 4B). These findings demonstrate
that, while most maturation stimuli tested induce dissolution of
podosomes, the extent to which this occurs as well as timing differs
between agonists. To examine the kinetics of podosome dissolution
in response to maturation stimuli, we expressed a β-actinGFP con-
struct in iDCs and performed live cell imaging. We observed a rapid
turnover of individual podosomes in iDCs expressing β-actinGFP
(lifetime of individual podosomes was less than 10 min), while the
total number of podosomes remained relatively constant (Figure 6).
Addition of PGE2 or TNFα to iDCs caused a rapid and complete dis-
solution of podosomes within minutes after stimulation (Figure 4C
and movie 1 and 2). Together our results show that podosomes in
DCs are highly dynamic and that podosome dissolution is a first
effect of DC maturation. 
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Figure 5: PGE2 is able to mediate complete
podosome dissolution at a concentration of 10
µg/ml. 
Immature DCs were seeded on fibronectin-coated
coverslips and left untreated (control) or stimulated
for 5 min or 16 h with different concentrations of
PGE2. Subsequently, the cells were stained with an
anti-vinculin Ab and phalloidin-Texas Red to stain F-
actin. The number of cells containing podosomes
was counted in 7 images per condition. The per-
centage of cells expressing podosomes ±SEM is
depicted.  One representative experiment is shown.
Conditions that are different from the control situa-
tion (p< 0.05) are indicated with an asterisk.
Figure 6: The lifetime of individual podosomes is
less than 10 minutes. 
The lifetime of individual podosomes in unstimulat-
ed cells was determined by counting in how many
frames individual podosome are observed
(Supplementary video 2). The lifetime of 50
podosomes was determined and the distribution of
podosome lifetimes is depicted.  
Activation of β1-integrins interferes with podosome dissolu-
tion and high-speed migration
We have shown that β1-integrins are prominently present in
podosomes and DC maturation is initiated by a loss of these adhe-
sion sites, as well as a global decrease in β1-integrin activity.
Therefore we examined if and how stimulation of β1-integrin activity
using a β1-integrin activating Ab (TS2/16) affects cytoskeletal
changes and the onset of high-speed migration in response to DC
maturation. Stimulation with TS2/16 effectively interfered with PGE2-
induced podosome dissolution (Fig 7A) as well as the induction of
rapid migration after prolonged incubation (Fig 7B). These results
demonstrate that loss of α5β1-integrin activity during DC maturation
is key to the induction of high-speed migration.
PGE2 in DC maturation
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Figure 7: Podosomes dissolution and migration can be inhibited by activating α5β1-inte-
grin. 
(A/B) Podosome dissolution in response to PGE2 can be blocked by activation of α5β1-
integrin. Immature DCs (control) were seeded on fibronectin-coated coverslips and left
untreated or stimulated 5 minutes or 16 h with PGE2, PGE2 with the β1-integrin activat-
ing Ab (TS2/16) or with TS2/16 alone. Subsequently, the cells were stained with phal-
loidin-Texas Red to stain F-actin. The anti-vinculin Ab could not be used since it has the
same isotype as the TS2/16 Ab used to activate β1-integrins. (A) Representative
images of unstimulated DCs or cells stimulated for 16 h with 10 µg/ml PGE2 in the pres-
ence or absence of TS2/16 Ab are shown. (B) The number of cells containing
podosomes was counted in 7 images per condition. The percentage of cells expressing
podosomes ±SEM is depicted. A representative experiment is shown. Conditions that
are significantly different from the control situation (p<0.05) are indicated with an aster-
isk. (C) PGE2-induced migration is inhibited by activating α5β1-integrin. Immature DCs
(control) or DCs matured with PGE2 with or without TS2/16 were added to fibronectin-
coated plates and migration was monitored for 60 min. A representative experiment is
shown. The percentage of migrating cells ±SD is depicted. Significant differences
(p<0.05) are indicated with an asterisk.
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LPS induced podosome dissolution and high-speed migration
are dependent on the production of prostaglandins
The disassembly of podosomes in response to LPS occurs with a lag
phase of 16 h (Figure 4B) and therefore cannot be a direct conse-
quence of TLR activation. We investigated whether podosome dis-
solution induced by LPS involves production of PGE2 by the DCs.
Therefore, iDCs were seeded on fibronectin and stimulated with LPS
for 16 h, either in the presence or absence of indomethacin. This
drug inhibits the production of PGE2 and other PGs by inhibiting
cyclooxygenases, enzymes involved in the production of PGs [24].
Indeed, an effective inhibition of LPS-induced podosome dissolution
was observed in the presence of indomethacin (Figure 8A and 8B).
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Figure 8: LPS induced podosome disassembly and migration are mediated by
prostaglandins. 
(A/B) LPS mediated podosome dissolution is PG mediated. Immature DCs were seed-
ed on fibronectin-coated coverslips and left untreated or stimulated for 16 h with LPS in
the presence or absence of indomethacin. Subsequently, cells were stained with an
anti-vinculin Ab (green) and phalloidin-Texas Red to stain F-actin (red). (A)
Representative images of DCs either unstimulated (control) or stimulated for 16 h with
2 µg/ml LPS in the presence or absence of 50 µM indomethacin. (B) Immature DCs
were left unstimulated (control) or stimulated with 2 µg/ml LPS with or without
indomethacin (10 µM) or with only indomethacin. The number of cells containing
podosomes was counted in 7 images per condition per experiment. The percentage of
cells expressing podosomes ±SEM is depicted. Significant differences (p<0.05) are indi-
cated by an asterisk. An average of 3 experiments is shown. (C) Migration of LPS-
matured DCs is blocked by indomethacin. DCs were matured with 2 µg/ml LPS with or
without indomethacin (50 µM). During maturation indomethacin was refreshed every 12
h. Immature (control) and mature DCs were added to fibronectin-coated plates and
migration with or without indomethacin was monitored for 60 min. The percentage of
migrating cells ±SD is depicted. Significant differences (p<0.05) are indicated by an
asterisk. 
In the absence of LPS, no effect of indomethacin on podosomes was
seen. Similarly we observed that indomethacin affects the migratory
capacity of LPS-matured DCs (Figure 8C). These results identify
PGs, such as PGE2, as important mediators of maturation-induced
DC migration.
PGE2 and LPS induce podosome dissolution in myeloid DCs
To examine whether our findings also apply to DCs generated ex
vivo, human myeloid DCs were isolated from peripheral blood by
magnetic sorting of CD1c-positive/CD19-negative cells (Figure 9A).
These myeloid DCs, although much smaller than the monocyte-
derived DCs, similarly formed podosomes on fibronectin, which rap-
idly dissolved in response to PGE2 stimulation (Figure 9B and 9C).
Furthermore, PGE2-induced podosome dissolution was efficiently
PGE2 in DC maturation
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Figure 9: Podosome dissolution in myeloid DCs. 
(A) Myeloid DCs (CD1c/BDCA positive cells) were isolated from PBMCs. The obtained
myeloid DCs were analyzed by flow cytometry. These myeloid DCs were 99% pure
(CD19-CD1c+), express high levels of CD11c and a subset of these myeloid DCs
express CD14. (B) Myeloid DCs were seeded on fibronectin-coated coverslips and stim-
ulated with PGE2 for 5 min. Subsequently, the cells were stained with an anti-vinculin
Ab (green) and phalloidin-Texas Red to stain F-actin (red). Representative images are
depicted. (C) Myeloid DCs were seeded on fibronectin-coated coverslips and stimulat-
ed with PGE2 for 5 min in the presence or absence of TS2/16 Ab. Subsequently, the
cells were stained with phalloidin-Texas Red to stain F-actin (red). The number of cells
containing podosomes was counted in 15 images per condition. The percentage of cells
expressing podosomes ±SEM is depicted. Conditions that are significantly different
(p<0.05) are indicated with an asterisk. (D) Myeloid DCs were seeded on fibronectin-
coated coverslips and stimulated with LPS in the presence or absence of indomethacin.
Subsequently, the cells were stained with an anti-vinculin Ab (green) and phalloidin-
Texas Red to stain F-actin (red). The number of cells containing podosomes was count-
ed in 7 images per condition. The percentage of cells expressing podosomes ±SEM is
depicted. Conditions that are significantly different (p<0.05) are indicated with an aster-
isk. One representative experiment is shown.
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blocked by stimulation with the β1-integrin activating Ab TS2/16
(Figure 9C), while stimulation with TS2/16 without PGE2 had no
effect on podosomes. We also investigated the effect of LPS on
podosome dissolution in these myeloid DCs. Similar to monocyte-
derived DCs, no immediate effects of LPS on podosome dissolution
were observed, wereas a complete loss of podosomes was seen
after 16 h stimulation with LPS (Figure 9D). Again, LPS-induced
podosome dissolution was effectively inhibited in the presence of
indomethacin (Fig 9D). These results indicate that both in monocyte-
derived DCs as well as myeloid DCs, the effects of LPS on
podosome dissolution are dependent on the production of PGs by
the DCs.
Movies can be found at http://www.ncmls.eu/NCMLS/Visual
/movie.asp
Discussion 
In this paper we report how maturation-induced podosome dissolu-
tion and loss of α5β1-integrin activity allow DCs to switch from a
strongly adhesive to a highly migratory phenotype. Although a sub-
stantial amount of reports describe the biogenesis of podosomes in
different cell types [17, 25] mechanisms responsible for podosome
disassembly have remained elusive. Consistent with earlier findings
in osteoclasts [26], we show that these structures are very dynamic.
Although podosomes are generally considered to be features of
migratory cells [25, 27], we find a strong inverse correlation between
the presence of podosomes and DC migratory capacity. This appar-
ent discrepancy can be easily explained by the fundamental differ-
ences in the way immature and mature DCs interact with the sub-
strate to produce migration. While iDCs display very strong mem-
brane protrusive activity, as indicated by the presence of lamellipodia
and membrane ruffles, strong interactions with the substrate (i.e.
podosomes) only allow low-speed migration (0.5 µm/min). Mature
DCs display short-lived, weak interactions with the substrate result-
ing in high-speed migration, similar to the migration of T cells [9].
Consistent with the notion that podosomes restrict high-speed migra-
tion, we observed that the active form of the α5β1-integrin is enriched
in these structures. Moreover, DC maturation is accompanied by a
nearly complete loss of α5β1-integrin mediated adhesion as well as
dissolution of podosomes. As a consequence, mDCs show migration
speeds that are 10-fold higher (5 µm/min) than those observed in
iDCs. We also show that loss of fibronectin binding, as it occurs dur-
ing DC maturation, is due to loss of α5β1-integrin activity rather than
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expression. Furthermore, activation of the α5β1-integrin, using an
activating Ab, prevents podosome disassembly and restricts high-
speed migration in mDCs. Although preinbucation with this integrin-
activating Ab effectively inhibits podosome disassembly, the Ab failed
to induce new podosomes in fully mature DCs (data not shown). This
suggests that, although down-regulation of integrin activity during DC
maturation is important for the induction of high-speed migration, α5
β1-integrin activation cannot fully reverse the effects of DC matura-
tion on the cytoskeleton. While there are many examples where inte-
grin activation of leukocytes triggers the induction of cell migration
[28-30], we show here that down-regulation of integrin activity may
be equally important. Similarly, the importance of integrin de-activa-
tion in the induction of cell migration was recently demonstrated for
αLβ2-integrin (LFA-1). Mice expressing a constitutively active variant
of LFA-1 showed defective cell migration and compromised immune
function due to impaired de-adhesion from its ligand ICAM-1 [31].
A maturation cocktail, consisting of MCM, PGE2 and TNFα, was used
to induce DC maturation. This combination effectively induces all
aspects of DC maturation and is used in clinical DC-vaccination stud-
ies [22, 32]. Here we show that PGE2 is an essential component in
the induction of full migratory capacity by this cytokine cocktail. DCs
matured in the presence of PGE2 not only migrate more efficiently
than without, we also observed that PGE2 alone is sufficient to
induce DC migration. The importance of PGE2-mediated signaling in
DC migration and consequently the induction of a proper immune
response is also supported by mouse models. Mice deficient in EP4,
a PGE2 receptor, show impaired skin immune responses due to
impaired migration and maturation of Langerhans cells [33].
Moreover it was shown in human DCs that PGE2 enhances both the
expression and the sensitivity of CCR7 [34-36], the receptor for the
chemokines CCL19 and CCL21 that controls DC migration into lym-
phatic vessels and lymph nodes [37, 38]. Consistent with these find-
ings, preliminary results in two melanoma patients participating in a
DC-vaccination trial suggest that the percentage DCs that migrate to
the lymph nodes is higher when DCs are matured in the presence of
PGE2 (data not shown). These findings emphasize the importance of
PGE2 in promoting efficient DC maturation and migration, a prereq-
uisite for the induction of an efficient immune response in vivo. 
The effect of PGE2 on podosome dissolution is immediate, as well as
the partial effect of TNFα. This partial response may be due to a lack
of TNFα receptor expression in part of the DCs. In contrast, the
effects of LPS are only observed after a long lag time. Importantly,
LPS-induced podosome disassembly as well as the induction of
PGE2 in DC maturation
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high-speed migration can be efficiently inhibited by blocking the pro-
duction of PGs by the DCs. Furthermore, in response to LPS stimu-
lation DCs start to produce PGE2 after 6 h and this production is max-
imal after 24 h [39, 40], which coincides with the loss of podosomes
and the induction of migration. These results demonstrate that
pathogen-derived molecules, such as LPS, induce podosome disso-
lution and high-speed migration by stimulating the production of
PGE2 by DCs during an inflammatory response. 
Ex vivo myeloid DCs form podosomes on fibronectin similar to mono-
cyte-derived DCs. In addition, myeloid DCs also dissolve their
podosomes rapidly in response PGE2. Furthermore, this PGE2-
induced podosome dissolution can be inhibited by activating β1-inte-
grins, indicating that also in myeloid DCs regulation of the activity of
β1-integrins is important in adhesion and migration. Moreover, also in
myeloid DCs the LPS-induced podosome dissolution is depending
on PG production by the DCs. These findings indicate that ex vivo
DCs behave in the same way as the monocyte-derived DCs and fur-
ther emphasize the importance of PGE2 for the proper function of
DCs.
What could be the function of podosomes in iDCs? Podosomes are
found in cells that have the capacity to cross tissue boundaries. The
observation that podosomes are sites of active matrix degradation
[41, 42] and that matrix metalloproteinases are needed for
transendothelial migration of leukocytes [43], supports the idea that
podosomes are required for crossing tissue barriers. In osteoclasts
podosomes are involved in bone resorption and remodeling [44],
while in macrophages podosomes are considered regulators of cell
adhesion and migration [45]. In addition to a role during transmigra-
tion, podosomes in iDCs may contribute to the movement of iDCs
within peripheral tissues, while patrolling for antigens. 
Disassembly of podosomes observed in DCs upon stimulation with
maturation inducing agents is probably unique for DCs, and an inte-
gral part of the DC maturation process. In mouse DCs, West et al
have described increased antigen macropinocytosis leading to
enhanced antigen presentation on MHC class I and II molecules and
a simultaneous disappearance of podosomes in response to LPS [6].
The observed disappearance of podosomes was rapid and transient,
while we find that podosome dissolution in response to LPS is only
observed after prolonged stimulation. A transient disappearance of
podosomes could have gone unnoticed in our system, however after
5, 10, 15 min or 1 h stimulation with LPS no effect on podosomes
was observed. Therefore, it is likely that this difference is species
related similar to other processes [46]. Podosome dissolution during
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DC maturation may serve to redeploy actin and actin-binding or reg-
ulatory proteins to other processes in the cell that require high actin
turnover. Podosome biogenesis has been linked to lysosome exocy-
tosis and late endosomal/lysosomal proteins (p61Hck, CD63 and
LYAAT-1) localize to podosomes [47-49]. Therefore it has been put
forward that late endosomal vesicles fusing with the plasma mem-
brane contribute to podosome formation [49]. During podosome dis-
solution the opposite process could be taking place in order to fuel
increased vesicle transport as it occurs during DC maturation.
How does PGE2 induce podosome disassembly? The effects of
PGE2 on podosomes occur within minutes, which implies that these
are a direct consequence of PGE2 receptor activation rather than
changes in gene expression. Spatial and temporal regulation of acto-
myosin contractility was shown to be important for the assembly/dis-
assembly of focal adhesions and podosomes [25, 50]. Two receptors
for PGE2 (EP2/4) are expressed on DCs affecting DC migration [33,
34, 51]. Both these receptors couple to Gαs to increase cAMP levels,
leading to activation of protein kinase A [52]. Changes in activity reg-
ulate actomyosin contractility, either by affecting the activity of the
small GTPase RhoA, a key regulator of myosin II function, or by inac-
tivation of myosin light chain kinase (reviewed by Burridge et al and
references therein [53]). Future experiments will therefore be aimed
at determining how these signal transduction pathways contribute to
DC adhesion and migration.
Materials and methods
Chemicals and antibodies
The following antibodies were used: anti-HLA class I (W6/32), anti-
HLA-DR/DP (Q5/13), anti-CD80 (all from Becton Dickinson & Co.,
Franklin Lakes, NJ), anti-CD14 and anti-CD83 (both Beckman
Coulter, Mijdrecht, The Netherlands), anti-CD86 (Pharmingen, San
Diego, CA), anti-CD209/DC-SIGN (AZN-D1) [54], anti-β1-integrin
activating epitope (TS2/16) [55], anti-β1-integrin blocking epitope
(AIIB2) (Developmental Studies Hybridoma Bank, Iowa City, IA), anti-
β1-integrin recognizing an active conformation (12G10) [23] (kind gift
of M. Humphries, Manchester, UK), anti-α5-integrin (SAM-1), anti-
vinculin (Sigma, St. Louis, MO), mIgG1 (Becton Dickinson & Co.),
mIgG2a, mIgG2b, rIgG1 isotype (Pharmingen). Alexa Fluor 488-
labeled secondary antibodies were from Molecular Probes
(Molecular Probes, Leiden, The Netherlands) and FITC-labeled sec-
ondary antibodies from Zymed (Zymed, San Francisco, CA) and
Cappel (Cappel, MP Biomedicals, Irvine, CA). Texas Red-conjugated
PGE2 in DC maturation
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phalloidin (Molecular Probes) was used to stain F-actin.
Indomethacin was obtained from Sigma (Sigma). 
Preparation of DCs
DCs were generated from PBMCs as described previously [22, 56].
Monocytes were derived from buffy coats or from a leukapheresis
product. Plastic-adherent monocytes were cultured in X-VIVO 15
medium (BioWhittaker, Walkersville, MD) supplemented with 2%
pooled human serum (PAA laboratories, Linz, Austria), IL-4 (500
U/ml) and GM-CSF (800 U/ml) (both Schering-plough, International,
Kenilworth, NJ) [57] or in RPMI 1640 medium (Gibco; Life
Technologies, Breda, The Netherlands) supplemented with 10% (v/v)
FCS (Greiner, Kremsmuenster, Austria), IL-4 (500 U/ml) and GM-
CSF (800 U/ml) [18]. Immature DCs were harvested on day 7. DCs
were matured with LPS (2 µg/ml) (Sigma), rTNFα (75 ng/ml) (kind gift
of Dr. Adolf, Bender, Vienna, Austria) or a combination of monocyte-
conditioned medium (MCM) (50% v/v), rTNFα (10 ng/ml) and PGE2
(10 µg/ml) (Pharmacia & Upjohn, Puurs, Belgium), for 2 days. Mature
DCs were harvested on day 9. Expression of MHC class I/II, costim-
ulatory molecules and DC-specific markers on DCs were measured
by flow cytometry (data not shown) and the expression of MHC mol-
ecules, costimulatory molecules and DC-markers was similar to what
was described before [3]. Immature DCs expressed MHC class I and
II, the costimulatory molecule CD86, the DC-specific marker
CD209/DC-SIGN, low levels of the costimulatory molecule CD80 and
lacked expression of the maturation marker CD83. Maturation result-
ed in the induction of CD83, up-regulation of MHC class I and II,
CD86 and CD80 and a down modulation of CD209/DC-SIGN expres-
sion. 
Isolation of myeloid DCs
Myeloid DCs (CD19-CD1c+) were isolated from PBMCs derived from
buffy coats. PBMCs were labeled with a FITC conjugated mAb to
CD3 (Dako, Glostrup, Denmark) and T cells and B cells were deplet-
ed with anti-FITC and anti-CD19 beads (both Miltenyi Biotec,
Bergisch Gladbach, Germany). Myeloid DCs were then isolated from
the CD3-CD19- cells using a biotinylated anti-CD1c (BDCA-1) Ab
and anti-biotin beads (both Miltenyi Biotec) following the manufactur-
er's instructions. To assess purity, isolated cells were labeled with
streptavidinCy5 (Jackson Immunoresearch, Cambridgeshire, UK)
and a PE-conjugated anti-CD19Ab (Miltenyi Biotec), PE-conjugated
anti-CD14 (Beckman Coulter) or anti-CD11c (Becton Dickinson &
Co.) Abs. Myeloid DCs were identified as cells that expressed CD1c
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and CD11c but were negative for CD19. Myeloid were up to 99%
pure and 0.3% of the PBMCs were myeloid DCs.
Flow cytometry
Cells (1 x 105) were incubated with 2% (v/v) human serum in PBA
(PBS containing 1% (w/v) BSA and 0.05% (w/v) NaN3) for 15 min at
4°C. After washing with cold PBA the cells were incubated with pri-
mary Ab (5 µg/ml) for 30 min at 4°C. Subsequently, the cells were
incubated with FITC-labeled goat anti-mouse. Cells were washed
and resuspended in 100 µl PBA. Fluorescence was measured using
a FACSCalibur™ with CellQuest software (Becton Dickinson & Co.).
Fluorescence microscopy
Coverslips were coated with fibronectin (20 µg/ml) (Roche,
Mannheim, Germany) in PBS for 1 hour at 37°C. Cells were seeded
on fibronectin-coated coverslips, left to adhere for 1 to 12 h and fixed
in 3.7% (w/v) formaldehyde in PBS for 10 min. Cells were permeabi-
lized in 0.1% (v/v) Triton X-100 in PBS for 5 min and blocked with 2%
(w/v) BSA in PBS. The cells were incubated with primary Ab for 1 h.
Subsequently the cells were incubated with Alexa Fluor 488-labeled
secondary antibodies for 45 min. Subsequently, cells were incubated
with Texas Red-conjugated Phalloidin for 30 min. Images were col-
lected on a Leica DMRA fluorescence microscope with a 63x PL APO
1.3 NA oil immersion lens (or a 40x PL FLUOTAR 1.0 NA oil immer-
sion lens for overview images) and a COHU high performance inte-
grating CCD camera (COHU, San Diego, CA). Pictures were ana-
lyzed with Leica Qfluoro version V1.2.0 (Leica) and Adobe
Photoshop 7.0 (Adobe Systems, Mountain View, CA) software.
Migration assay
96-wells flat bottom plates (Costar, Corning, Acton, MA) were coated
with fibronectin, washed and blocked with 0.01% (w/v) gelatin
(Sigma) in PBS for 30 min at 37°C. Per well, 3 x 103 cells were added
and mineral oil was pipetted on top of the medium to prevent pH
changes and evaporation of the medium. The cells were monitored
with a previously described migration system [58]. Cells were record-
ed for 1 h followed by analysis of individual cells. The speed was
defined as traversed path during the entire experiment divided by the
imaging time.
Adhesion assay
96-wells flat bottom plates (Costar) were coated with fibronectin and
blocked with gelatin. Cells (7x 106/ml) were labeled with Calcein-AM
PGE2 in DC maturation
57
Chapter 3
(25 µg/ml) in PBS (Molecular Probes) for 30 min at 37°C, either
untreated or preincubated for 10 min at RT with blocking Ab (10
µg/ml), and seeded on the fibronectin-coated plates (3 x 104/well) for
45 min at 37°C in the presence or absence of activating Ab (1 µg/ml).
Non-adherent cells were removed by washing with 0.5% (w/v) BSA
in TSM (150 mM NaCl, 10 mM Tris/HCl, 2mM MgCl2, 1 mM CaCl2,
pH 8.0) at 37°C. Adherent cells were lysed in 100 µl lysisbuffer (50
mM Tris, 0.1% (w/v) SDS) and fluorescence was quantified using a
cytofluometer (PerSeptive Biosystems, Framingham, MA). Results
are expressed as the mean percentage of adhesion of triplicate
wells.
Transfection and live imaging of DCs
DCs (3 x 106) were electroporated with pCMV-β-actinGFP on day 5
using Amaxa nucleofection (Amaxa biosystems, Cologne, Germany).
Transfected DCs were seeded on fibronectin-coated Willco glass
bottom dishes (Willco Wells BV, Amsterdam, The Netherlands). Cells
were imaged at 37°C in RPMI 1640 without phenol red (Gibco) sup-
plemented with 10% (v/v) FCS using a Zeiss LSM 510-meta micro-
scope equipped with a type S heated stage CO2 controller and
PlanApochromatic 63x 1.4 NA oil immersion DIC lens (Carl Zeiss
GmbH, Jena, Germany). Podosomes were imaged for 20 min with
20-second intervals without PGE2 and for 17 min with 10-second
intervals with PGE2 (10 µg/ml). In addition, podosomes were imaged
for 60 min without TNFα, and 20 min in the presence of TNFα (75
ng/ml) at 30-second intervals. Cells were imaged using Zeiss LSM
Image Browser version 32 (Carl Zeiss) and images were processed
with Image J version 1.32j software (National Institutes of Health,
http://rsb.info.nih.gov/ij).
Statistical analysis
An ANOVA test or a two-tailed student-t test was used for statistical
analysis.
Acknowledgements
We thank M. Humphries for providing the 12G10 Ab. We thank F. de
Lange from the Microscopic Imaging Center of the NCMLS and B.
Joosten for assistance with microscopic imaging. We thank I. de
Vries, N. Meeuwsen-Scharenborg, A. de Boer, M. Brouwer and M.
van de Rakt for providing DCs. This study was supported by research
58
funding from the Foundation for Fundamental Research on Matter
(FOM01FB06-01) and the national research council (NWO901-10-
092).
References
PGE2 in DC maturation
59
1. Banchereau, J. and R.M. Steinman, Dendritic
cells and the control of immunity. Nature,
1998. 392(6673): p. 245-52.
2. Steinman, R.M., The dendritic cell system
and its role in immunogenicity. Annu Rev
Immunol, 1991. 9: p. 271-96.
3. De Vries, I.J., et al., Effective migration of
antigen-pulsed dendritic cells to lymph nodes
in melanoma patients is determined by their
maturation state. Cancer Res, 2003. 63(1): p.
12-7.
4. Sallusto, F. and A. Lanzavecchia,
Understanding dendritic cell and T-lympho-
cyte traffic through the analysis of chemokine
receptor expression. Immunol Rev, 2000.
177: p. 134-40.
5. Gunzer, M., et al., Migration of dendritic cells
within 3-D collagen lattices is dependent on
tissue origin, state of maturation, and matrix
structure and is maintained by proinflamma-
tory cytokines. J Leukoc Biol, 2000. 67(5): p.
622-9.
6. West, M.A., et al., Enhanced dendritic cell
antigen capture via toll-like receptor-induced
actin remodeling. Science, 2004. 305(5687):
p. 1153-7.
7. Eggert, A.A., et al., Analysis of dendritic cell
trafficking using EGFP-transgenic mice.
Immunol Lett, 2003. 89(1): p. 17-24.
8. Friedl, P. and K. Wolf, Proteolytic and non-
proteolytic migration of tumour cells and leu-
cocytes. Biochem Soc Symp, 2003(70): p.
277-85.
9. Wolf, K., et al., Amoeboid shape change and
contact guidance: T-lymphocyte crawling
through fibrillar collagen is independent of
matrix remodeling by MMPs and other pro-
teases. Blood, 2003. 102(9): p. 3262-9.
10. Mould, A.P., et al., Defining the topology of
integrin alpha5beta1-fibronectin interactions
using inhibitory anti-alpha5 and anti-beta1
monoclonal antibodies. Evidence that the
synergy sequence of fibronectin is recog-
nized by the amino-terminal repeats of the
alpha5 subunit. J Biol Chem, 1997. 272(28):
p. 17283-92.
11. Garcia, A.J., J.E. Schwarzbauer, and D.
Boettiger, Distinct activation states of
alpha5beta1 integrin show differential binding
to RGD and synergy domains of fibronectin.
Biochemistry, 2002. 41(29): p. 9063-9.
12. D'Amico, G., et al., Adhesion, transendothelial
migration, and reverse transmigration of in
vitro cultured dendritic cells. Blood, 1998.
92(1): p. 207-14.
13. Jancic, C., et al., Interactions of dendritic cells
with fibronectin and endothelial cells.
Immunology, 1998. 95(2): p. 283-90.
14. Petit, V. and J.P. Thiery, Focal adhesions:
structure and dynamics. Biol Cell, 2000.
92(7): p. 477-94.
15. Linder, S., et al., Microtubule-dependent for-
mation of podosomal adhesion structures in
primary human macrophages. J Cell Sci,
2000. 113 Pt 23: p. 4165-76.
16. Zamir, E., et al., Dynamics and segregation of
cell-matrix adhesions in cultured fibroblasts.
Nat Cell Biol, 2000. 2(4): p. 191-6.
17. Buccione, R., J.D. Orth, and M.A. McNiven,
Foot and mouth: podosomes, invadopodia
and circular dorsal ruffles. Nat Rev Mol Cell
Biol, 2004. 5(8): p. 647-57.
18. Sallusto, F. and A. Lanzavecchia, Efficient
presentation of soluble antigen by cultured
human dendritic cells is maintained by granu-
locyte/macrophage colony-stimulating factor
plus interleukin 4 and downregulated by
tumor necrosis factor alpha. J Exp Med,
1994. 179(4): p. 1109-18.
19. Romani, N., et al., Generation of mature den-
dritic cells from human blood. An improved
method with special regard to clinical applica-
bility. J Immunol Methods, 1996. 196(2): p.
137-51.
20. Zhou, L.J. and T.F. Tedder, CD14+ blood
monocytes can differentiate into functionally
mature CD83+ dendritic cells. Proc Natl Acad
Sci U S A, 1996. 93(6): p. 2588-92.
21. McIlroy, D. and M. Gregoire, Optimizing den-
dritic cell-based anticancer immunotherapy:
maturation state does have clinical impact.
Cancer Immunol Immunother, 2003. 52(10):
p. 583-91.
22. De Vries, I.J., et al., Phenotypical and func-
tional characterization of clinical grade den-
dritic cells. J Immunother, 2002. 25(5): p. 429-
38.
23. Mould, A.P., et al., Identification of a novel
anti-integrin monoclonal antibody that recog-
nises a ligand-induced binding site epitope on
the beta 1 subunit. FEBS Lett, 1995. 363(1-
2): p. 118-22.
24. Dubois, R.N., et al., Cyclooxygenase in biolo-
gy and disease. Faseb J, 1998. 12(12): p.
1063-73.
25. Linder, S. and M. Aepfelbacher, Podosomes:
adhesion hot-spots of invasive cells. Trends
Cell Biol, 2003. 13(7): p. 376-85.
26. Destaing, O., et al., Podosomes display actin
turnover and dynamic self-organization in
Chapter 3
60
osteoclasts expressing actin-green fluores-
cent protein. Mol Biol Cell, 2003. 14(2): p.
407-16.
27. Burns, S., et al., Configuration of human den-
dritic cell cytoskeleton by Rho GTPases, the
WAS protein, and differentiation. Blood, 2001.
98(4): p. 1142-9.
28. van Kooyk, Y. and C.G. Figdor, Avidity regula-
tion of integrins: the driving force in leukocyte
adhesion. Curr Opin Cell Biol, 2000. 12(5): p.
542-7.
29. Springer, T.A., Traffic signals for lymphocyte
recirculation and leukocyte emigration: the
multistep paradigm. Cell, 1994. 76(2): p. 301-
14.
30. Worthylake, R.A. and K. Burridge, Leukocyte
transendothelial migration: orchestrating the
underlying molecular machinery. Curr Opin
Cell Biol, 2001. 13(5): p. 569-77.
31. Semmrich, M., et al., Importance of integrin
LFA-1 deactivation for the generation of
immune responses. J Exp Med, 2005.
201(12): p. 1987-98.
32. De Vries, I.J., et al., Maturation of dendritic
cells is a prerequisite for inducing immune
responses in advanced melanoma patients.
Clin Cancer Res, 2003. 9(14): p. 5091-100.
33. Kabashima, K., et al., Prostaglandin E2-EP4
signaling initiates skin immune responses by
promoting migration and maturation of
Langerhans cells. Nat Med, 2003. 9(6): p.
744-9.
34. Luft, T., et al., Functionally distinct dendritic
cell (DC) populations induced by physiologic
stimuli: prostaglandin E(2) regulates the
migratory capacity of specific DC subsets.
Blood, 2002. 100(4): p. 1362-72.
35. Scandella, E., et al., CCL19/CCL21-triggered
signal transduction and migration of dendritic
cells requires prostaglandin E2. Blood, 2004.
103(5): p. 1595-601.
36. Legler, D.F., P. Krause, E. Scandella, E.
Singer, and M. Groettrup., Prostaglandin E2
is generally required for human dendritic cell
migration and exerts its effect via EP2 and
EP4 receptors. J Immunol, 2006. 176: p. 966-
973.
37. Sallusto, F., et al., Switch in chemokine
receptor expression upon TCR stimulation
reveals novel homing potential for recently
activated T cells. Eur J Immunol, 1999. 29(6):
p. 2037-45.
38. Forster, R., et al., CCR7 coordinates the pri-
mary immune response by establishing func-
tional microenvironments in secondary lym-
phoid organs. Cell, 1999. 99(1): p. 23-33.
39. Fogel-Petrovic, M., et al., Activated human
dendritic cells express inducible cyclo-oxyge-
nase and synthesize prostaglandin E2 but not
prostaglandin D2. Immunol Cell Biol, 2004.
82(1): p. 47-54.
40. Verhasselt, V., et al., Bacterial lipopolysac-
charide stimulates the production of cytokines
and the expression of costimulatory mole-
cules by human peripheral blood dendritic
cells: evidence for a soluble CD14-dependent
pathway. J Immunol, 1997. 158(6): p. 2919-
25.
41. Burgstaller, G. and M. Gimona, Podosome-
mediated matrix resorption and cell motility in
vascular smooth muscle cells. Am J Physiol
Heart Circ Physiol, 2005. 288(6): p. H3001-5.
42. Osiak, A.E., G. Zenner, and S. Linder,
Subconfluent endothelial cells form
podosomes downstream of cytokine and
RhoGTPase signaling. Exp Cell Res, 2005.
307(2): p. 342-53.
43. Faveeuw, C., G. Preece, and A. Ager,
Transendothelial migration of lymphocytes
across high endothelial venules into lymph
nodes is affected by metalloproteinases.
Blood, 2001. 98(3): p. 688-95.
44. Kanehisa, J., et al., A band of F-actin contain-
ing podosomes is involved in bone resorption
by osteoclasts. Bone, 1990. 11(4): p. 287-93.
45. Linder, S., et al., Wiskott-Aldrich syndrome
protein regulates podosomes in primary
human macrophages. Proc Natl Acad Sci U S
A, 1999. 96(17): p. 9648-53.
46. Rehli, M., Of mice and men: species varia-
tions of Toll-like receptor expression. Trends
Immunol, 2002. 23(8): p. 375-8.
47. Zhao, H., et al., Downregulation of small
GTPase Rab7 impairs osteoclast polarization
and bone resorption. J Biol Chem, 2001.
276(42): p. 39295-302.
48. Toyomura, T., et al., From lysosomes to the
plasma membrane: localization of vacuolar-
type H+ -ATPase with the a3 isoform during
osteoclast differentiation. J Biol Chem, 2003.
278(24): p. 22023-30.
49. Cougoule, C., et al., Activation of the lyso-
some-associated p61Hck isoform triggers the
biogenesis of podosomes. Traffic, 2005. 6(8):
p. 682-94.
50. Burgstaller, G. and M. Gimona, Actin
cytoskeleton remodelling via local inhibition of
contractility at discrete microdomains. J Cell
Sci, 2004. 117(Pt 2): p. 223-31.
51. Scandella, E., et al., Prostaglandin E2 is a
key factor for CCR7 surface expression and
migration of monocyte-derived dendritic cells.
Blood, 2002. 100(4): p. 1354-61.
52. Honda, A., et al., Cloning and expression of a
cDNA for mouse prostaglandin E receptor
EP2 subtype. J Biol Chem, 1993. 268(11): p.
7759-62.
53. DeMali, K.A., K. Wennerberg, and K.
Burridge, Integrin signaling to the actin
cytoskeleton. Curr Opin Cell Biol, 2003.
15(5): p. 572-82.
54. Geijtenbeek, T.B., et al., Identification of DC-
SIGN, a novel dendritic cell-specific ICAM-3
receptor that supports primary immune
responses. Cell, 2000. 100(5): p. 575-85.
55. Hemler, M.E., et al., Glycoproteins of 210,000
and 130,000 m.w. on activated T cells: cell
distribution and antigenic relation to compo-
nents on resting cells and T cell lines. J
Immunol, 1984. 132(6): p. 3011-8.
56. Thurner, B., et al., Generation of large num-
bers of fully mature and stable dendritic cells
from leukapheresis products for clinical appli-
cation. J Immunol Methods, 1999. 223(1): p.
1-15.
57. Mackensen, A., et al., Homing of intravenous-
ly and intralymphatically injected human den-
dritic cells generated in vitro from CD34+
hematopoietic progenitor cells. Cancer
Immunol Immunother, 1999. 48(2-3): p. 118-
22.
58. Krooshoop, D.J., et al., An automated multi
well cell track system to study leukocyte
migration. J Immunol Methods, 2003. 280(1-
2): p. 89-102.
PGE2 in DC maturation
61
Chapter 3
62
1Suzanne F.G. van Helden, 1Machteld M. Oud, 2Reinier A.P.
Raymakers, 3Mihai G. Netea, 4Frank N. van Leeuwen and 1Carl G.
Figdor
Submitted
4Chapter
TLR4-mediated discrimination between
Gram-negative and Gram-positive bac-
teria directs migration and maturation of
DCs
1Department of Tumor Immunology, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen,
The Netherlands
2Department of Hematology, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The
Netherlands
3Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The
Netherlands
4Laboratory of Pediatric Oncology, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The
Netherlands
Chapter 4
Abstract
Recognition of pathogenic bacteria, mediated by TLRs expressed on
antigen presenting cells, represents a critical step in the induction of
adaptive immune responses against such pathogens. Investigating
the effects of different pathogens on dendritic cell (DC) maturation,
we found that Gram-negative bacteria are much more potent induc-
ers high-speed migration, cytokine secretion and expression of
CCR7 and costimulatory molecules than Gram positive bacteria. In
addition, only Gram-negative bacteria, are capable of inducing
podosome dissolution in DCs. Similar to whole bacteria, purified lig-
ands for TLR4, but not TLR2, induce podosome loss. The effects of
Gram-negative bacteria on DC maturation and podosome dissolution
are mainly dependent on the adaptor protein TRIF and involve the
production of prostaglandins by the DCs. We conclude that DCs dif-
fer in their capacity to respond to these different classes of bacteria
and this could account for the distinct pathology of these bacteria.
Introduction
Pathogenic bacteria are an important cause of morbidity and mortal-
ity worldwide. The two classes, Gram-negative and Gram-positive
bacteria, preferentially localize to distinct anatomical sites in the
body. In the lower gastrointestinal tract mostly Gram-negative bacte-
ria are found, while the upper gastrointestinal tract and the respirato-
ry airways are mainly colonized with Gram-positive bacteria. The dif-
ferent composition and structure of the cell wall of Gram-negative
and Gram-positive bacteria results in recognition by different
pathogen recognition receptors (PRRs). TLRs are a family of PRRs,
which at least 11 members [1], recognizing very different pathogen
associated molecular patterns (PAMPs) [2], leading to activation of
nuclear factor κB (NF-κB)-dependent and interferon (IFN)-regulatory
factor (IRF)-dependent signaling pathways [3]. Gram-negative bac-
teria are mainly recognized by TLR4 through their lipopolysaccharide
(LPS), whereas structural components of Gram-positive bacteria,
such as peptidoglycans, lipoteichoic acid (LTA) and lipoproteins acti-
vate TLR2 [4-6], which forms heterodimers with TLR1 or TLR6. TLRs
can modulate the function of each other and the cross talk between
PRRs can modify the resulting immune responses [3]. 
Dendritic cells (DCs) are the most potent antigen presenting cells of
the immune system [7] and they express different PRRs, such as C-
type lectins, NOD-like receptors and Toll-like receptors (TLRs) [8-10].
Stimulation of PRRs, especially TLRs, on DCs bridges innate to
adaptive immune responses by inducing signaling that will induce
cytokine production and DC-maturation and thereby induce efficient
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T cell stimulation by mDCs. Most studies on the effects of PRR trig-
gering in DCs have been performed using purified or synthetic lig-
ands, while the effects of whole pathogens are largely unknown. As
DCs come in contact with Gram-negative or Gram-positive bacteria,
depending on the anatomical site, we investigated if and how Gram-
negative and Gram-positive bacteria differ in their ability to stimulate
DCs. 
By comparing Gram-positive with Gram-negative bacteria, we find
that the latter are far more efficient inducers of DC-maturation.
Previously we showed that podosomes, specialized adhesion struc-
tures found in DCs, dissolve in response to LPS [11]. Here we find
that only Gram-negative bacteria are capable of inducing podosome
dissolution and high speed migration in DCs. These effects are
dependent on TLR4, TRIF, MyD88 and the production of
prostaglandins by the DCs. We conclude that the preferred ability of
Gram-negative bacteria to stimulate DCs is determined by TLR4 lig-
ands expressed on the surface of these pathogens.
Results
Gram-negative bacteria are superior to Gram-positive bacteria
in inducing DC-maturation.
We investigated the effects of the Gram-negative bacteria Neisseria
meningitidis and Salmonella enteritidis, as well as the Gram-positive
bacteria Staphylococcus aureus and Streptococcus pneumoniae, on
the induction of cytokine secretion and expression of CD80, CD83
and CCR7. LPS or Gram-negative bacteria induced high levels of
TNFα, IL-6 and IL-8 by the DCs, while exposure to Gram-positive
bacteria resulted in much lower levels of these pro-inflammatory
cytokines (Figure 1A). In addition, the expression of the costimulato-
ry molecules, CD80 and CD83, and CCR7, a chemokine receptor
required for migration to the lymph nodes, was investigated. Gram-
negative bacteria were capable of inducing upregulation of CD80,
CD83 as well as CCR7 to the same level (or even higher) as LPS
(Figure 1B). However, the up-regulation of these markers in
response to Gram-positive bacteria was lower (Figure 1B). The dif-
ferential effects of these pathogens on CCR7 expression prompted
us to also explore effects of pathogen-stimulation on migratory
behavior. We observed that whereas only 20-40% of the unstimulat-
ed iDCs or DCs stimulated with Gram-positive bacteria showed cell
migration in vitro, exposure to Gram-negative bacteria induced high-
speed migration in about 70% of the DCs, levels comparable to those
obtained in response to LPS (Figure 1C). Taken together, these data
Gram- vs Gram+ bacteria in DC maturation
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show that Gram-negative bacteria are superior to Gram-positive bac-
teria in inducing DC-maturation and migration.
Gram-negative, not Gram-positive, bacteria induce podosome
loss in DCs.
Previously, we showed that podosome dissolution in response to
maturation stimuli is required for the induction of high-speed migra-
tion [11]. Therefore, we tested whether the differential effects of
Gram-negative and Gram-positive bacteria on cytokine secretion,
expression of CD80, CD83 and CCR7 and induction of high-speed
migration are reflected by the ability to induce podosome dissolution
in DCs. Indeed, whereas Gram-negative bacteria induced podosome
dissolution, Gram-positive bacteria produced no significant effect on
the number of cells displaying podosomes (Figure 2A, B). 
The reduced ability Gram-positive pathogens to stimulate DCs is not
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Figure 1. Gram-negative bacteria are superior to Gram-positive bacteria in inducing DC-
maturation.
iDCs were left untreated or incubated with LPS, N. meningitidis (meningo), S. enteritidis
(salmon), S. aureus (staphyl) or S. pneumoniae (strept) for 42-48h. (A) Supernatants
were harvested from the stimulated DCs and the levels of human TNFα, IL-6 and IL-8
were measured with an inflammatory cytokine beads array. An average of 5 experi-
ments (±SEM) is depicted. (B) The expression of the costimulatory molecules CD80 and
CD83, and the chemokine receptor CCR7 was analyzed by flow cytometry. The aver-
age mean fluorescence intensity (MFI) (±SEM) of 4 experiments is depicted. (C)
Random migration on fibronectin-coated plates was monitored for 60 min. The percent-
age of migrating cells (±SEM) is depicted.
due to a difference in binding or internalization. Both Gram-negative
and Gram-positive bacteria showed similar binding to DCs, as deter-
mined by flow cytometry using FITC-labeled bacteria (Figure 2C). In
addition, using confocal microscopy we generated Z stacks to
demonstrate that Gram-negative as well as Gram-positive bacteria
are efficiently internalized by the DCs (Figure 2D). We conclude
therefore that the reduced ability of Gram positive bacteria to stimu-
late DC maturation is not caused by a lack of binding or internaliza-
tion by the DCs.
Pure TLR ligands mimic the effect of whole bacteria.
Gram-negative bacteria are mainly recognized by TLR4, while Gram-
positive bacteria predominantly activate TLR2. Therefore, we inves-
tigated whether activating these receptors with purified ligands mim-
ics the effect of whole bacteria. Indeed, LPS, a TLR4 ligand, was able
Gram- vs Gram+ bacteria in DC maturation
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Figure 2. Gram-negative bacteria induce podosome loss, while Gram-positive bacteria
do not.
(A/B) iDCs were left untreated or stimulated with LPS, N. meningitidis (meningo), S.
enteritidis (salmon), S. aureus (staphyl) or S. pneumoniae (strept) at moi 20 for 16h. (A)
Representative images are depicted. Scale bar indicates 20 µm. (B) The average num-
ber of cells displaying podosomes of 4 experiments is shown. (C/D) iDCs were incu-
bated for 45-60 min with FITC-labeled bacteria. (C) The amount of DCs that had bound
(or internalized) bacteria was analyzed by flow cytometry. A representative experiment
is shown. (D) Internalization was confirmed by making z-stacks using a Zeiss LSM 510-
meta microscope. Representative images are depicted. Scale bar indicates 10 µm.
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to induce podosome loss, while the TLR2/1 ligand Pam3cys and the
TLR2/6 ligand FSL-1, either alone or in combination, did not affect
podosomes (Figure 3A, B). DCs were not completely unresponsive
to these TRL2 ligands, as stimulation with Pam3cys or FSL-1
induced the production of TNF and IL-6, albeit at lower levels in com-
parison to LPS (Figure 3C).
A potential synergy between de TLR4 and 2 ligands was investigat-
ed by combining a suboptimal concentration of LPS (6 ng/ml),
derived from LPS serial dilutions (Figure 3D), with TLR2 ligands.
However, no synergy between LPS and TLR2 ligands was observed
(Figure 3E). These data demonstrate that purified TLR4 and TLR2
ligands differ in their capacity to induce podosome dissolution, which
mirrors the effects observed with whole pathogens that express
either of these ligands.
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Figure 3. TLR4, but not TLR2 activation, induces podosome dissolution in iDCs.
(A/B) iDCs were left untreated or stimulated with LPS, Pam3cys, FSL-1 or a combina-
tion of Pam3cys and FSL-1 for 16h. (A) Representative images are depicted. Scale bar
indicates 20 µm. (B) The average number of cells displaying podosomes of 4 experi-
ments is shown. (C) Supernatants were harvested from unstimulated, LPS, Pam3cys or
FSL-1 stimulated DCs and the levels of human TNF and IL-6 were measured. An aver-
age of 8 experiments (±SEM) is depicted. (D) iDCs were left untreated or stimulated
with different concentrations of LPS for 16h. The average number of cells displaying
podosomes of 3 experiments is shown. (E) iDCs were left untreated or stimulated with
LPS or a suboptimal concentration of LPS (6 ng/ml) with or without Pam3cys or FSL-1
for 16h. The average number of cells displaying podosomes of 3 experiments is shown.
Podosome loss induced by Gram negative bacteria is TLR4
dependent.
Intracellular Gram-negative bacteria, Bartonella quintana and
Chlamydia pneumoniae, which carry a structurally different LPS that
is incapable of triggering TLR4 signaling [12-14], were also tested.
Stimulation of iDCs with B. quintana or C. pneumoniae had no effect
on the amount of podosomes (Figure 4A), consistent with the notion
that Gram-negative bacteria induce podosome loss by triggering
TLR4 signaling through LPS exposed on the cell surface of these
bacteria. Moreover, addition of the TLR4 antagonist Bartonella quin-
tana LPS [14] completely blocked the LPS- or Gram-negative bacte-
ria-induced podosome loss (Figure 4B), showing that the response is
indeed TLR4 mediated. 
In order to unequivocally demonstrate the importance of TLR4 stim-
ulation in podosome-dissolution, we examined (bacterially-induced)
podosome dissolution in mouse bone marrow-derived DCs (BDMCs)
from either wild type or TLR deficient mice. Similar to human mono-
cyte-derived DCs (MODCs), podosome dissolution was observed in
normal BDMCs in response to LPS and Gram-negative bacteria but
Gram- vs Gram+ bacteria in DC maturation
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Figure 4. LPS- and Gram-negative bacteria-induced podosome dissolution is mediated
by TLR4.
(A) iDCs were left untreated or stimulated with LPS, B. quintana or C. pneumoniae at
moi 20 for 16h. The average number of cells displaying podosomes of 3 experiments is
shown. (B) iDCs were left untreated or stimulated with LPS with or without the TLR4
antagonist (TLR4a) B. quintana LPS or the TLR4 antagonist alone for 16h. The average
number of cells displaying podosomes of 4 experiments is shown. (C/D) Immature
BMDCs from wild-type (WT), TLR2-/-, TLR4-/- mice were left untreated or stimulated
with LPS, Pam3cys, FSL-1, N. meningitidis (menigo), S. enteritidis (salmon), S. aureus
(staphyl) or S. pneumoniae (strept) for 16h. (C) Representative images are depicted.
Scale bar indicates 20  m. (D) The average number of cells displaying podosomes of 4
experiments is shown.
Chapter 4
not in response to Pam3cys, FSL-1 or Gram-positive bacteria (Figure
4C, D). Moreover, we observed that the LPS- and Gram-negative
bacteria-induced responses were unaffected in TLR2-/- BMDCs,
whereas these were completely abrogated in TLR4-/- BMDCs
(Figure 4C, D). At the same time, these TLR4-/- BMDCs showed
rapid podosome dissolution in response to PGE2 stimulation, similar
to MODCs [11], WT and TLR2-/- BMDCs (data not shown), showing
that signaling downstream of TLR4 is unaffected in these knockout
cells. Together, these data show that both LPS- and Gram-negative
bacteria-induced podosome dissolution is completely dependent on
TLR4 signaling. 
TLR4-mediated podosome loss is mainly TRIF dependent.
To date, two major signaling routes downstream of TLR4 have been
described. The first depends on the adaptor protein myeloid differen-
tiation primary response gene 88 (MyD88), whereas the second
depends on the adaptor protein TIR domain-containing adaptor-
inducing IFNβ (TRIF) [15]. To investigate the involvement of these
signaling routes, we made use of MyD88-/- mice and Lps2 mice,
which carry a natural mutation resulting in TRIF deficiency [16].
BMDCs from these mice were able to form podosomes and showed
podosome dissolution in response to PGE2, while TLR2 ligands and
Gram-positive bacteria had no effect (Figure 5A, B and data not
shown). However, the LPS-, S. enteritidis- as well as the N. meningi-
tidis-induced responses were partly abrogated in Lps2 BMDCs
(Figure 5A, B). In MyD88-/- BMDCs, LPS and S. enteritidis-induced
podosome loss, although not significant, seemed somewhat
impaired (Figure 5A, B). In addition, the N. meningitidis-induced
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Figure 5. LPS- and Gram-negative bac-
teria-induced podosome loss in mediat-
ed by TRIF and MyD88.
(A/B) Immature BMDCs from wild-type
(WT), lps2 (TRIF-/-) and MyD88-/- mice
were left untreated or stimulated with
LPS, Pam3cys, FSL-1, N. meningitidis
(menigo), S. enteritidis (salmon), 
S. aureus (staphyl) or S. pneumoniae
(strept) for 16h. (A) Representative im-
ages are depicted. Scale bar indicates
20 µm. (B) The average number of cells
displaying podosomes of 4 experiments
is shown.
response was partly abrogated (Figure 5A, B). These findings sug-
gest that these responses are mainly TRIF mediated and that TRIF
and MyD88 dependent signaling might synergize in these respons-
es. 
Gram-negative bacteria-induced podosome loss is mediated
by production of prostaglandins.
We have shown earlier that PGE2 can induce rapid podosome loss
and that the LPS response is dependent on prostaglandin production
by the DCs [11]. Therefore, we investigated whether podosome loss,
induced by Gram-negative bacteria, also involved the production of
prostaglandins. Indomethacin, a COX inhibitor and known to interfere
with prostaglandin production [17], interfered with podosome loss
induced by Gram-negative bacteria (Figure 6A), suggesting that this
response is, at least in part, mediated by the production of
prostaglandins by the DCs. 
To further investigate a role for prostaglandins, we tested whether tis-
sue culture medium conditioned by DCs that had been stimulated
with different TLR ligands or bacteria, was capable of inducing (rapid)
podosome loss in other DCs. Medium obtained from unstimulated,
Pam3cys- or S. aureus-stimulated DCs induced no podosome disso-
lution (Figure 6B). However, supernatant of DCs stimulated with
Gram- vs Gram+ bacteria in DC maturation
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Figure 6. Gram-negative bacteria-induced
podosome loss is mediated by production of
prostaglandins by the DCs.
(A) iDCs were left untreated or stimulated with
LPS, N. meningitidis (meningo) or S. enteritidis
(salmon) at moi 20 for 16h with or without
indomethacin (indo) or indomethacin alone.
The average number of cells displaying
podosomes of 3 experiments is shown. (B)
iDCs were left untreated or stimulated with
LPS, Pam3cys, S. enteritidis (salmon) or S.
aureus (staphyl) for 16h. Supernatants of
these stimulated DCs were harvested and
added for 30 min to DCs from a different donor.
The average number of cells displaying
podosomes of 4 experiments is shown. (C)
iDCs were left untreated or stimulated with
LPS, Pam3cys, S. enteritidis (salmon) with or
without indomethacin (indo) or indomethacin
alone for 16h. Supernatants of these stimulat-
ed DCs were harvested and added for 30 min
to DCs from a different donor. The average
number of cells displaying podosomes of 2
experiments is shown.
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PGE2 (data not shown), LPS or S. enteritidis induced podosome dis-
solution in at least part of the DCs (Figure 6B). Moreover, super-
natants from DCs stimulated with LPS or S. enteritidis in the pres-
ence of indomethacin were unable to induce podosome loss in other
DCs (Figure 6C). Although the levels were low, we could detect PGE2
in the supernatants of DCs stimulated with LPS, but not when DCs
were stimulated with Pam3cys or FSL-1 (data not shown). Together
these findings support the notion that prostaglandins produced by the
DC, possibly PGE2, are needed for podosome turnover in response
to TLR4 stimulation.
Discussion
Bacterial infections are an important cause of morbidity and mortali-
ty worldwide. The interaction between colonizing microorganisms
and the host has important effects on the normal development of the
immune system or the intestinal tract. This fact is also mirrored by the
specific microbial flora of anatomic segments, such as the abun-
dance of Gram-positive bacteria as colonizers of the mouth, nose
and the respiratory tract, and the colonization of the lower intestinal
tract by Gram-negative bacteria. APCs are cells of the innate host
defense system that ingest and present bacterial antigens, regulating
the type of interaction of a colonizing or infecting microorganism with
the immune system. The prototype APC is the DC, and in the pres-
ent study we have investigated the interactions of specific microor-
ganisms with these cells. Surprisingly, our data show a significant dif-
ference between the various bacterial classes, with Gram-negative
bacteria being superior to Gram-positive bacteria in inducing DC
maturation. 
Effective maturation of DCs is essential for the induction of adaptive
immune responses. During maturation adhesive, antigen recognizing
iDCs are transformed into highly migratory mDCs that efficiently stim-
ulate T cells. DC maturation is accompanied by relocalization of MHC
molecules to the plasma membrane, upregulation of costimulatory
molecules as well as the production of cytokines. Gram-negative
bacteria are much more potent in inducing the secretion of pro-
inflammatory cytokines such as TNFα, IL-6 and IL-8, [18, 19], and
upregulation of expression of the costimulatory molecules CD80 and
CD83. 
In addition, DC maturation involves elaborate changes in cytoskele-
tal organization and integrin-mediated cell adhesion [11, 20], which
allows mature DCs to migrate to and into the lymph nodes and stim-
ulate T cells. 
Although Gram-positive and Gram-negative bacteria do not differ in
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their ability to be bound and internalized by DCs, we find that the lat-
ter are much more efficient in stimulating the cytoskeletal changes
required for the induction of DC migration. For instance, only Gram-
negative bacteria trigger podosome dissolution in DCs, and they
more strongly induce upregulation of CCR7, a chemokine receptor
directing DC migration to the lymph nodes [21]. Hence, we conclude,
that Gram-negative and Gram-positive bacteria differ in their ability to
regulate adhesive and migratory properties of DCs.
Bacteria bind and activate different PRRs on DCs, for instance
Gram-negative bacteria mostly signal through TLR4, while Gram-
positive bacteria mainly activate TLR2. Although TLR2 ligands were
shown to affect DCs [22, 23] and induce cytokine secretion, we and
others [24] found that the cytokine secretion in response to intact
Gram-positive bacteria was very low or absent. This discrepancy
may be due to the relatively high concentration of pure TLR ligands
(10 µg/ml) used, in comparison to the amounts of TLR ligands that
can be presented to the DCs when complete bacteria are used.
However, even with purified ligands, cytokine responses observed
with purified TLR2 ligands were significantly lower when compared to
LPS stimulation. Moreover, stimulation with LPS [11], but not
Pam3cys or FSL-1, resulted in podosome loss in DCs, suggesting
that irrespective of concentration or context, TLR4 is a much more
effective inducer of DC maturation than TLR2. 
Our experiments using a TLR4 antagonist and the TLR4-/- BMDCs,
show that the effects of Gram-negative bacteria are completely
dependent on TLR4 signaling. Previously, it was shown that a mutant
strain of N. meningitidis lacking LPS is less potent in inducing pro-
inflammatory cytokines and largely incapable of inactivating DCs [25,
26]. We show that the effects of Gram-negative bacteria can be mim-
icked by LPS, whereas Gram-negative bacteria possessing an LPS
unable to activate TLR4 [12-14] are unable to induce podosome loss
in DCs. Together these results show that the effects of Gram-nega-
tive bacteria on DC maturation are largely TLR4-mediated and sug-
gest that TLR4 antagonist might be used in clinical applications to
treat Gram-negative bacteria induced infection and sepsis. 
TLR4 can activate MyD88 [27, 28] as well as TRIF dependent sig-
naling [15, 29]. LPS- or Gram-negative-induced podosome loss is
partly abrogated in lps-2 BMDCs, suggesting that the TRIF-depend-
ent signaling pathway is involved in podosome dissolution in DCs.
Previously, it was suggested that the effects of live of heat-killed
Escherichia coli on DCs are mediated through TLR4 and TRIF [30].
This is in line with the finding that activation of TLR2, which only uses
the MyD88 dependent pathway [31, 32], fails to induce podosome
Gram- vs Gram+ bacteria in DC maturation
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loss. The importance of the MyD88 dependent pathway is less
straightforward. Although the LPS- or S. enteritidis-induced
podosome loss appeared somewhat impaired in MyD88-/- BMDCs,
this effect was not significant. However, the N. meningitidis-induced
podosome loss was significantly impaired in MyD88-/- BMDCs. This
could either mean that MyD88 is only involved when TLR4 is trig-
gered by certain strains of Gram-negative bacteria or that there is
some involvement of MyD88 in the responses of DCs to TLR4 trig-
gering. The latter seems more likely since we have observed that
triggering of TLR3, which only uses the TRIF dependent pathway, is
unable to induce podosome loss in DCs (data not shown), suggest-
ing that both pathways are involved. This suggests that both path-
ways may cooperate during DC-maturation. Until now, TLR4 is the
only TLR known to signal both through the MyD88- and TRIF-
dependent pathways, which may account for the fact that TLR4 lig-
ands are the most potent inducers of DC maturation. The need for
activation of both pathways could be an explanation for the synergy
often observed between TLR-ligands signaling via MyD88 and TLR-
ligands activating TRIF-dependent signaling [33, 34]. 
The ability of conditioned supernatants to induce podosome loss and
the effects of COX inhibition on podosome dissolution, show that
Gram-negative bacteria induced podosome loss is mediated by the
production of prostaglandins, similarly to the LPS induced responses
[11]. This could be mediated through PKC and p38MAPK signaling
downstream of TLR4, which is known to induce COX enzymes [35].
PGE2, needed for the induction of high-speed migration during DC-
maturation [36], is in itself very efficient in inducing podosome disso-
lution in DCs [11]. In addition, LPS, but not Pam3cys or FSL-1, stim-
ulation led to PGE2 production by DCs (data not shown), suggesting
that Gram-negative bacteria may also trigger PGE2 secretion. It was
shown already that Gram-negative bacteria and not Gram-positive
bacteria can induce production of PGE2 in monocytes [37]. Together,
these findings emphasize the importance of prostaglandin production
by DCs and suggest that PGE2 might be the prostaglandin involved. 
In addition to the bacteria described in this study, the Gram-negative
bacterium Klebsiella pneumoniae (ATCC 10031), the Gram-positive
strain Mycobacterium BCG, and additional strains of S. pneumoniae,
with and without capsules, give similar results (data not shown). The
LPS used here is derived from E. coli, suggesting that this strain will
induce the same responses. This indicates that our findings are like-
ly to apply to a broad range of bacteria. The finding that Gram-nega-
tive bacteria induced enhanced DC maturation suggests that these
bacteria might be more effective in the induction of T cell dependent
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responses. Indeed, the induction of adaptive immunity appears to be
important in the prevention of diseases involving Gram-negative bac-
teria. Immunocompromised patients, especially in combination with
mucositis, are at high risk to develop infections and Gram-negative
sepsis [38]. These patients routinely receive antibiotics directed
against Gram-negative bacteria (selective gut decontamination) [39].
Alternatively, it could mean that although DCs are predominantly acti-
vated by Gram-negative bacteria, Gram-positive bacteria activate
other APCs, monocytes and macrophages. Although there it has
been suggested that macrophages produce more cytokines in
response to Gram-negative bacteria [24], we find that macrophages
produce cytokines in response to Gram-negative as well as Gram-
positive bacteria (data not shown). In addition, in vivo the activation
of other APCs could also induce activation of DCs and thus induce
efficient T cell responses.
In conclusion, we find that Gram-negative and Gram-positive bacte-
ria differ in their ability to activate DCs. The differential effects of 
Gram-negative and Gram-positive bacteria on DC maturation could
account for the different pathology of these bacteria.
Materials and methods
Chemicals and antibodies
The following antibodies were used: anti-hCD80 and mIgG1 (Becton
Dickinson & Co., Franklin Lakes, NJ), anti-hCD83 (Beckman Coulter,
Mijdrecht, The Netherlands), mIgG2a and mIgG2b (Pharmingen, San
Diego, CA), anti-hCCR7 (R&D systems, Minneapolis, MN) and anti-
vinculin (Sigma, St. Louis, MO). Alexa Fluor 488-labeled secondary
antibodies were from Molecular Probes (Molecular Probes, Leiden,
The Netherlands), FITC-labeled secondary antibodies from Zymed
(Zymed, San Francisco, CA), and PE-labeled secondary antibodies
from Beckman Coulter and Becton Dickinson & Co. Texas Red-con-
jugated phalloidin (Molecular Probes) was used to stain F-actin.
Indomethacin and LPS (which was purified before use) were
obtained from Sigma. Pam3cys and FSL-1 were obtained from EMC
microcollections (EMC microcollections GmbH). Salmonella enteri-
tidis [40] and Streptococcus pneumoniae were a clinical isolates.
Neisseria meningitidis H44/76 was isolated from a patient with inva-
sive meningococcal disease. Staphylococcus aureus was obtained
from the ATCC (ATCC 43300). Bartonella quintana Oklahoma strain
[14] and Chlamydia pneumoniae strain TW-183 [41] were used.
Bartonella quintana derived LPS is used as TLR4 antagonist [14].
Streptococcus pneumoniae OXC14 was kindly provided by P.
Hermans (Radboud University Nijmegen Medical Centre, Nijmegen,
Gram- vs Gram+ bacteria in DC maturation
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The Netherlands). All bacteria were heat killed and used at a mode
of infection (moi) of 20. To label bacteria with FITC, they were
washed in PBS and incubated in 0.5 mg/ml FITC for 60 min. FITC-
labeled bacteria were washed and stored in PBS at -20 C.
Preparation of human DCs
DCs were generated from PBMCs as described previously [42, 43].
Monocytes were derived from buffy coats or from a leukapheresis
product. Plastic-adherent monocytes were cultured in RPMI 1640
medium (Gibco; Life Technologies, Breda, The Netherlands) supple-
mented with 10% (v/v) FCS (Greiner, Kremsmuenster, Austria), IL-4
(500 U/ml) and GM-CSF (800 U/ml). Immature DCs were harvested
on day 6. Expression of MHC class I/II, costimulatory molecules and
DC-specific markers on DCs were measured by flow cytometry (data
not shown) and the expression of MHC molecules, costimulatory
molecules and DC-markers was similar to what was described before
[44]. Immature DCs expressed MHC class I and II, the costimulatory
molecule CD86, the DC-specific marker CD209/DC-SIGN, low levels
of the costimulatory molecule CD80 and lacked expression of the
maturation marker CD83. 
Mice 
C57BL/6 mice were obtained from Charles River WIGA Gmbh.
TLR2-/- [6], TLR4-/-, and MyD88-/- [45] mice were obtained from S.
Akira (Osaka University, Osaka, Japan). The MyD88-/- mice were
backcrossed more than 8 times on the C57BL/6 background. Lps2
mice were obtained from B. Beutler (The Scripps Research Institute,
La Jolla, USA).
Preparation of mouse DCs
Bone marrow was isolated from femurs of C57BL/6 WT, TLR2-/- or
TLR4-/- mice. Bone marrow cells were cultured in RPMI 1640 medi-
um supplemented with 10% (v/v) FCS, 50 µM β-mercaptoethanol
(Sigma), mouse IL-4 (10 ng/ml) (DNAX, Schering-Plough, Palo Alto,
CA) and GM-CSF (10 ng/ml) (PeproTech EC Ltd., London, UK).
Immature BMDCs were harvested at day 7. Expression of MHC class
I/II, costimulatory molecules and DC-specific markers on DCs were
measured by flow cytometry. The iBMDCs expressed high levels of
MHC class I/II, CD11c and CD11b, moderate levels of CD80, CD86,
CD40 and GR-1 and no expression of F4/80 could be detected (data
not shown). 
Flow cytometry
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Cells (1 x 105) were incubated with 2% (v/v) human serum in PBA
(PBS containing 1% (w/v) BSA and 0.05% (w/v) NaN3) for 15 min at
4 C. After washing with cold PBA the cells were incubated with pri-
mary Ab (5 µg/ml) for 30 min at 4°C. Subsequently, the cells were
incubated with PE-labeled goat anti-mouse. Cells were washed and
resuspended in 100 µl PBA. Fluorescence was measured using a
FACSCalibur™ with CellQuest software (Becton Dickinson & Co.).
Fluorescence microscopy
Coverslips were coated with fibronectin (20 µg/ml) (Roche,
Mannheim, Germany) in PBS for 1 hour at 37°C. Cells were seeded
on fibronectin-coated coverslips, left to adhere for 1 to 6 hrs. After
stimulation or being left unstimulated the cells were fixed in 3.7%
(w/v) formaldehyde in PBS for 10 min. Cells were permeabilized in
0.1% (v/v) Triton X-100 in PBS for 5 min and blocked with 2% (w/v)
BSA in PBS. The cells were incubated with primary Ab for 1 hour.
Subsequently the cells were incubated with Alexa Fluor 488-labeled
secondary antibodies for 45 min. Subsequently, cells were incubated
with Texas Red-conjugated Phalloidin for 30 min. Images were col-
lected on a Leica DMRA fluorescence microscope with a 63x PL APO
1.3 NA oil immersion lens (or a 40x PL FLUOTAR 1.0 NA oil immer-
sion lens for overview images) and a COHU high performance inte-
grating CCD camera (COHU, San Diego, CA). Pictures were ana-
lyzed with Leica Qfluoro version V1.2.0 (Leica) and Adobe
Photoshop 7.0 (Adobe Systems, Mountain View, CA) software.
Podosome assay
Cells were seeded on fibronectin-coated coverslips, stimulated as
indicated and stained with an anti-vinculin mAb and phalloidin-Texas
Red to detect F-actin. The number of cells displaying podosomes
was counted in 7 images per condition per experiment and n indi-
cates the number of independent experiments. An average with SEM
is given.
Cytokine measurement
Concentrations of human TNF, IL-6 and IL-8 were measured using a
human inflammation cytokine bead array (CBA) (Becton Dickinson &
Co.) according to the instructions of the manufacturer.
Concentrations of human TNFα in were measured using specific
RIAs as described previously [46]. Concentrations of human IL-6
were measured by a commercial ELISA kit (Sanquin, Amsterdam,
The Netherlands).
Gram- vs Gram+ bacteria in DC maturation
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Migration assay
96-wells flat bottom plates (Costar, Corning, Acton, MA) were coated
with fibronectin, washed and blocked with 0.01% (w/v) gelatin
(Sigma) in PBS for 30 min at 37°C. Per well, 3 x 103 cells were added
and mineral oil was pipetted on top of the medium to prevent pH
changes and evaporation of the medium. The cells were monitored
with a previously described migration system. Cells were recorded
for 1 hour followed by analysis of individual cells. The speed was
defined as traversed path during the entire experiment divided by the
imaging time.
Statistical analysis
An ANOVA test or a two-tailed student-t test was used for statistical
analysis. P<0.05 was considered significant.
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Abstract
Podosomes are dynamic adhesion structures found in dendritic cells
(DCs) and other cells of the myeloid lineage. We previously showed
that prostaglandin E2 (PGE2), an important proinflammatory media-
tor produced during DC maturation, induces podosome disassembly
within minutes after stimulation. Here we demonstrate that this
response is mediated by cAMP elevation, occurs downstream of Rho
kinase and is dependent on myosin II. Whereas PGE2 stimulation
leads to activation of the small GTPase RhoA, decreased levels of
Rac1-GTP and Cdc42-GTP are observed. These results show that
PGE2 stimulation leads to activation of the RhoA-Rho kinase axis to
promote actomyosin-based contraction and subsequent podosome
dissolution. Because podosome disassembly is accompanied by de
novo formation of focal adhesions (FAs), we propose that the disas-
sembly/formation of these two different adhesion structures is oppo-
sitely regulated by actomyosin contractility and relative activities of
RhoA, Rac1 and Cdc42.
Introduction
Based on stability, composition and subcellular localization, different
classes of cell-matrix adhesions can be recognized. In most cell
types, focal adhesions (FAs), which are present at the end of actin
stress fibers, are the most prominent. However, cells of the myeloid
lineage, such as macrophages, osteoclasts and dendritic cells (DCs),
form podosomes, specialized punctuate adhesions clearly distinct
from FAs [1]. Podosomes consist of an actin-dense core surrounded
by a ring of cytoskeletal proteins also present in FAs, such as vin-
culin, paxillin and talin, known to connect integrins to the actin
cytoskeleton [2]. Unlike FAs, podosomes are sites of active matrix
degradation that promote cell migration and invasion, although, in
osteoclasts they have a more specialized role in bone resorption [2].
Moreover, it has been suggested that podosomes facilitate
transendothelial migration [3, 4]. 
DCs are highly specialized antigen presenting cells that play a cen-
tral role in the induction of T cell-mediated immunity. In response to
antigen uptake and exposure to inflammatory stimuli DCs undergo a
dramatic phenotypic conversion from a tissue-resident, antigen-cap-
turing cell to a highly migratory antigen presenting cell, a process
known as DC maturation [5]. Not surprisingly, this transition is
accompanied by extensive changes in cell adhesion and cytoskele-
tal organization [6-8]. A prominent feature of immature DCs (iDCs),
which strongly interact with the extracellular matrix, is the presence
of podosomes [6, 9]. Mature DCs (mDCs) on the other hand, which
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are loosely adherent [6], no longer form podosomes on fibronectin
(FN) and instead display characteristic actin-rich extensions (den-
drites) that maximize the contact area for T cell interactions [10].
Although podosomes are generally considered a feature of migrato-
ry and invasive cells, migration speeds in (podosome bearing) iDCs
are 10-fold lower than those observed in mDCs [9]. The migratory
capacity of DCs on FN in vitro correlates well to the migratory capac-
ity in vivo and the high-speed migration is essential for efficient
induction of immune responses in cancer patients treated with DC-
vaccination [7]. The presence of podosomes appears to be incom-
patible with the high-speed migration observed in mDCs, which could
explain why these structures are lost during DC maturation.
Podosomes are influenced by both actin and microtubule dynamics
[1, 11] and regulated by coordinated activity of the Rho GTPases
Rho, Rac and Cdc42 [11]. However, the mechanisms that lead to
podosome formation/dissolution are still poorly understood.
Previously we found that stimulation of iDCs with maturation induc-
ing agents, such as lipopolysaccharide, leads to a loss of podosomes
and that this response is dependent on the production of
prostaglandins by the DCs [9]. Moreover, addition of prostaglandin
E2 (PGE2) was sufficient to induce podosome dissolution within min-
utes after stimulation. These results illustrate that (early) DC matura-
tion involves extensive changes in cytoskeletal organization and cell
adhesion, which requires coordinate interactions between signaling
molecules, integrins and the actomyosin cytoskeleton. Because
PGE2 plays a key role in the DC maturation process [12, 13] and lit-
tle is known about the signal-transduction pathways responsible for
cytoskeletal remodelling during DC maturation, we have examined in
detail how PGE2 signaling affects podosome turnover in DCs.
Results
iDCs rapidly dissolve podosomes and form FAs in response to
PGE2 stimulation.
Immature DCs, seeded on FN, form prominent podosomes. We have
shown that PGE2 causes a nearly complete dissolution of
podosomes (from 89 ± 1% in the control situation to 10 ± 2% of the
DCs displaying podosomes after 5 min of PGE2 stimulation) within
minutes after stimulation, an effect that is maintained in the continued
(16 h) presence of PGE2 (Fig. 1A, B, C, D). In addition, in part of the
DCs we observed adhesion structures mostly at the cell periphery
(Fig. 1A), which either represented FAs or (more peripherally locat-
ed) precursors of FAs known as focal complexes [14]. Podosome
dissolution in response to PGE2 was accompanied by rapid de novo
PGE2 signals via Rho kinase in DCs
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formation of these structures (from 56 ± 3% in the control situation to
84 ± 2% of the DCs displaying FAs after 5 min of PGE2 stimulation)
(Fig. 1A, B). The cytoskeletal protein zyxin, an established marker for
mature FAs [15], was prominently present both in podosome-rings as
well as in the in the newly formed adhesion structures (Fig. 1C), sug-
gesting that the latter represent FAs rather than focal complexes.
After prolonged exposure to PGE2 the amount of cells displaying FAs
gradually decreased (Fig. 1A, B). 
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Figure 1. PGE2 stimulation mediated by EP2 and EP4 receptors or by cAMP elevation,
leads to podosome dissolution in DCs.
(A/B/C/D) PGE2 stimulation of iDCs leads to podosome loss and the appearance of
FAs. (A/B) iDCs seeded on FN-coated coverslips were left untreated or stimulated with
PGE2 for 5 minutes (min) or 16 hours (h) and stained with an anti-vinculin mAb (green)
and phalloidin-Texas Red (to detect F-actin, red). (A) Representative images are depict-
ed. (B) The number of cells displaying podosomes or FAs was counted in 7 images per
condition per experiment and an average (with s.e.m.) of 6 experiments is shown. (C)
iDCs seeded on FN-coated coverslips were left untreated or stimulated with PGE2 for 5
minutes (min) and stained with an anti-zyxin antibody (green) and phalloidin-Texas Red
(to detect F-actin, red). (D) iDCs seeded on FN-coated coverslips were left untreated or
stimulated with PGE2 for 1-5 min and stained with an anti-vinculin mAb and phalloidin-
Texas Red (to detect F-actin). The number of cells displaying podosomes was deter-
mined in 7 images per condition per experiment and an average (with s.e.m.) of 4
experiments is shown. Asterisks indicate significant differences (P<0.05).
The transition from podosomes to FAs was further confirmed using
Interference Reflection Microscopy (IRM). In iDCs podosomes were
seen as dark dots and in part of the cells FAs were visible as dark
stripes (Fig. 2A, B and Movie 3, Movie 3 and Fig. S1A in supple-
mentary material). Immunofluorescence detection of F-actin (staining
the podosome core) and vinculin (to reveal the podosome ring as
well as FAs) was used to confirm that these IRM patterns accurately
detect podosomes and FAs in these cells (Fig. 2A). In some DCs we
observed bundles of actin filaments, stress fibers, connected to the
FAs (Fig 2A lower panel). The average size of the dark spots (0.75
µm) closely corresponds to the average size of the actin core (0.78
µm), whereas the vinculin ring was slightly larger (0.91 µm) (Fig. 2C,
D, E, F and Fig. S1A in supplementary material), suggesting that the
structures observed with IRM represent the actin cores of the
podosomes. 
By live cell imaging of iDCs using IRM we determined that
podosomes dissolve within minutes after stimulation with PGE2,
while FAs are forming within the same time frame (Fig. 2B and 3 and
4 in supplementary material). In addition, stimulation with PGE2
appeared to induce a contractile response, which can be seen in the
DIC part of the movies (Movie 3 and 4 in supplementary material).
IRM imaging revealed that podosome dissolution was consistently
preceded by the appearance of bright rings surrounding the
podosome cores (Fig. 2B and Movie 3 and 4 in supplementary mate-
rial), suggesting that changes in the podosome ring structure pre-
cede dissolution of the actin-rich core. 
In order to look at the onset of podosome dissolution in more detail,
we fixed cells during live-cell imaging at the moment that the forma-
tion of these bright rings was apparent, followed by staining with var-
ious podosome components that either localize to the podosome ring
or the podosome core. Hence we found that in podosomes undergo-
ing disassembly, as indicated by the presence of the bright rings in
the IRM image, the actin core was still largely intact, whereas vinculin
could no longer be detected (Fig. S1B in supplementary material). In
contrast, the podosome-ring component zyxin could still be observed
in these podosomes undergoing disassembly (Fig. S1B in supple-
mentary material). We conclude therefore that the rapid loss of
podosomes, induced by PGE2 stimulation, involves the sequential
loss of podosome components, accompanied by the formation of
FAs. 
PGE2 signals via Rho kinase in DCs
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Figure 2. Podosome loss and FA formation in DCs upon PGE2 stimulation, visualized
with IRM. Also see Movies 1, 2 and Fig. S1A,B in the supplementary material. 
(A) IRM images compared to fluorescent images (detected with anti-vinculin mAb, GaM-
ATTO633 and phalloidin-Texas Red, to detect F-actin) identify adhesion structures as
podosomes (seen as dark dots with IRM and as actin dots surrounded by vinculin rings
in the fluorescent images) and FAs (seen as dark stripes with IRM and as vinculin
stripes in the fluorescent images). (B) Images from an IRM movie (Movie 1 in the sup-
plementary material) showing podosomes before stimulation and loss of podosomes in
response to PGE2. Note how the dissolution of podosomes is (transiently) preceded by
the formation of bright rings surrounding the podosome core. FA formation in response
to stimulation can be observed in the upper-right part of the images. (C) Overlay of the
fluorescence intensity of the vinculin staining (broken line) and the actin staining (solid
line) from straight-line selections with ImageJ through the middle of the podosome. The
actin peak flanked by two vinculin peaks reflects the actin core surrounded by the vin-
culin-containing ring. (D,E,F) The size of the adhesive contacts observed by live-imag-
ing IRM, the actin core and the vinculin ring were determined in 50 podosomes from ten
different cells by making straight-line selections with ImageJ through the middle of the
podosome. A representative curve of one podosome is shown and the average size is
depicted in the upper-right corner of the curves with errors depicted as SEM. (D) The
fluorescence intensity of the actin staining from a straight-line selection through the mid-
dle of a podosome. The width of the peak at half the height was used to determine the
width of the actin core (0.78 ± 0.01µm). (E) The fluorescence intensity of the vinculin
staining from a straight-line selection through the middle of a podosome. The distance
from one peak to the other peak was measured to obtain the size of the vinculin ring
(0.91 ± 0.02 µm). (F) The light intensity in the IRM image from a straight-line selection
through the middle of a podosome. The width of the peak at half the height was used to
determine the width of the adhesive contact (0.75 ± 0.02 µm).
Figure 3. PGE2 induced podosome loss is mediated by the EP2 and EP4 receptors.
(A) iDCs and mDCs express the EP2 and EP4 receptors. On iDCs and mDCs a RT-
PCR for the PGE2 receptors EP1-4 was performed. Controls include β-actin (actin) and
minus RT (-). A specific product is detected for EP2 and EP4, but not for EP1 and EP3
receptors. (B) EP2 and EP4 antagonists block PGE2-induced podosome dissolution.
iDCs seeded on FN-coated coverslips were left untreated or stimulated with PGE2 in the
presence or absence of AH6809 (5 µM for 30 minutes) or AH23848 (50 µM for 30 min-
utes), or with AH6809 or AH23848 alone and stained with anti-vinculin mAb and phal-
loidin-Texas Red (to detect F-actin). The number of cells displaying podosomes was
counted in 7 images per condition per experiment and an average (with SEM) of 4
experiments is shown. (C) EP2 and EP4 agonists and cAMP elevation mimic PGE2 in
inducing podosome dissolution. iDCs seeded on FN-coated coverslips were left untreat-
ed or stimulated with PGE2, butaprost (buta, 2 µM for 15 min), PGE1-OH (5 µg/ml for 30
min), sulprostone (sulp, 2µ M for 15 min), IBMX (10 µM for 15 min) or IBMX with
forskolin (IBMX/fors, 10 µM for 15 min) and stained for vinculin and F-actin. The num-
ber of cells displaying podosomes was counted in 7 images per condition per experi-
ment and an average (with SEM) of 3 experiments for the EP agonists (buta, PGE1-OH
and sulp) and 7 experiments for cAMP elevation (IBMX and fors) is shown. Asterisks
indicate significant differences (P<0.05).
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PGE2-induced podosome dissolution is mediated by the EP2
and EP4 receptors and can be mimicked by elevating cAMP
levels.
To date, four PGE2 receptors (EP1-EP4) have been identified [16]. To
investigate which PGE2 receptors are expressed in DCs, we ana-
lyzed expression of these receptors by RT-PCR on iDCs and mDCs.
Hence, we detected expression of EP2 and EP4, but not EP1 and
EP3, receptors in these cells (Fig. 3A). Consistent with these obser-
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Figure S1. Podosome dissolution imaged in IRM mode after PGE2 stimulation. 
(A) Podosome cores are seen in IRM mode as dark spots. IRM image and the IRM
image merged with the vinculin (green) or actin (red) staining. Representative images
are depicted. (B) Vinculin is already absent form the podosome-rings at the time the
bright rings appear, while zyxin is still present. IRM images alone, combined with vin-
culin (green) or zyxin (green) and/or actin (red) and vinculin (green) or zyxin (green)
combined with the actin (red) staining are shown. Representative images are depicted.
(C) Myosin IIA localizes to the areas of the bright rings. IRM images alone or combined
with myosin IIA (green) and/or actin (red) staining or myosin IIA (green) combined with
actin (red) staining. Representative images are depicted. The white arrow indicates a
region with bright rings and prominent myosin IIA staining.
vations, both AH6809 - an antagonist of EP1, EP2 and EP3 [17] - and
AH23848, which selectively blocks EP4 [18], alone had no effect on
the amount of cells displaying podosomes, although they effectively
interfered with PGE2-induced podosome dissolution (Fig. 3B). In
addition, sulprostone, a specific agonist for the EP1/EP3 [19], had no
effect, whereas butaprost or PGE1-OH, selective agonists for the
EP2 and EP4 respectively [19], rapidly induced podosome dissolu-
tion (Fig. 3C). Furthermore, we observed that addition of IBMX,
forskolin or a combination thereof, resulting in elevated cAMP levels,
could induce podosome dissolution (Fig. 3C and data not shown). 
PGE2 mediated podosome loss is dependent on myosin IIA
function
Because PGE2 appears to induce a contractile response in DCs (as
shown by DIC images Movie 3 and 4 supplementary material), we
further explored a role for myosin II in PGE2-induced podosome dis-
solution. We determined by Western blot analysis that myosin IIA is
the predominant isoform expressed in human iDCs, whereas expres-
sion of myosin IIB was low and myosin IIC was undetectable (Fig.
4A). In most cells, we observed a fine punctuate pattern of myosin IIA
distribution that was enriched in the podosome-ring structures or
podosome-rich areas of the cell, whereas myosin IIB was nearly
undetectable (Fig. 4B). 
Importantly, inhibition of myosin II function, by preincubation with 10
µM of the myosin II specific inhibitor blebbistatin [20] blocked PGE2-
induced podosome loss (from 10 ± 2% with PGE2 to 60 ± 4% with
PGE2 and blebbistatin); FAs failed to develop (Fig. 4C and Movie 5
in supplementary material). Although it has been reported that
myosin II function is also required for the formation (and mainte-
nance) of podosomes, incubation with blebbistatin had no effect on
the amount of podosomes in unstimulated cells nor did it significant-
ly affect myosin IIA distribution at the indicated concentration (Fig.
4D). Although in unstimulated control cells myosin IIA was enriched
in podosome rings, in cells stimulated with PGE2 a more fibrillar
organization of myosin IIA was observed (Fig. 4D). This PGE2-
dependent reorganization of myosin IIA into fibrils was not observed
when cells were pre-treated with blebbistatin. In addition, the forma-
tion of fibrillar myosin IIA coincided with the dissolution of podosomes
and fibrillar myosin IIA assemblies appeared to specifically localize to
those areas of the cell in which podosomes were actively dissolving
(as indicated by the IRM ring structures) (Fig. S1C in supplementary
material), suggesting that an increase in myosin IIA activity con-
tributes to podosome dissolution at these sites. Together these find-
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Figure 4. Myosin II is enriched in podosomes and myosin II function is needed for PGE2-
induced podosome dissolution. (A) Myosin IIA is the predominant isoform in DCs. Cell
lysates from iDCs and N1E-115 cells (N115, positive control expressing all isoforms)
were analyzed for expression of myosin (myo) IIA, IIB and IIC. (B) Myosin IIA is enriched
in podosome-rings, whereas myosin IIB is nearly undetectable. iDCs were plated on
FN-coated coverslips and subsequently stained with an anti-myosin IIA or IIB antibody
(green) and phalloidin-Texas Red (to detect F-actin, red). (C,D) iDCs were plated on
FN-coated coverslips and left untreated or stimulated with PGE2 for 5 min in the pres-
ence or absence of blebbistatin (bleb, 10 µM for 30 min) or treated with blebbistatin
alone. (C) Inhibition of myosin II function blocks PGE2-induced podosome dissolution.
iDCs were stained with anti-vinculin antibodies and phalloidin-Texas Red. The number
of cells displaying podosomes was counted in 7 images per condition per experiment
and an average (with SEM) of 3 experiments is shown. Asterisks indicate significant dif-
ferences (P<0.05). (D) Inhibition of myosin II function blocks PGE2-induced myosin IIA
redistribution. iDCs were stained with anti-myosin IIA antibodies and phalloidin-Texas
Red. 
ings indicate that PGE2-mediated podosome dissolution and the sub-
sequent formation of FAs require myosin II-mediated contraction. 
PGE2 stimulation activates RhoA and reduces Rac1 and Cdc42
activity
Small GTPases of the Rho family (Rho, Rac and Cdc42) are key reg-
ulators of adhesion dynamics that control the formation and turnover
of filamentous actin as well as microtubules and modulate myosin II-
based contractility [21, 22]. Therefore, we examined the effects of
PGE2 stimulation on Rho GTPase activity using GTPase pull down
assays. The number of cells needed for such experiments and the
high protease activity observed in DC-lysates precluded the use of
primary DCs for this purpose. Instead we used HL-60 cells, a mono-
cytic leukaemia cell line that can be induced to form podosomes in
response to PMA. We determined by RT-PCR that, similar to DCs,
HL-60 cells predominantly express EP2 and EP4 receptors and
respond to PGE2 by dissolving podosomes within the same
timescale as observed in DCs. In HL-60 cells, this response
PGE2 signals via Rho kinase in DCs
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Figure 5. HL-60 cells form podosomes upon PMA stimulation and respond to PGE2.
(A/B) HL-60 cells form podosomes upon stimulation with PMA, which dissolve after
stimulation with PGE2 or an EP4-agonist. HL-60 cells seeded on FN-coated coverslips
were left untreated or stimulated with PMA for 24h and left untreated or stimulated with
PGE2 for 5 min and stained with an anti-vinculin mAb and phalloidin-Texas Red (to
detect F-actin). (A) Representative images are depicted. (B) The number of cells dis-
playing podosomes was counted in 7 images per condition per experiment and an aver-
age (with SEM) of 3 experiments is shown. (C) HL-60 cells show expression of EP2 and
EP4, while EP1 and EP3 receptors are nearly undetectable as determined by RT-PCR.
Asterisks indicate significant differences (P<0.05).
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appeared to be mediated primarily by the EP4 receptor, because
these cells responded well to the EP4 agonist PGE-OH (Fig. 5), but
not butaprost (data not shown)
When measuring RhoA activity, using a Rhotekin-GST fusion protein,
we observed a 2.6 fold increase in RhoA-GTP levels in response to
92
Figure 6. PGE2 receptor stimulation leads to activation of RhoA and inactivation of
Rac1. (A) Activation of the small GTPase RhoA in response to PGE2.  GTP-RhoA lev-
els were determined in lysates (pd: pull down, TL: total lysate) of HL-60 cells using a
Rhotekin-GST pull down assay. In cells treated with PGE2 for 5 min, Rho-GTP levels
showed a 2.6 ± 0.9 (s.d.) fold increase relative to untreated cells (n=7). (B) Loss of Rac1
GTPase activity in response to PGE2. Rac1-GTP levels were determined in lysates of
HL-60 cells using a biotinylated Pak1 peptide. In cells stimulated with PGE2 Rac1 activ-
ity was decreased, 0.5 ± 0.2 (s.d.)-fold relative to untreated cells (n=6). (C) Loss of
Cdc42 GTPase activity in response to PGE2. Cdc42-GTP levels were determined in
lysates of HL-60 cells using a biotinylated Pak1 peptide. In cells stimulated with PGE2
Cdc42 activity was decreased, 0.7 ± 0.2 (s.d.)-fold relative to untreated cells (n=6).
(D/E) Activation of the small GTPase RhoA in response to PGE1-OH or 8-Bromo-cAMP.
GTP-RhoA levels were determined in lysates (pd: pull down, TL: total lysate) of HL-60
cells using a Rhotekin-GST pull down assay. (D) In cells treated for 5 min with an EP4
agonist (PGE1-OH), Rho-GTP levels showed a 1.6 ± 0.5 (s.d.) fold increase relative to
untreated cells (n=8). (E) In cells treated for 5 min with 8-Bromo-cAMP (8-Bromo, 200
µM), which elevates cAMP levels, Rho-GTP levels showed a 2.5 ± 0.9 (s.d.) fold
increase relative to untreated cells (n=5). Asterisks indicate significant differences
(P<0.05).
PGE2 (Fig. 6A). We similarly determined Rac1 and Cdc42 activity in
response to PGE2 stimulation using a biotinylated Pak1 peptide.
Stimulation with PGE2 led to a decrease in Rac1 activity (0.5 fold of
control) and a comparable decrease in Cdc42 activity (0.7 fold of
control) (Fig. 6B and C), whereas the total amount of Rac1 and
Cdc42 remained constant. These results indicate that PGE2-induced
podosome dissolution involves activation of RhoA accompanied by
inactivation of Rac1 and Cdc42. 
In addition, the activity of RhoA was determined upon stimulation
with butaprost or PGE1-OH, EP2 and EP4 agonists respectively.
Stimulation with butaprost did not change the amount of active RhoA
(1.1 fold of control) (data not shown), whereas PGE1-OH led to an
increase in RhoA activity (1.6 fold of control) (Fig. 6D). These find-
ings are consistent with our observation that PGE2-mediated
podosome dissolution in these cells appears to be predominantly
mediated by EP4. Furthermore, the effect of the cAMP-analog 8-
Bromo-cAMP on RhoA activity was investigated. Hence we deter-
mined that a 5 minute stimulation with 8-Bromo-cAMP led to 2.5 fold
increase in RhoA activity (Fig. 6E). Together, these findings suggest
that raising cAMP levels, by stimulation of EP-receptors, leads to
activation of RhoA. 
PGE2-induced podosomes dissolution is mediated by Rho
kinase.
We subsequently investigated a role for Rho kinase, a prominent
downstream effector of RhoA, in PGE2-induced podosome dissolu-
tion. The Rho kinase inhibitor Y27632 [23] effectively blocked
podosome dissolution induced by PGE2 in DCs (from 22 ± 3% with
PGE2 to 69 ± 5% with PGE2 and Y27632) (Fig. 7A) as well as HL-60
cells (data not shown). In addition, EP2 and EP4 agonist-induced
podosome loss was effectively blocked by Y27632 (Fig. 7A).
Podosome dissolution induced by IBMX or IBMX/forskolin was simi-
larly blocked by Rho kinase inhibition (from 13 ± 5% with IBMX to 80
± 4% with IBMX and Y27632) (Fig. 7B). The distribution of
podosomes in response to Y27632 treatment alone was unaffected,
whereas when cells were treated with Y27632 in combination with
PGE2, podosomes were still present (Fig. 7C). We conclude that
PGE2 receptors that are present on dendritic cells as well as HL-60
monocytic leukaemia cells signal to activate the RhoA-Rho kinase
axis and promote actomyosin-based contractility, leading to
podosome dissolution and the formation of FAs. 
PGE2 signals via Rho kinase in DCs
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Movies can be found at http://www.ncmls.eu/NCMLS/Visual
/movie.asp
Discussion
In response to antigen uptake and exposure to inflammatory stimuli
iDCs mature into highly migratory mDCs [5]. PGE2, a proinflammato-
ry mediator and maturation-inducing factor is essential for the induc-
tion of full migratory capacity in DCs [9, 12, 24]. Immature DCs dis-
play podosomes while part of the cells also displays vinculin-con-
taining adhesions at the cell periphery. The presence of zyxin in
these structures identifies these as FAs [15]. Upon stimulation with
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Figure 7. Podosome loss induced by PGE2, EP-agonists and elevated cAMP-induced
podosome loss is mediated by Rho kinase. 
(A) Rho kinase inhibition blocks PGE2- and EP-agonist induced podosome dissolution.
iDCs seeded on FN-coated coverslips were left untreated or stimulated with PGE2 for 5
min, butaprost (buta, 2 µM for 15 min) or PGE1-OH  (5 µg/ml for 30 min) in the presence
or absence of Y27632 (20 µM for 1 h) or treated with Y27632 alone and stained with
anti-vinculin mAb and phalloidin-Texas Red to detect F-actin. The number of cells dis-
playing podosomes was determined in 7 images per condition per experiment and an
average (with SEM) of 3 experiments is shown. (B) IBMX and IBMX/forskolin-induced
podosome dissolution is efficiently blocked by Y27632. iDCs seeded on FN-coated cov-
erslips were left untreated or stimulated with IBMX (10 µM for 5 min) or IBMX with
forskolin (IBMX/fors, both 10 µM for 5 min) in the presence or absence of Y27632 (20
µM for 1 h) or with Y27632 alone, and stained with anti-vinculin mAb and phalloidin-
Texas Red (to detect F-actin). The number of cells displaying podosomes was counted
in 7 images per condition per experiment and an average (with SEM) of 3 experiments
is shown. Asterisks indicate significant differences (P<0.05). (C) Rho kinase inhibition
blocks podosome loss in response to PGE2, EP2/EP4-agonists or cAMP elevation.
Representative images are depicted.
PGE2, iDCs rapidly dissolve podosomes and start to form FAs, sug-
gesting that signals inducing podosome dissolution favor the forma-
tion of FAs. When, after prolonged exposure to PGE2, the transition
from strongly adhesive iDCs to highly migratory mDCs is made, the
amount of cells displaying FAs gradually decreases. 
Because transfection of fluorescently-labeled proteins in primary
DCs is difficult, we applied IRM to follow the effects of PGE2 on DC
adhesion structures in living cells. With this technique, which has
been previously used to visualize either FAs or podosomes [25-27],
structures close to the glass, such as podosomes and FAs, come out
dark whereas structures further away from the glass appear lighter.
By combining IRM with immunofluorescence detection after fixation,
we confirmed that the dark spots observed by IRM correspond in size
and localization to the actin-rich cores of podosomes. The latter may
seem counter-intuitive, as the (integrin containing) podosome rings
are the primary sites for adhesion; however, the fact that podosomes
are highly protrusive structures driven by actin polymerization in the
core may explain why the podosome core appears closer to the glass
than the surrounding ring structure [3, 4, 28]. Interestingly, podosome
dissolution is invariably preceded by the transient appearance of
bright rings in the IRM image, surrounding the actin-rich cores. By in
situ fixation of podosomes undergoing dissolution, we showed that at
the time these bright rings appear, vinculin is no longer present in
these podosome-remnants, whereas the actin-rich cores, as well as
associated zyxin are still clearly detectable. Together these results
suggest that initial changes affect the podosome ring prior to (com-
plete) dissolution of the actin core. 
Mouse knockout studies have revealed an important role for EP4 in
Langerhans cell migration [29], while in humans, both EP2 and EP4
have been linked to DC function [30]. In line with earlier findings [31],
expression of EP2/EP4 but not EP1/EP3 was detected in DCs. The
effects of specific EP4-(ant)agonists implicate this receptor in PGE2-
induced podosome loss. Similarly, the effects of a specific EP2 ago-
nist and the lack thereof in response to an EP1/EP3 agonist similar-
ly support a role for the EP2 receptor in PGE2-mediated podosome
loss. These pharmacological studies, combined with the observed
expression pattern, suggest that these PGE2-induced responses in
DCs are mediated by EP2/EP4 receptors both of which signal
through Gs to elevate cAMP levels [16]. Indeed we observed that
raising cAMP levels mimics the effects of PGE2 on podosome disso-
lution. 
Although podosome formation has been studied in some detail,
much less is known about signaling mechanisms that trigger
PGE2 signals via Rho kinase in DCs
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podosome dissolution. Small GTPases of the Rho family (RhoA,
Rac1 and Cdc42) are key regulators of adhesion dynamics that con-
trol the formation and turnover of filamentous actin as well as micro-
tubules, and modulate myosin II-based contractility [21, 22]. In
endothelial cells, podosome organization is regulated by RhoA and
Cdc42 [32] and in Src-transformed fibroblasts active RhoA localizes
to podosomes [33]. Inhibition of RhoA maintains the podosome belt
at the osteoclast periphery despite depolymerization of microtubules
by nocodazole [34], suggesting that RhoA activity is needed to
induce podosome loss. Consistent with these observations in osteo-
clasts, we found that PGE2-induced podosome dissolution involves
activation of RhoA. Ourselves and others have shown that activation
of RhoA is often accompanied by a loss of Rac1 activity, whereas
active forms of these two Rho GTPases often produce opposite
effects on the cytoskeleton [35, 36]. Indeed, PGE2-mediated activa-
tion of RhoA is accompanied by a decrease in activity of both Rac1
and Cdc42. It was shown earlier that Rac1 as well as Cdc42 are
needed for podosome formation in DCs [11], while the Cdc42/Rac1-
regulated kinases Pak1 and Pak4 either induce podosome formation
or reduce podosome turnover [37-39]. Another effector of Cdc42, the
Wiskott Aldrich Syndrome protein (WASp), also plays an essential
role in the formation and maintenance of podosomes in both in
human macrophages [40] and endothelial cells [32], whereas WASp
deficient DCs and macrophages lack podosomes [6, 40]. Together,
these data suggest that PGE2-mediated activation of RhoA combined
with a simultaneous inactivation of Rac1 and Cdc42 contribute to the
dissolution of podosomes in DCs and HL-60 cells. 
In most cell types cAMP-mediated activation of PKA antagonizes the
effects of RhoA on actomyosin contractility, leading to cytoskeletal
relaxation [41-43]. In DCs however, PGE2 stimulation appears to
induce a contractile response while activating RhoA. Similar to PGE2,
we observed cytoskeletal contraction and increased RhoA-GTP lev-
els in response to EP-agonists as well as to stimulation with the
cAMP-analog 8-Bromo-cAMP. In addition, stimulation with a PKA
activator resulted in increased levels of RhoA-GTP in HL-60 cells,
whereas PKA inhibition interfered with PGE2-induced podosome loss
in DCs (results not shown). Together these results indicate that acti-
vation of RhoA as well as PGE2-induced podosome dissolution is
mediated by cAMP-PKA signaling. 
In most adherent cells, the formation of stress fibers and stable FAs
is triggered by activation of RhoA and its downstream effector Rho
kinase, promoting actomyosin contractility [21]. Rho kinase acts by
promoting phosphorylation of the myosin II regulatory light chain [44,
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45]. In addition, Rho kinase activity can enhance stress fiber forma-
tion by inactivation of the actin severing protein cofilin [46], whereas
direct activation of mDia by RhoA stimulates actin polymerization [21,
47]. Therefore, we assessed the effects of Rho kinase inhibition on
PGE2-induced podosome dissolution. In smooth muscle cells, phor-
bol-dibutyrate-induced podosome formation appears to be Rho
kinase independent [48, 49]. In our experiments however, inhibition
of Rho kinase not only effectively interfered with podosome dissolu-
tion induced by PGE2, but also interfered with that induced by EP-
agonists and by elevated cAMP levels. This effect of Rho kinase was
observed in primary DCs as well as in HL-60 cells, demonstrating
that PGE2-induced podosome dissolution is dependent on Rho
kinase activity both in DCs and these monocytic leukaemia cells.
This is the first demonstration that (cAMP elevating) EP2/EP4 recep-
tors can signal to activate the RhoA-Rho kinase axis, and our results
indicate that inhibition of RhoA signaling downstream of cAMP is not
a universal principle. 
A number of studies have implicated myosin II in podosome-regula-
tion. For instance, formation of podosomes was shown to involve
(local) inhibition of myosin II in smooth muscle cells as well neurob-
lastoma cells [49, 50], whereas in macrophages [51] or fibroblasts
[52] myosin II-based activity is needed for the formation and mainte-
nance of these structures.
Although these different experimental outcomes may be in part
dependent on cell type or culture conditions, we propose that basal
myosin IIA activity is required for the formation and maintenance of
podosomes, whereas a sudden (stimulus induced) increase in
myosin II activity may trigger podosome dissolution. This idea is sup-
ported by our findings that relatively low concentrations of blebbis-
tatin (10 µM) effectively block PGE2-induced podosome loss without
affecting podosome turnover, whereas higher concentrations (40-100
µM) interfere with the formation and/or maintenance of these struc-
tures [51, 52]. Hence we conclude that, dependent on cell type and
experimental conditions, local changes in myosin II activity can either
trigger formation of podosomes or contribute to their demise. 
In mammalian cells three myosin II isoforms have been identified,
known as myosin IIA, myosin IIB and myosin IIC [53-55]. Here we
show that myosin IIA, the predominant isoform expressed in DCs,
localizes to podosome rings, whereas only trace amounts of myosin
IIB are present. Although we cannot exclude a role for myosin IIB in
podosome dissolution in DCs, the prominent expression and local-
ization of myosin IIA to podosome-rich areas of the cells, suggest
that this myosin isoform is primarily involved in PGE2-mediated
PGE2 signals via Rho kinase in DCs
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podosome dissolution. Pharmacological inhibition of myosin II func-
tion, using blebbistatin, demonstrated a requirement for myosin II in
PGE2-induced podosome dissolution. In addition, PGE2 stimulation
in DCs leads to a noticeable change in myosin II distribution, from a
punctuate cytosolic pattern to a more fibrillar distribution. These fib-
rillar structures are reminiscent of the myosin II ribbons described in
fibroblasts [56] and most likely reflect increased association with F-
actin and/or a change in solubility of myosin filaments.
We have shown previously, in mouse neuroblastoma cells, that phar-
macological inhibition of myosin II leads to a loss of focal adhesions
accompanied by the formation of podosomes [50]. In addition,
WASp-interacting-protein deficient DCs lack podosomes, but still
form FAs [25]. Furthermore, in avian multinucleated giant cells dis-
ruption of the microtubules by nocodazole induced the loss of
podosomes accompanied by the formation of stress fibers and FAs
and activation of RhoA and inactivation of Rac1, whereas repoly-
merization of microtubules induced loss of FAs and reformation of
podosomes [57]. These findings suggest that, in different cell types,
podosomes and FAs are oppositely affected by Rho GTPase activity
and actomyosin contractility. Hence we propose that localized
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Figure 8. Regulation of adhesion dynamics in dendritic cells by PGE2.
PGE2 signaling, mediated by EP2 and EP4 receptors leads to elevation of the level of
cAMP, activation of RhoA and inactivation of Rac1.  PGE2-mediated activation of RhoA
promotes Rho kinase activity and, subsequently, myosin II dependent contraction, lead-
ing to podosome dissolution and FA formation. By contrast, pathways leading to activa-
tion of Rac1 are known to promote podosome formation and induce cytoskeletal relax-
ation accompanied by a loss of FAs.
changes in actin dynamics in combination with the contractile state of
a cell, determine whether FAs or podosomes are formed. 
Besides enabling high-speed migration, PGE2-induced podosome
dissolution could have additional functions. It may serve to redeploy
actin to other processes in the cell, such as vesicle movement, which
has been linked to podosome dynamics [58, 59]. Furthermore, micro-
tubules were shown to influence FA and podosome dynamics, an
effect that could be mediated by (microtubule dependent) vesicle
transport [51, 60]. In mouse DCs a loss of podosomes was associat-
ed with a transient increase in antigen uptake [8]. Similarly, we
observed a moderate increase in antigen uptake in human DCs
shortly after stimulation with PGE2 (data not shown). Thus in addition
to enabling high-speed migration, podosome dissolution in DCs
could transiently enhance antigen uptake and thereby add to the
induction of immune responses. 
As summarized in the model shown in Fig. 8, our data show that
PGE2 mediates podosome dissolution by myosin II-mediated con-
tractility downstream of both RhoA and Rho kinase activation. This is
the first report showing activation of the RhoA-Rho kinase axis down-
stream of receptors (EP2/EP4) known to couple to cAMP elevation.
Moreover, our data provide novel insights in the dynamics of the DC-
cytoskeleton and its regulation during the induction of DC-matura-
tion. 
Materials and methods
Chemicals and antibodies
Antibodies used were: mIgG1 (Becton Dickinson & Co.), GaM-
ATTO633, anti-vinculin and anti-myosin IIB (Sigma), anti-myosin IIA
(Biomedical Technologies Inc.), anti-myosin IIC (obtained from dr. R.
Adelstein (NIH), anti-RhoA and anti-zyxin (Santa Cruz biotechnolo-
gy), anti-Rac1 (Upstate biotechnology, Millipore), IRDye 800 CW-
labeled secondary antibodies (LI-COR Biosciences), and Alexa Fluor
488-labeled secondary antibodies and Texas Red-conjugated phal-
loidin (Molecular Probes). Chemicals used were: blebbistatin,
Y27632 and PMA (Calbiochem), FN, butaprost, sulprostone,
AH23848, AH6809, IBMX, forskolin and 8-Bromo-cAMP (Sigma),
and PGE1-OH (Cayman chemical company). PGE2 was used at 10
µg/ml (Pharmacia & Upjohn). 
Isolation of monocytes, preparation of DCs and cell culture
DCs were generated from peripheral blood mononuclear cells as
described previously [7]. Expression of major histocompatibility com-
plex class I/II, costimulatory molecules and DC-specific markers
PGE2 signals via Rho kinase in DCs
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were measured by flow cytometry on iDCs d6 and expression was
similar to what was described before (data not shown) [7]. HL-60
cells (generous gift from Dr. L. Machesky) were cultured in IMDM
medium (Invitrogen) supplemented with 10% (v/v) FCS (Greiner).
N1E-115 cells were cultured in DMEM medium (Invitrogen) supple-
mented with 10% (v/v) FCS.
Fluorescence microscopy
Fluorescence microscopy was performed as described previously
[9]. A Leica DMRA fluorescence microscope with 63x PL APO 1.3 NA
or 40x PL FLUOTAR 1.0 NA oil immersion lens and COHU high per-
formance integrating CCD camera were used. Pictures were ana-
lyzed with Leica Qfluoro version V1.2.0 and Adobe Photoshop 7.0
software. 
Interference Reflection Microscopy (IRM)
IRM was performed using a Zeiss LSM 510-meta microscope with
488 nm laser with a band pass filter at 470-500 nm or 633 nm laser
with a long pass filter at 560 nm and a Plan-Apochromatic 63x 1.4 NA
oil immersion DIC lens (Carl Zeiss GmbH). Cells were seeded on
FN-coated Willco glass bottom dishes (Willco Wells BV) and either
fixed and stained for vinculin and actin before fluorescent and IRM
images were obtained, or cells were live-imaged in IRM mode with
20-second intervals at 37°C in RPMI 1640 without phenol red
(Invitrogen) during addition of PGE2. In addition, cells were live-
imaged in IRM mode and fixed while podosomes were dissolving
upon PGE2 stimulation and stained for actin and vinculin, myosin IIA
or zyxin and fluorescent and IRM images were obtained. Cells were
imaged using Zeiss LSM Image Browser version 32 and images
were processed with Image J version 1.32j software (National
Institutes of Health, http://rsb.info.nih.gov/ij). 
RT-PCR
RNA was isolated from iDCs, mDCs and HL-60 cells with Trizol
reagent (Gibco) according to the instruction of the manufacturer. A
RT-PCR was performed using a T3 Thermocycler at 20°C for 10 min,
42°C for 45 min and 95°C for 10 min. An annealing temperature of
55°C with 30 cycles was used. The following primers were used: EP1
forward, 5'-ATCATGGTGGTGTCGTGCATC-3'; EP1 reverse, 5'-
GGTCCAGG ATCTGGTTCCAG-3'; EP2 forward, 5'-ATGACCAT-
CACCTTCGCC-3'; EP2 reverse, 5'-CAAAGACCCAAGGGTCAATT-
3'; EP3 forward, 5'-GTATGCGAGCCACATGAAGA-3'; EP3 reverse,
5'-CAGAGGCGAAGAAAAGGTTG-3'; EP4 forward, 5'-TCCTGGCTT
100
TTGAGCACTTT-3'; EP4 reverse, 5'-CCTCTGCTGTGTGCCAAATA-
3'; actin forward, 5'-GCTACGAGCTGCCTGACGG-3'; actin reverse,
5'-GAGGCCAGGATGGAGCC-3'.
RhoA-, Rac1- and Cdc42-activation assay and myosin II iso-
form detection
RhoA, Rac1 and Cdc42 pull down experiments were performed as
described previously [61]. Samples were analyzed by Western blot-
ting using a mouse anti-RhoA or anti-Rac1 or a rabbit anti-Cdc42
antibodies. Cell lysates were analyzed for myosin II isoform expres-
sion by Western blotting using rabbit anti-myosin IIA, -myosin IIB or
-myosin IIC antibodies. Samples were analyzed on an Odyssey
infrared imaging system (LI-COR Biosciences).
Statistical analysis
ANOVA or the two-tailed t test were used for statistical analysis.
Significant differences or significant differences from control are indi-
cated with asterisks (p<0.05).
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Abstract
Dendritic cells (DCs) are professional antigen presenting cells and
play a key role in the initiation of adaptive immune responses. During
their life DCs encounter and interact with very different tissue envi-
ronments. How physical as well as chemical parameters of their
microenvironment affect DCs, in particular cell-substrate adhesion, is
largely unknown. Here, we investigate how DCs respond to changes
in substrate composition, physicochemical properties or topology.
We find that DCs adhere to and form specific adhesion structures,
known as podosomes, on a variety of substrates. Clearly, hydropho-
bicity or substrate composition do not appear to have much effect on
DC adhesion or podosome formation in vitro. To investigate the
effects of substrate area dimensions on cell adhesion, surfaces con-
sisting of permissive and non-permissive substrates are needed. We
show that hydrogels are non-permissive for DC-adhesion and, in
combination with microcontact printing, can be used to create sub-
strate-areas with well-defined sizes. This should allow us to deter-
mine the minimal contact area required for efficient DC adhesion.
Interestingly, we observed that podosome formation is strongly trig-
gered by changes in substrate topology. Specifically, podosomes
preferentially form on the edges of height patterns, suggesting that
mechanical stress induced by the slopes of these patterns triggers
the local formation of podosomes. 
Introduction
Dendritic cells (DCs) are the most potent antigen presenting cells of
the immune system [1]. Immature DCs (iDCs) specialized in antigen
recognition and uptake are adhesive, while antigen presenting
mature DCs (mDCs) are highly migratory [2-5]. The adhesive and
migratory properties are tightly regulated during the DC life cycle and
dependent on interactions with elements of the micro-environment,
such as the extracellular matrix (ECM). The ECM provides stability
and is able to sequester growth factors and cytokines. The main
components of the ECM are glycosaminoglycans often linked to pro-
teins to form proteoglycans and fibrous proteins, such as fibronectin,
collagen and laminin. DCs adhere to collagen and laminin, although
fibronectin is the preferred substrate in vitro [6, 7]. Regulation of
expression and activity of adhesion receptors is important for DCs [8-
12]. For example, DCs express the fibronectin binding integrins α4β
1 and α5β1, but the adhesion to fibronectin is exclusively α5β1-inte-
grin dependent [3, 13] while the activity of this receptor is downregu-
lated during DC maturation [8]. 
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In addition to regulating the activity of adhesion receptors and the
spacing of ligands [14], the organization of adhesion receptors into
specialized adhesion structures is important. When seeded onto 2-
dimensional surfaces, most adherent cells form (integrin containing)
adhesion structures, such as focal adhesions (FAs) or podosomes.
FAs are relatively stable structures connected to actin stress fibers
and present in a broad range of cell types [15, 16]. Podosomes are
more dynamic structures [8, 17] found in Src-transformed cells,
endothelial cells and cells of the myeloid lineage, such as osteo-
clasts, monocytes, macrophages and DCs [18, 19]. Podosomes
have a characteristic morphology consisting of an actin core sur-
rounded by a ring containing integrins and structural proteins, such
as vinculin. Although FAs can also be found in iDCs, the main adhe-
sion structures in these cells are podosomes [5, 15, 19]. We have
shown earlier [8] that DC maturation involves the rapid dissolution of
podosomes, which is presumably required to accommodate the high
speed migration observed in these cells. Hence, regulation of cell-
substrate adhesion and adhesion structures is carefully controlled
during the DC life cycle.
The adhesive properties of cells, including DCs, are influenced by
intrinsic factors, such as differentiation or the contractile state of the
cell, while external stimuli also affect adhesive behavior. It is becom-
ing increasingly clear that also the physical aspects of the cellular
environment can affect adhesive behavior. For instance, the flexibili-
ty of the substrate influences the adhesive properties of cells [20, 21].
In addition, also the hydrophobicity of the substrate is known to influ-
ence cell adhesion, with hydrophobic surfaces being less permissive
for adhesion than hydrophilic surfaces [22]. However, how such
aspects influence the adhesive properties of DCs is largely unknown.
As DCs encounter a range of different tissue environments during
their life cycle, we explored how DC adhesion is affected by sub-
strate composition, - topology and - shape.
Results
DCs form podosomes on different components of the ECM. 
Knowing that DCs form podosomes and FAs on fibronectin, we
examined whether DCs are also able to form these structures on
other ECM components or substrates. Therefore, iDCs were seeded
on fibronectin, laminin or gelatin. Indeed we found that DCs generat-
ed podosomes as well as FAs on these ECM components (Figure
1A). In addition to these integrin substrates, iDCs were seeded on
uncoated glass and poly-L-lysine (PLL), a positively-charged
DCs on micro-patterned substrates 
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aminoacid used to promote cell adhesion to poorly adhesive sur-
faces. Surprisingly, DCs not only attached but also formed prominent
podosomes and FAs on glass and PLL (Figure 1A). Moreover, the
amount of DCs able to form podosomes or FAs was similar on all
substrates (Figure 1B and data not shown). Podosome formation
was not affected by the presence or absence of serum in the medi-
um (data not shown). These findings show that DCs can form
podosomes as well as focal adhesions on 2-D surfaces irrespective
of matrix composition or charge. 
Hydrophobicity influences FA-formation, but not podosome
formation in DCs.
The hydrophobicity of a substrate affects the ability of cells to adhere
with hydrophobic surfaces generally being non-permissive. To test
the effect of hydrophobicity on DC adhesion, we tested a range of
108
Figure 1. DCs form podosomes on different substrates
(A/B) DCs were seeded on coverslips coated with fibronectin, gelatin or laminin, uncoat-
ed or PLL coated coverslips. The cells were fixed and stained with an anti-vinculin mAb
(green) and phalloidin-Texas Red (red) to detect F-actin. (A) Representative images are
depicted. (B) The number of cells displaying podosomes was counted in 7 images per
condition per experiment and an average (with SD) of 2 experiments is shown.
substrates with different hydrophobicity. From hydrophobic to more
hydrophilic we used: Teflon, polystyrene (PS), poly(ethylene naph-
thalate) (PEN) and poly(methyl methacrylate) (PMMA). Surprisingly,
the DCs attached and formed podosomes and FAs on each of these
substrates (Figure 2A). The amount of cells that formed podosomes
was comparable in all conditions, however FAs were much more fre-
quently observed when cells were seeded on hydrophobic surfaces
(Fig. 2B). These results indicate that hydrophobicity does not affect
DC adhesion to 2-D surfaces per se, but may affect the type of adhe-
sion structures formed.
Hydrogels are non-permissive for DCs, but upon spotting or
microcontact printing become locally permissive allowing
DCadhesion and podosome formation.
In addition to hydrophobicity, we wanted to assess how the relative
size of the adhesive surfaces may affect cell adhesion and the for-
mation of specific adhesion structures in DCs. Therefore, a surface
composed of adhesive and non-adhesive areas is needed. For DCs
this is problematic as they adhere even to hydrophobic substrates,
such as Teflon, which are non-permissive for most cell types.
Hydrogels consist of a type of poly(ethylene glycol) (PEG) coating
DCs on micro-patterned substrates 
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Figure 2. FA formation, but not adhesion and podosome formation, are regulated by
substrate hydrophobicity 
(A/B) DCs were seeded on materials of different hydrophobicity. From hydrophobic to
hydrophilic: Teflon, PS, PEN and PMMA.  The cells were fixed and stained with an anti-
vinculin mAb (green) and phalloidin-Texas Red (red) to detect F-actin. (A)
Representative images are depicted. (B) The number of cells displaying podosomes or
FAs was counted in 7 images per condition. The average amount of cells displaying
podosomes or FAs (with SD) is shown. Significant differences from Teflon are indicated
with asterisks (p<0.05).
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Figure 3. DCs adhere specifically to spotted and microcontact-printed areas of hydro-
gels
(A) Solutions of fibronectin, PLL with PMA or PLL with zymosan-FITC (green) were
spotted onto hydrogels. DCs were seeded onto these hydrogels and fixed and stained
with an anti-vinculin mAb (green) (except when zymosan-FITC was present) and phal-
loidin-Texas Red (red) to detect F-actin. The edge of the spotted area is depicted with
a dotted line. Representative images are depicted. (B) A solution of fibronectin with
KLH-Alexa488 (green) was spotted onto hydrogels. DCs were seeded onto these
hydrogels and fixed and stained with phalloidin-Texas Red (red) to detect F-actin.
Representative images are depicted. (C) The method of microcontact printing. A PMMA-
stamp with an array of dots of different size and spacing (gray) is incubated with the pro-
tein mixture to be printed (green). Excess solution is removed and the stamp covered
with the remaining protein solution is placed onto the hydrogel (blue), which is coated
on a glass slide (darker blue). The stamp can be removed and a pattern of printed pro-
tein is left on the hydrogel. DCs (red) can be seeded on these printed hydrogels. (D)
DCs were seeded on the fibronectin/rIgG1-FITC (green) printed hydrogel and fixed and
stained with phalloidin-Texas Red (red) to detect F-actin. A representative image with 25
µm dots is depicted in the left panel and representative images form 10 µm dots are
depicted. A higher magnification of part of the image is shown in the upper left corner of
the overlay.
that prevents adhesion of cells. Therefore, we tested if DCs adhesion
would be impaired on uncoated hydrogel. Indeed we found that DCs
were unable to adhere to the uncoated hydrogel, but efficiently
adhered to parts of the hydrogel spotted with fibronectin, PLL or PLL
in combination with FITC-labeled zymosan (Figure 3A). Proteins and
even big particles, such as the pathogen-mimic zymosan, can be
absorbed onto hydrogels (Figure 3A). In addition, hydrogels were
spotted with fibronectin mixed with Alexa488-labeled keyhole limpet
hemocyanin (KLH). Similarly to the other proteins, this fluorescent
mixture was absorbed onto the hydrogel. The fluorescence disap-
peared specifically underneath podosome clusters (Figure 3B), sug-
gesting that these proteins are degraded underneath podosomes. In
addition to spotting proteins, we wanted to test whether microcontact
printing would work on hydrogels, since this would allow a precise
spacing of adhesive substrates. The process of microcontact printing
is depicted in Figure 3C. A poly(dimethyl siloxane) (PDMA)-stamp, in
our case with an array of different sized dots with different spacing,
was incubated with (inking) fibronectin mixed with rIgG1-FITC for
visualization. Excess protein solution is removed and the stamp cov-
ered with the fibronectin mixture can be put onto the hydrogel leav-
ing a pattern of different sizes of fibronectin/rIgG1-FITC dots on the
hydrogel. Then DCs can be added and left to adhere. Indeed, this
method was highly effective as the DCs only formed podosomes on
the well-defined printed areas (Figure 3D). These findings indicate
that hydrogels are a promising tool to study effects of the size of the
permissive area and the spacing thereof on adhesion and podosome
formation. 
DCs can sense and respond to changes in substrate topology.
To explore potential effects of substrate topology on cell adhesion,
we used substrates consisting of higher and lower parts of variable
width. Teflon substrates with a height of 0.5 µm and width of 2, 5, 10
and 20 µm were generated. Surface topology was evaluated by
atomic force microscopy (AFM), in order to confirm that the dimen-
sions of the substrates resemble the expected height and width
(Figure 4A). We observed that the DCs adhere to these substrates
and the podosomes specifically aligned on the edges of these Teflon
ridges (Figure 4B). Within these podosomes-alignments substruc-
tures were still recognizable as individual podosomes. On the 2 µm
wide substrates, a double row of podosomes was formed while very
few podosomes were found on other parts of the substrate (Figure
4B left panel). When the distance between the Teflon ridges became
wider than 2 µm, podosomes and FAs were observed on the flat
DCs on micro-patterned substrates 
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areas. (Figure 4B). In addition to Teflon, the same effect was
observed on PS, PEN and PMMA 3-D substrates (Figure 4C), con-
firming that the material itself had little effect on podosome align-
ment. Furthermore, Teflon substrates of other heights were tested to
investigate how DC-podosome formation was affected by height dif-
ferences. Substrates containing ridges of 1 and 0.1 µm were tested
in addition to the 0.5  µm high substrates used above. Alignment of
podosomes at the edges of these substrates was observed in all
cases (Figure 4D), showing that DCs can sense a height difference
of 0.1 µm. In addition, the same effect was observed with PMMA 3-
D substrates (data not shown), again showing that the type of mate-
112
Figure 4. DCs align podosomes on the angles of substrates with higher and lower parts
(A) The topology and shape of Teflon substrates as determined by AFM. (B) DCs were
seeded on Teflon substrates of 0.5 µm high and 2, 5, 10 or 20 µm wide. Cells were fixed
and stained with an anti-vinculin mAb (green) and phalloidin-Texas Red (red) to detect
F-actin. Representative images are depicted. (C) DCs were seeded on PS, PEN and
PMMA substrates with different topologies. The cells were fixed and stained with an
anti-vinculin mAb (green) and phalloidin-Texas Red (red) to detect F-actin.
Representative images of the 10 µm wide lines are depicted. (D) DCs were seeded on
Teflon substrates of 1 and 0.1 µm high. The cells were fixed and stained with an anti-
vinculin mAb (green) and phalloidin-Texas Red (red) to detect F-actin. Representative
images of 5 µm wide substrates are depicted.
rial does not affect the ability of the DCs to respond to these changes
in substrate topology. 
In addition to the ridges used above, other shapes were also tested.
Rods of 5 by 2 µm with rounded edges were used in 2 orientations,
octagons with squares of 25 µm on each side each and circles of 2
µm width and a diameter of 50 µm were scanned by AFM (Figure
5A). Also on these substrates DCs aligned podosomes on the edges
(Figure 5B). In addition, we observed that the DCs maximized their
contact area to the edges of the octagons with squares and circles
by spreading along the edge. The podosome alignment observed on
these substrates suggest that topography but not the shape of the
substrate determines where podosomes are formed. Taken together,
we postulate that the sharp angle at these topographic boundaries
induces curvature of the cell membrane resulting in mechanical
stress, which triggers podosome formation at these sites.
Discussion
The adhesive properties of cells are influenced by cell intrinsic fac-
tors, but also by the type of substrate they encounter [14, 15, 23-25].
Here we show that ECM components support DC-adhesion,
podosome- and FA-formation. In addition, DCs adhere and form
podosomes and FAs on PLL and glass, showing that DCs can
adhere and form adhesion structures on 2-D surfaces irrespective of
the type of substrate. Whether integrins are involved in adhesion to
DCs on micro-patterned substrates 
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Figure 5. DCs align podosomes on differentially shaped substrates with high and low
parts
(A) The shape and topology of Teflon substrates determined by AFM scanning. Rods of
5 by 2 µm in 2 orientations, octagons with on each side squares of 25 µm and circles of
2 µm width and a diameter of 50 µm. (B) DCs were seeded on Teflon shapes. The cells
were fixed and stained with an anti-vinculin mAb (green) and phalloidin-Texas Red (red)
to detect F-actin. Representative images are depicted.
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glass and PLL is unclear at this point. However, it is likely that there
is some role for integrins since integrin-containing adhesion struc-
tures, such as podosomes and FAs, are formed upon ligand binding
by integrins. It would be interesting to investigate the involvement of
integrins in the adhesion and formation of these structures on non-
ECM components by using blocking antibodies. Hydrophobicity is
one of the physical aspects known to influence cell adhesion. For
instance, fibroblasts were shown to adhere best to the least
hydrophobic substrates on a range of substrates with similar chemi-
cal properties but different hydrophobicity, [22]. In addition,
hydrophobic substrates, such as Teflon, are often used to avoid cell
adhesion. Surprisingly, DC adhesion is does not appear to be much
affected by the hydrophobicity of the substrate. The number of cells
with podosomes, the most prominent adhesion structure in DCs, is
unaffected, although the number of cells displaying FAs increases
somewhat on hydrophobic substrates. 
In addition to hydrophobicity, the size and spacing of the adhesive
area can influence cell adhesion. To be able to investigate these
properties, substrates consisting of adhesive and non-adhesive
areas are needed. Teflon or other hydrophobic surfaces are often
used as non-permissive substrate, however for DCs this is not feasi-
ble as these cells can still efficiently adhere to these surfaces.
Therefore, we have sought for alternative substrates. Hydrogels are
designed for use in DNA and protein microarrays and consist of poly-
mer with NHS-ester-groups that can react with amines [26]. These
hydrogels show a very low non-specific binding thus minimizing
background. Untreated hydrogels were non-adhesive even for DCs
and can be used to produce a substrate containing adhesive
(fibronectin or PLL) and non-adhesive (untreated) areas. These
adhesive areas allow DC-adhesion and podosome formation. In
addition, the disappearance fluorescently-labeled mixtures under-
neath podosomes, which are known to be sites of active matrix
degradation [27-30], shows local degradation on hydrogels.
Together, these data show the potential of hydrogels for studying DC
adhesion on partially permissive substrates.
To control the size and pattern of the adhesive part, microcontact
printing is often used [31-33]. We tested microcontact printing on
hydrogels and found that this method works well, providing us with
the opportunity to start investigating the effect of substrate area size
on adhesion and podosome formation. By applying stamps with sub-
micron size patterns the minimal size required for individual
podosomes to be formed could be determined. 
Another aspect that can influence cell adhesion is the topology of the
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substrate [23, 34]. To investigate this we used substrates in which
ridges were introduced by hot embossing. Surprisingly, we observed
that DCs aligned their podosomes at the topological boundaries on
these substrates. Variations in the height of these ridges had no
effect on the podosome alignment and we observed that DCs could
sense a height difference of 100 nm. The preferred podosome-align-
ment on the topological boundaries, suggests that the angle of the
substrate induces a curvature of the cell membrane resulting in
mechanical stress leading to local podosome formation. It will be
interesting to see if this podosome-alignment is conserved on sub-
strates with different angles. 
By linking the ECM to the inside of the cell (cytoskeleton), integrins
and integrin-containing adhesion structures play a key role in sens-
ing mechanical stresses [25]. The regulation of basic cellular func-
tions, such as differentiation, apoptosis, adhesion and migration, is
dependent on the balance between forces generated by the ECM on
the outside of the cells and forces generated by myosin II-mediated
contraction inside the cell [15, 25]. Cells could sense external forces
in different ways; stretching can lead to an altered organization of an
adhesion structure, to conformational changes in components of the
structures, or to opening of specific (stretch-activated) ion channels
[24, 35-37]. It is well known that FAs increase in size in response to
force and shrink upon relaxation [38]. As the size of FAs is propor-
tional to the force, FAs are considered mechanosensing structures.
The force influencing FAs can be generated externally, through
applied force or shear stress [39-41], or by myosin II-mediated con-
traction [42-44]. An increase in myosin II-mediated contraction leads
to the formation of FAs, while relaxation induces FA disassembly [15,
45, 46]. The effects of contractility on podosomes are less well under-
stood. In addition to FA loss, relaxation of the cytoskeleton was
shown to induces podosome formation in smooth muscle cells and
neuroblastoma cells [45, 46]. Interestingly, we previously demon-
strated that an increase in myosin II-mediated contractility, through
activation of the RhoA-Rho kinase axis, leads to podosome loss in
DCs [47]. This indicates that podosomes and FAs may be inversely
regulated by contractility. The finding that contractility influences
podosomes makes it likely that also forces generated outside the cell
can influence these structures. The effects of substrate topography
on podosome formation show that podosomes are regulated by and
can respond to mechanical stress which suggests that podosomes,
similar to focal adhesions, are mechanosensing structures. The
external forces applied by the substrate on a cell may lead to open-
ing or closing of (stress-activated) ion channels and this in turn could
DCs on micro-patterned substrates 
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induce responses that lead to the local formation of a podosome. To
our knowledge, this is the first report describing effects of mechani-
cal stress on podosome formation. The mechanical effects on for-
mation and regulation of podosomes could have implications for DC-
behavior in different tissues and be important when DC cells
encounter tissue boundaries (for instance when moving from the
peripheral tissues into the lymph vessels).
It would be interesting to see if the effects of physical aspects of sub-
strates on podosomes in DCs are conserved between myeloid cells
and other cells that form podosomes. Information on how physical
aspects of substrates, especially those leading to mechanical stress,
affect podosome formation/turnover will provide much needed insight
into the function and regulation of these structures in DCs or other
podosome-bearing cell types. 
Materials and methods
Chemicals and antibodies
The following antibodies were used: rIgG1-FITC (BD Bioscience
Pharmingen, San Diego, Ca), anti-vinculin (Sigma, St. Louis, MO),
Alexa Fluor 488-labeled secondary antibody (GaM) and Texas Red-
conjugated phalloidin were from Molecular Probes (Molecular
Probes, Leiden, The Netherlands). The following chemicals were
used: fibronectin (Roche, Mannheim, Germany), gelatin, laminin and
PLL (Sigma), PMA and KLH (Calbiochem, Merck, Nottingham, UK),
Teflon, PS, PEN, and impact modified PMMA (Goodfellow Gmbh,
Bad Nauheim, Germany). Zymosan (Sigma) was coupled to FITC
(Sigma) and KLH was labeled with Alexa Fluor 488 labeling kit (GE
Healthcare, General Electric Company, London, UK). Hydrogels are
p-slides form Nexterion (Schott, Mainz, Germany).
Preparation of human DCs
DCs were generated from PBMCs as described previously.
Monocytes were derived from buffy coats or from a leukapheresis
product. Plastic-adherent monocytes were cultured in RPMI 1640
medium (Gibco; Life Technologies, Breda, The Netherlands) supple-
mented with 10% (v/v) FCS (Greiner, Kremsmuenster, Austria), IL-4
(500 U/ml) and GM-CSF (800 U/ml). Immature DCs were harvested
on day 6. Expression of MHC class I/II, costimulatory molecules and
DC-specific markers on DCs were measured by flow cytometry (data
not shown) and the expression of MHC molecules, costimulatory
molecules and DC-markers was similar to what was described before
[3]. Immature DCs expressed MHC class I and II, the costimulatory
molecule CD86, the DC-specific marker CD209/DC-SIGN, low levels
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of the costimulatory molecule CD80 and lacked expression of the
maturation marker CD83. 
Substrate preparation
Different types of substrates: Coverslips were coated with fibronectin
(20 µg/ml) in PBS for 1 hour at 37 C, gelatin (0.01% w/v) in PBS for
30 minutes at 37 C, laminin (20 µg/ml) in PBS for 1 hour at 37 C, PLL
(100 µg/ml) in PBS for 30 minutes at 37 C or left untreated. 
Substrates with parts with different heights: The substrates with dif-
ferent heights of Teflon, PS, PEN and PMMA were made with hot
embossing [48].
Hydrogel spotting: Drops (0.5 µl) of PBS with fibronectin (200 µg/ml),
PLL (100 µg/ml) with 0.2 µM PMA (to enhance podosome formation),
zymosan-FITC (6 mg/ml)/PLL (100 µg/ml) or KLH-Alexa488 (200
µg/ml)/fibronectin (200 µg/ml) were spotted on hydrogels. The spot-
ted hydrogels were washed with PBS and 40000 DCs in 100 µl RPMI
1640 medium with cytokines were seeded. 
Microcontact printing: A silicon wafer was made with photolithogra-
phy. PDMS Sylgard 184 silicone elastomer was mixed with a
crosslinking agent containing a Pt-catalysator (both from Dow
Corning, Midland, MI) in the ratio 10:1. Gas bubbles were removed
in the exsiccator for approximately 30 min. The wafer was placed
with the structured surface faced up and a few ml of the PDMS was
poured onto it. The mixture was degassed again. Polymerization was
achieved during incubation at 60-65°C for approx. 20 h. After poly-
merization, the stamp was peeled off the wafer. The stamps were
incubated with fibronectin (100 µg/ml)/rIgG1-FITC (5 µg/ml) for 1
hour at RT in the dark. The solution is removed and the stamp is
washed with mQ and dried with oil-free N2 using waferguard pistol
(Millipore, Billerica, MA). The stamp is placed on the hydrogel and
removed again. The printed area of the hydrogel is washed with 200
µl PBS and 9x104 DCs in 150 µl RPMI 1640 with cytokines were
seeded. 
Atomic force microscopy 
Surface topography was quantitatively evaluated using a Dimension
atomic force microscope (AFM; Dimension 3100, Veeco, Santa
Barbara, CA). Tapping in ambient air was performed with two types
of cantilevers; for the lines and low patterns, a 118 ?m long high
aspect ratio silicon cantilever (NW-AR5T-NCHR, NanoWorld AG,
Wetzlar, Germany) was used, the rest of the patterns were analyzed
with 100 µm long gold-coated silicon cantilevers (NSG-10, NT-MDT,
Moscow, Russia). Both types have a nominal radius of curvature of
the AFM probe tip less than 10 nm. Height images of each field/sam-
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ple were captured in ambient air at 50% humidity at tapping frequen-
cies of 271 kHz and 261 kHz for the NSG-10 and NW-AR5T-NHCR
cantilevers respectively. The analyzed field was scanned at a scan
rates between 0.2-0.8 Hz and at a 512x256 or 512x512 scanning
resolution. Nanoscope imaging software (version 6.13r1, Veeco) was
used to analyze the resulting images. 
Fluorescent microscopy
DCs were seeded on substrates and left to adhere for 16 h. The cells
were fixed in 3.7% (w/v) formaldehyde in PBS for 10 min. Cells were
permeabilized in 0.1% (v/v) Triton X-100 in PBS for 5 min and
blocked with 2% (w/v) BSA in PBS. The cells were incubated with pri-
mary Ab for 1 hour. Subsequently the cells were incubated with Alexa
Fluor 488-labeled secondary antibodies for 45 min. Subsequently,
cells were incubated with Texas Red-conjugated Phalloidin for 30
min. Images were collected on a Leica DMRA fluorescence micro-
scope with a 63x PL APO 1.3 NA oil immersion lens (or a 40x PL
FLUOTAR 1.0 NA oil immersion lens for overview images) and a
COHU high performance integrating CCD camera (COHU, San
Diego, CA). Pictures were analyzed with Leica Qfluoro version
V1.2.0 (Leica) and Adobe Photoshop 7.0 (Adobe Systems, Mountain
View, CA) software.
Statistical analysis
ANOVA test was used for statistical analysis. Significant differences
are indicated with asterisks (p<0.05).
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Introduction
The immune system plays a key role in our body's defense against
infections. In addition, it can protect against cancer by recognizing
and eradicating aberrant cells such as cancer cells. However, hyper-
stimulation of the immune system can lead to autoimmune diseases
and allergy. The innate immune system is an evolutionary conserved
system that recognizes and eliminates invading pathogens [1]. In
vertebrates a second line of defense is created by the adaptive
immune system. The adaptive immune system is activated by anti-
gen presenting cells (APCs) of the innate immune system, i.e. den-
dritic cells (DCs), macrophages and monocytes. The DC lifecycle
involves a series of developmental stages. Precursors move from the
blood into the tissue, were the immature DCs (iDCs) scan for anti-
gen. When the iDCs encounter antigen they transform into mature
DCs (mDCs) and migrate to the lymph nodes where they activate T
cells. DCs are considered the most potent APC, as they are the most
effective inducers of T cell activation [2, 3]. To fulfill these functions,
DCs have to interact with different cellular environments depending
on their life-stage, and these interactions have to be tightly regulat-
ed. For instance, the ability to cross tissue boundaries and to migrate
to the lymph nodes, as it occurs in response to DC maturation, is
essential for the induction of efficient immune responses [4, 5]. In this
thesis, we investigated the regulation of adhesive and migratory
properties during DC-maturation. 
DC cell lines
Several difficulties arise when studying the biology of DCs. DCs are
primary cell that have to be isolated from blood or spleen. An alter-
native is the isolation of DC-precursors, such as CD34+ cells or
monocytes, and subsequent differentiation in vitro. The number of
cells that can be obtained is limited, as is the life span of these cul-
tures. In addition, expensive cytokines are needed and manipulation
of DCs or DC-precursors is difficult. Additional complications arise
from differences between donors. Therefore, a good DC-model cell
line would be very useful. In chapter 2 we have compared different
mouse and human cell lines for their use as a DC-model cell line. In
the mouse setting, the D1 cell line most closely resembles in vivo
DCs. However, when large numbers of cells or manipulation of these
cells is required, the macrophage-like Raw264.7 cell line provides a
better alternative. In the human setting, the MUTZ-3 cell line is the
best model available thus far, especially when studying mature DC-
function. Similarly to the D1 cells however, these cells are difficult to
manipulate and have to be cultured under tightly controlled situa-
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tions. MUTZ-3 cells are poorly adhesive and therefore less suited as
a model for DC adhesion. For these studies, THP-1 cells or HL-60
cells provide a good alternative. Although there is not one cell line
that can fulfill all aspects of DC-biology, the use of combination of cell
lines, each for a certain application, will contribute to our under-
standing of DC-biology.
DC maturation and regulation of adhesion and
migration
In the tissues iDCs interact with the surrounding extracellular matrix
(ECM) and it turns out that iDCs are able to bind to several compo-
nents of the ECM. DCs bind the ECM component fibronectin through
the α5β1-integrin [5]. During maturation strongly adherent iDCs
change into highly migratory mDCs (chapter 3). This is reflected
both by changes in the cytoskeleton of these cells as well as the
activity of α5β1-integrin. While iDCs show prominent cell-substrate
adhesions, in mDCs those structures are absent. Instead mDCs dis-
play characteristic dendritic extensions that give these cells their
name. Although in iDCs focal adhesions (FAs) can be found, the
main adhesion structures in these cells are podosomes. In chapter
3 we describe that the active form of the α5β1-integrin is enriched in
podosomes and that the activity of this integrin is downregulated dur-
ing maturation. Moreover, keeping the integrin in the active form pre-
vents the loss of podosomes and the induction of migration, showing
that a tight regulation of the activity of integrins is essential for the
proper DC function. 
We observed that upon addition of a maturation-inducing combina-
tion of monocyte-conditioned medium (MCM), TNFα and
prostaglandin E2 (PGE2) DCs show a rapid loss of podosomes
(chapter 3). PGE2 can substitute for this combination and is suffi-
cient to induce podosome loss and migration. By using live-cell imag-
ing in combination with interference refection microscopy (IRM), we
have investigated the dynamics of podosome loss in DCs (chapter
5). IRM allows one to image adhesion structures without a need for
fluorescently-tagged molecules [6-8]. Structures close to the glass
substrate appear dark with IRM, hence podosome appear as dark
spots and FAs as dark stripes. Prior to dissolution of a podosome, a
bright ring surrounding the podosome-core was observed, suggest-
ing a local change in the proximity of the cell to its substrate. In addi-
tion to a loss of podosomes, PGE2 stimulation led to contraction of
the DCs accompanied by an increase in the number of FAs (chapter
5). In other cell types, the reversed process, a loss of FAs accompa-
nied by podosome formation, was shown [9, 10], suggesting that FAs
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and podosomes are oppositely regulated. After prolonged stimulation
the number of DCs with FAs decreased again, with mDCs being
completely devoid of FAs. Loss of FAs is associated with increased
Rac1 activity [9] and may involve the microtubule network [11].
However, much remains unknown about the function and regulation
of FA loss, especially during DC maturation. The dendritic extensions
displayed by mDCs can be induced by CCL19, a chemokine that reg-
ulates migration to the lymph nodes [12]. Although the regulation of
this process is largely unknown, the actin-bundling protein fascin and
the Rho GTPases Rac and Cdc42 appear to be involved [13, 14].
However, detailed information on the mechanisms responsible for
loss of FAs and subsequent induction of dendritic extensions during
DC maturation is still lacking.
Reactions to bacteria and TLR4 signaling in DCs
The bacterial cell wall component lipopolysaccharide (LPS), a potent
DC maturation stimulus, also induced podosome dissolution in DCs
(chapter 3). However, this effect occurred much more slowly than
the PGE2-induced podosome loss. LPS is specifically found on
Gram-negative bacteria and binds to Toll-like receptor 4 (TLR4) [15].
Components of Gram-positive bacteria activate TLR2, which dimer-
izes either with TLR1 or TLR6 [16]. In chapter 4 we have compared
the effects of Gram-negative and Gram-positive bacteria on DC-mat-
uration. We observed that expression of costimulatory molecules as
well as secretion of inflammatory cytokines is higher in response to
Gram-negative bacteria than to Gram-positive bacteria. Moreover,
Gram-negative bacteria were found to be more effective inducers of
migration and expression of CCR7, the chemokine receptor required
for CCL19/21-induced migration to the lymph nodes. Furthermore,
only Gram-negative bacteria are able to induce podosome dissolu-
tion. These findings show that Gram-negative bacteria are superior
to Gram-positive bacteria in inducing DC-maturation. An explanation
for these difference could be that evolutionarily the number of Gram-
negative bacteria infections led to the development of an APC dedi-
cated to respond to this class of pathogens; the DC. Other APCs,
such as monocytes and macrophages, may have evolved to coordi-
nate immune responses against Gram-positive as well as Gram-neg-
ative bacteria. Indeed, macrophages effectively secrete cytokines,
such as IL-6 and TNFα, in response to both classes of bacteria. At
least our findings demonstrate that DCs discriminate between Gram-
positive and Gram-negative bacteria. It will be interesting to see
whether DCs also differentially respond to distinct classes of other
pathogens, such as viruses. 
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Stimulation with purified ligands for TLR2 did not induce podosome
loss. In addition, the amount of cytokines produced in response to
TLR2 ligands was significantly lower than in response to LPS. This
suggests that activation of TLR4 induces better DC activation than
TLR2. Responses induced by LPS or Gram-negative bacteria could
be efficiently blocked by TLR4-receptor antagonists, suggesting that
these responses are fully dependent on TLR4 (chapter 4). By using
mouse bone marrow derived DCs (BMDCs), we showed that these
responses are conserved between mouse and men. Responses
induced either by LPS or Gram-negative bacteria were absent in
TLR4-/- BMDCs, which further confirms the TLR4 dependency of
these responses (chapter 4). TLR4 can activate signaling pathways
that act either downstream of the myeloid differentiation primary
response gene 88 (MyD88) or the TIR domain-containing adaptor-
inducing IFNβ (TRIF) adaptor [17, 18]. We used MyD88- [19] and
TRIF-deficient [20] BMDCs to investigate the role of these signaling
pathways (chapter 4). The effects of LPS or Gram-negative bacteria
are mainly TRIF dependent, which is in line with the inability of TLR2
activation to induce potent DC maturation. However, MyD88 appears
to also be involved, suggesting that activation of both signaling path-
ways is needed to induce full DC maturation.
The importance of PGE2
The combination of MCM, TNFα and PGE2, to induce DC maturation,
is currently used in DC vaccination trials in melanoma patients. The
presence of PGE2 was shown to be essential for the induction of
migration and consequently efficient anti-tumor immune responses
[5, 21-24]. This effect is partly mediated by the effects on expression
and activation of CCR7, the chemokine receptor needed for migra-
tion to the lymph nodes [22, 23, 25]. Interestingly, we found that
PGE2 alone is sufficient to induce rapid podosome dissolution and
migration in DCs (chapter 3). Therefore, we tested whether the
effects of LPS or Gram-negative bacteria on DCs were dependent on
the production of prostaglandins. LPS-induced podosome dissolution
and the induction of migration could be inhibited by indomethacin, a
pharmacological inhibitor that blocks the production of
prostaglandins by inhibition of cyclooxygenase (COX) enzymes
(chapter 3). Similarly, also the Gram-negative bacteria induced
effect could be inhibited by using indomethacin (chapter 4). These
findings reinforce the notion that the production of prostaglandins by
DCs is important for the induction of an efficient immune response.
At the moment it is unclear which prostaglandins are involved in
these processes. PGE2 is very potent in inducing podosome loss and
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migration, both in vitro and in vivo, and is produced by DCs in
response to LPS. However, the involvement of other prostaglandins
cannot be ruled out at this point. 
Given the importance of prostaglandins, in particular PGE2, in the
regulation of adhesion (i.e. podosome dissolution) and migration dur-
ing DC-maturation, we investigated the signaling pathways involved
in PGE2-mediated podosome dissolution (chapter 5). From the four
receptors known for PGE2, EP1-4 [26], we detected EP2 and EP4 on
DCs. PGE2-induced responses were mediated through both of these
receptors. Activation of the EP2 and EP4 receptor induces signaling
through Gs to elevated cAMP levels [26] and these PGE2-induced
responses can be mimicked by elevating cAMP levels. Cell shape
and the organization of the cytoskeleton are influenced by numerous
processes regulated by the family of small Rho GTPases [27-29].
Therefore, the role of RhoA, Rac1 and Cdc42 in PGE2-induced
podosome loss was investigated (chapter 5). The active (GTP
bound) form of RhoA increases when cells were stimulated with
PGE2, EP agonists or cAMP raising drugs. At the same time, levels
of active Rac1 and Cdc42 decreased. This suggests that PGE2
induces podosome loss by activation of RhoA. In most cell types
cAMP-mediated activation of PKA antagonizes the effects of RhoA
on actomyosin contractility, leading to cytoskeletal relaxation [30-32].
In DCs however, PGE2 stimulation appears to induce a contractile
response while activating RhoA. At the moment, it is not clear how
the elevation of cAMP levels in DCs leads to activation of RhoA.
Probably, PKA activation is involved, however activation of the
EPAC-Rap1 pathway may also play a role [33]. We showed that the
function of Rho kinase, a downstream effector of RhoA, is needed for
PGE2, EP agonist or cAMP elevation-induced podosome loss.
Together our findings show that PGE2 induced podosome loss
occurs by activation of the RhoA-Rho kinase axis.
Podosome regulation: a balance of forces
Activation of the RhoA-Rho kinase axis is known to promote the for-
mation of FAs and induce cell contraction [27, 34, 35]. In addition,
Rho kinase activity enhances stress fiber formation by inactivation of
the actin severing protein cofilin [35], whereas direct activation of
mDia by RhoA stimulates actin polymerization [27, 36]. Contraction
of the cytoskeleton is generated through the function of the motor
protein myosin II [37] and Rho kinase promotes phosphorylation of
the myosin II regulatory light chain [38, 39]. Of the three myosin II iso-
forms (A, B and C) [40-42], myosin IIA is the predominant isoform
expressed in DCs. The involvement of the RhoA-Rho kinase axis and
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the contraction observed in DCs upon PGE2 stimulation, suggest a
role for myosin II-mediated contraction in these responses. Indeed,
by blocking myosin II with blebbistatin, a selective inhibitor of myosin
IIA ATPase activity, we were able to show the importance of myosin
II-mediated contraction in PGE2-induced podosome loss (chapter 5).
In addition, we found that the localization of myosin II changes dra-
matically upon PGE2 stimulation from a diffusely cytosolic to a more
fibrillar distribution. These fibrillar structures colocalize with the bright
rings observed by IRM, most likely reflecting an increased associa-
tion with F-actin and/or a change in solubility of myosin filaments. In
some cells, myosin II function was needed for podosome formation
and maintenance [43, 44], whereas in other cells inhibition of myosin
II function was important for podosome formation [9, 10]. We propose
that basal myosin IIA activity is required for the formation and main-
tenance of podosomes, whereas a sudden (stimulus induced)
increase in myosin II activity may trigger podosome dissolution.
The regulation of basic cellular functions, such as differentiation,
apoptosis, adhesion and migration, is dependent on the balance
between forces generated by myosin II-mediated contraction inside
the cell and forces generated by the ECM outside the cells [45, 46].
Integrins organized into adhesion structures form the link between
the surrounding of the cell and the cytoskeleton. Physical properties
of the substrate can influence the generation of forces outside the
cell. Therefore, we investigated the effects of some of these physical
aspects on DC-adhesion and podosome formation (chapter 6). The
ability of DCs to adhere and form podosomes and FAs appears to be
independent of the type or hydrophobicity of the substrate, although
DCs more frequently form FAs on hydrophobic substrates. It will be
interesting to determine, by using blocking antibodies, whether inte-
grins are important for the adhesion and formation of podosomes and
FAs on substrates other than ECM components. It has been sug-
gested that the dynamic behavior of podosomes, rather than their
size is affected by the substrate [44]. Therefore it will be important to
determine whether the life-time of podosomes varies on those differ-
ent substrates or whether the kinetics of podosome dissolution in
response to PGE2 is affected by substrate composition. To investi-
gate effects of spacing and size of substrate on DC adhesion char-
acteristics, we searched for a substrate that is non-adhesive for DCs
but that can be treated to locally allow DC-adhesion. We found that
hydrogels form such a non-permissive substrate for DCs. Moreover,
we found that (ECM) proteins or even large particles can be spotted
onto these hydrogels leading to local DC-substrate interactions and
podosome formation. Hydrogels can be used in combination with
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microcontact printing, which allows better controlled size and spac-
ing. We conclude therefore that hydrogels, combined with microcon-
tact printing, provide good tools to explore the role of substrate size
and spacing on DC adhesion (chapter 6). 
In addition, we investigated the effects of topography on DC-adhe-
sion and podosome formation by using substrates with ridges or
other forms of height structures. Surprisingly, DCs aligned
podosomes on the topological boundaries of these substrates (chap-
ter 6). This suggests that the angle of the substrate induces a cur-
vature of the cell membrane resulting in mechanical stress, giving
rise to local podosome formation. By using pharmacological
inhibitors, varying the angle of the ridges or by using a stretchable
substrate, regulation of podosome formation by mechanical stretch-
ing could be further investigated. The profound effects of substrate
topology on podosome formation show that podosomes are regulat-
ed by and can respond to mechanical stress, which suggests that
podosomes, similar to focal adhesions [47], are mechanosensing
structures. In line with this, we find zyxin, which has been suggested
to be a mechanosensor [48, 49], in the podosome rings. The
mechanical effects on formation and regulation of podosomes could
have implications for DC-behavior in different tissues and be impor-
tant when DC cells encounter tissue boundaries. 
Together, our findings suggest that podosomes, in addition to FAs,
are regulated by the contractile state of the cell as well as the forces
applied to the cell by the extracellular matrix. Interestingly,
podosomes appear to be oppositely regulated by force when com-
pared to FAs. While contraction induces FA formation and relaxation
leads to a loss of these adhesions [9, 10, 34], (myosin II-based)
cytoskeletal contraction leads to podosome loss while cytoskeletal
relaxation promotes the formation of podosomes. Hence, such a bal-
ance of forces may be key to the regulation of cell adhesion and
migration in DCs and consequently for the induction of adaptive
immune responses.
The function of podosomes in DCs
Although there is a time gap between the loss of podosomes (min-
utes) and the induction of migration (16 hours), we see a strong cor-
relation between the loss of podosomes and migration (chapter 3
and 4). This suggests that podosomes prevent the induction of this
high-speed, T cell-like migration needed for proper functioning of
mDCs. 
Dissolution of podosomes is a tightly regulated process. By fixing
DCs at the moment of bright ring formation and subsequent staining
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for various podosome components, we found that vinculin could no
longer be detected at the time that the actin core was still largely
intact (Chapter 5). At this time, zyxin was still present in the
podosome-ring, while myosin II redistributes to fibrillar-like struc-
tures. We conclude that loss of podosomes involves the sequential
loss of podosome components. Podosome formation probably
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Figure 1. Model of the morphology of podosomes
In the upper left an IRM image of a DC with podosomes (dark spots) is depicted. In the
upper right the same DC is stained for vinculin (green) and actin (red). An enlargement
of a podosome is depicted in the lower right corner of this image. In the lower part of
the figure a schematic model of a podosome is shown. A podosome consists of an actin-
rich core (red) connected to a surrounding ring structure (green). In the core actin poly-
merization takes place. Here, the actin nucleation complex Arp2/3 and its regulator
WASp, as well as the actin crosslinking protein α-actinin and the actin-bundling protein
cortactin are localized. Integrins binding their extracellular ligands, such as ECM mole-
cules, are found in the ring structure. Also the integrin binding proteins talin and paxillin,
the talin- and paxillin-binding protein vinculin, zyxin and myosin II are found there. In
podosomes integrins are connected to the actin cytoskeleton, mediating adhesion and
migration.  
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involves a similar sequential acquisition of podosome components
and detailed information on the acquisition or loss of components can
shed more light on the function of podosomes.
Although the role of podosomes in iDCs is still somewhat elusive,
some suggestions can be made. Similar to FAs, podosomes link inte-
grins to the actin cytoskeleton. Podosomes have a very distinct mor-
phology with a core that contains actin and actin binding proteins sur-
rounded by a ring that contains adaptor molecules and integrins
(Figure 1). In addition, they are highly dynamic adhesion structures
with a life-time of 2 to 12 minutes that often localize to the leading
edge of the iDCs. Therefore, it is likely that podosomes are important
for adhesion, the formation of polarity and directional crawling,
resembling slow, fibroblast-like migration. This could facilitate the
scavenging for antigens by iDCs in the tissues. In addition, local pro-
tein degradation takes place underneath podosomes as the result of
focalized release of matrix metalloproteases [50, 51]. Although the
adhesion-mediating integrins are found in the podosome ring, the
dark spots observed by IRM correspond in size and localization to
the actin-rich cores of podosomes, suggesting that the actin-rich core
is closer to the substrate. Actin polymerization in the core could drive
protrusion towards or into the substrate [52-54]. Moreover
podosomes have been suggested to palpate the substrate [54] and
they have been implicated in leukocyte transmigration [6]. Together,
these observations suggest that podosomes allow DCs to either
enter or leave the peripheral tissues and help the DCs to move from
the tissue into a lymph vessel.
Concluding remarks
In this thesis we show the importance of adhesion regulation during
DC-maturation and more specifically the need for these cells to dis-
solve podosomes in order to acquire migratory properties. Gram-
negative bacteria are more capable of inducing DC maturation rela-
tive to Gram-positive bacteria. This difference is due to differential
activation of TLR4. Prostaglandins such as PGE2 are key mediators
of DC maturation in response to either pathogen-derived molecules
such as LPS or Gram-negative bacteria. A model showing TLR4 acti-
vation and subsequent PGE2 signaling is depicted in Figure 2. PGE2-
induced podosome dissolution, which either involves the EP2 or the
EP4 receptor, raises cAMP levels. This increase in cAMP leads to
activation of the RhoA-Rho kinase pathway and consequently an
increase in myosin II-mediated contraction. This contractile response
leads to a rapid loss of podosomes and the (transient) formation of
FA. In conclusion, our results show that regulation of the actomyosin
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cytoskeleton, mediated by Rho GTPases in response to extracellular
signals, plays an important role during the transition from a (tissue
resident) iDC to a highly motile mDC.
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Figure 2. Regulation of podosomes loss during DC maturation
Stimulation with LPS or Gram-negative bacteria activates TLR4, MyD88 and TRIF
dependent signaling, resulting in COX-mediated production of prostaglandins, such as
PGE2. PGE2 activates the EP2 and EP4 receptors, resulting in cAMP elevation and
PKA activation. This leads to activation of RhoA and inactivation of Rac1 and Cdc42.
Active RhoA induces Rho kinase activation. Activation of the RhoA-Rho kinase axis
induces myosin II-mediated contraction, which results in podosome loss and temporary
FA formation.
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Samenvatting (Summary in Dutch)
Het immuunsysteem speelt een essentiële rol in de bescherming
tegen infecties. Misregulatie van het immuunsysteem kan leiden tot
aanhoudende infecties, kanker, auto-immuunziekten en allergie. Het
aangeboren immuunsysteem is een evolutionair geconserveerd sys-
teem dat pathogenen herkent en opruimt. Een tweede verdedi-
gingslijn wordt gevormd door het adaptieve immuunsysteem, dat
geactiveerd wordt door antigen presenterende cellen (APCs) van het
aangeboren immuunsysteem; dendritische cellen (DCs), macrofagen
en monocyten. DCs zijn de sterkste APCs als het gaat om het acti-
veren van T cellen. Tijdens hun leven doorlopen DCs meerdere
fasen waarin ze verschillende functies uitoefenen. DC voorloper
cellen verplaatsen zich van het bloed naar de weefsels, waar de
onvolwassen DCs (iDCs) patrouilleren op zoek naar antigenen. Na
interactie met zulke antigenen ondergaan de DCs een maturatiepro-
ces waardoor iDCs veranderen in volwassen DCs (mDCs) die mi-
greren naar de lymfeknopen waar de T cellen geactiveerd worden.
Deze migratie vanuit de weefsels naar de lymfeknopen is van groot
belang voor het induceren van een productieve immuun respons. In
dit proefschrift is de regulatie van adhesieve en migratoire eigen-
schappen tijdens DC-maturatie onderzocht. 
Het onderzoek naar de biologie van DCs wordt bemoeilijkt door een
aantal factoren. DCs zijn primaire cellen die moeten worden ge-
ïsoleerd uit het bloed of de milt. Een alternatief hiervoor is het iso-
leren van voorloper cellen, zoals CD34+ cellen of monocyten, om die
vervolgens te differentiëren tot DCs. Voor deze methode is het
gebruik van dure cytokinen vereist. Het aantal cellen dat op deze
manier verkregen kan worden is beperkt, net als de het tijdsbestek
waarin deze kweken gebruikt kunnen worden. Verder is het
(genetisch) manipuleren van (voorlopers van) DCs erg moeilijk. Extra
complicaties ontstaan door verschillen tussen donoren. Om de com-
plexe biologie van DCs beter te kunnen bestuderen zou een goede
model DC-cellijn erg nuttig zijn. Daarom hebben wij verschillende
muizen - en humane cellijnen vergeleken voor het gebruik als model
DC-cellijn (hoofdstuk 2). Voor de muis is de D1 cellijn degene die de
meeste overeenkomsten met DCs vertoont. Deze cellijn is evenwel
moeilijk (genetisch) te manipuleren en groeit langzaam. De (macro-
faag achtige) Raw264.7 cellijn is een goed alternatief wanneer cel-
manipulatie of grote aantallen nodig zijn. Van de humane cellijnen
lijkt op dit moment de MUTZ-3 cellijn het beste model om de biologie
van (vooral volwassen) DCs te bestuderen. Helaas zijn ook deze
cellen moeilijk genetisch te manipuleren en moeten deze onder strikt
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gecontroleerde omstandigheden gekweekt worden. Verder hechten
deze cellen relatief slecht waardoor ze minder geschikt zijn voor
studies naar DC-adhesie. Voor dit laatste vormen de THP-1 of HL-60
cellen een goed alternatief. Samenvattend kunnen we concluderen
dat er niet één cellijn is die in alle aspecten op DCs lijkt.
Desalniettemin kan het gebruikt van cellijnen, elk voor een eigen
toepassing, het onderzoek naar de biologie van DCs vergemakke-
lijken, zoals ook in dit proefschrift beschreven. 
Tijdens maturatie veranderen de sterk hechtende iDCs in snel mi-
grerende mDCs (hoofdstuk 3). Dit proces gaat gepaard met veran-
deringen in het cytoskelet van deze cellen. mDCs hebben dendri-
tische uitlopers, maar geen adhesiestructuren. iDCs hebben z.g.n.
'focal adhesions' (FAs), maar de belangrijkste adhesiestructuren in
deze cellen zijn podosomen. Wij hebben ontdekt dat DCs na
toevoeging van een maturatie-inducerende combinatie, bestaande
uit monocyt-geconditioneerd medium (MCM), TNF α en prostaglan-
dine E2 (PGE2), zeer snel hun podosomen verliezen (hoofdstuk 3).
Deze combinatie wordt ook gebruikt bij patiënten met huidkanker die
DC-vaccinatie ondergaan. Hierbij is gebleken dat PGE2 onmisbaar is
voor het induceren van migratie en goede antitumor responsen.
Onze in vitro experimenten bevestigen dat de toevoeging van PGE2
voldoende is om podosoomdissolutie en snelle migratie te induceren
in DCs. 
In de weefsels komen iDCs in contact met de omringende extra-
cellulaire matrix (ECM) waarbij deze aan verschillende ECM compo-
nenten kunnen binden. In vitro heeft binding aan fibronectine via het
α5β1-integrine de voorkeur. Wij hebben aangetoond dat actief α5β1-
integrine verrijkt is in podosomen en dat de activiteit van dit integrine
vermindert tijdens maturatie (hoofdstuk 3). Als het integrine in zijn
actieve vorm gehouden wordt remt dit het oplossen van podosomen
en het ontstaan van snelle migratie. Dit wijst erop dat een strikte re-
gulatie van de activiteit van integrines essentieel is voor het func-
tioneren van DCs. 
Hoewel het oplossen van podosomen (minuten) en het ontstaan van
snelle migratie (16 uur) in de tijd van elkaar gescheiden zijn, zien we
een sterke correlatie tussen het verdwijnen van podosomen en het
ontstaan van snelle migratie. Waarschijnlijk zijn podosomen van
belang bij de langzame, fibroblast-achtige migratie van iDCs, maar
verhinderen ze de snelle, T cel-achtige migratie noodzakelijk voor
het functioneren van mDCs. 
Ook hebben we gevonden dat lipopolysaccharide (LPS), een matu-
ratie stimulus afkomstig van de celwand van gram negatieve bac-
teriën ook podosoomdissolutie in DCs kan induceren. Dit effect
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treedt evenwel beduidend later op dan met PGE2. LPS bindt en
activeert Toll-like receptor 4 (TLR4). Componenten van
Grampositieve bacteriën leiden tot activatie van TLR2, dat dimeren
vormt met TLR1 of TLR6. Wij hebben de effecten van
Gramnegatieve en Grampositieve bacteriën op DC-maturatie in
detail onderzocht (hoofdstuk 4). Tot onze verbazing vonden we dat
Gramnegatieve bacteriën of LPS, maar niet Grampositieve bacteriën
of pure TLR2 liganden, podosoomdissolutie induceren. Verder
blijken de Gramnegatieve bacteriën superieur in het induceren van
snelle migratie en expressie van CCR7, de chemokine receptor
nodig voor de migratie naar de lymfeknopen. Ook de expressie van
costimulatoire moleculen en productie van inflammatoire cytokinen is
beduidend hoger na stimulatie van DCs met Gramnegatieve bac-
teriën dan wanneer hiervoor Grampositieve bacteriën worden
gebruikt. Deze bevindingen tonen aan dat Gramnegatieve bacteriën
beter zijn in het induceren van DC-maturatie dan Grampositieve bac-
teriën. 
De effecten van LPS of Gramnegatieve bacteriën kunnen worden
geblokkeerd door TLR4 te blokkeren and zijn afwezig in TLR4-/-
muize beenmerg DCs (BMDCs), wat aangeeft dat dit proces volledig
afhankelijk is van TLR4 en dat deze reacties geconserveerd zijn
tussen muis en mens (hoofdstuk 4). TLR4 kan twee signa-
leringsroutes activeren, de ene verlopend via het adapter molecuul
MyD88 en de andere via TRIF. Wij hebben MyD88- en TRIF-defi-
ciënte BMDCs gebruikt om de rol van deze signaleringsroutes op DC
maturatie verder te onderzoeken (hoofdstuk 4). Uit deze studies
blijkt dat de effecten van Gramnegatieve bacteriën op maturatie en
podosoom verlies, in hoofdzaak TRIF afhankelijk zijn. 
Omdat PGE2 stimulatie leidt tot het snel oplossen van podosomen, is
onderzocht of de effecten van LPS danwel Gramnegatieve bacteriën
op DCs afhankelijk zijn van de productie van prostaglandines. Het
door LPS geïnduceerde podosoomverlies en de snelle migratie blijkt
te kunnen worden geremd met indomethacine, een middel dat de
productie van prostaglandinen door de COX-enzymen remt (hoofd-
stuk 3). Op dezelfde manier kunnen de effecten geïnduceerd door
Gramnegatieve bacteriën geremd worden met indomethacine
(hoofdstuk 4). Deze resultaten bevestigen dat prostaglandines,
geproduceerd door DCs na stimulatie met bacteriële antigenen, een
belangrijke rol spelen bij de inductie van cel migratie tijdens DC ma-
turatie. 
Gezien het belang van prostaglandines zoals PGE2 voor DC
migratie, zijn de signaleringsroutes betrokken bij de PGE2-geïn-
duceerde podosoomdissolutie verder onderzocht (hoofdstuk 5). Van
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de vier bekende receptoren voor PGE2, EP1-4, blijken vooral EP2 en
EP4 betrokken bij PGE2-geinduceerde responsen in DCs. Activatie
van EP2 en EP4 leidt tot productie van cAMP en het (pharmacolo-
gisch) verhogen van cAMP concentraties in de cel kan de PGE2-
geïnduceerde effecten nabootsen. 
Door 'Live Cell Imaging' te combineren met interferentie reflectie
microscopie (IRM), zijn we in staat geweest om de dynamiek van
podosoomverlies in tijd te volgen (hoofdstuk 5). IRM maakt het
mogelijk om adhesiestructuren in levende cellen te volgen in de tijd
zonder gebruik te maken van fluorescent-gelabelde moleculen.
Gebruik makend van deze techniek worden podosomen zichtbaar
als donkere stippen en FAs als donkere strepen. Behalve tot het ver-
lies van podosomen, leidt PGE2 stimulatie ook tot een toename in het
aantal DCs met FAs (hoofdstuk 5). Direct voorafgaand aan het
oplossen van de podosomen ontstaat een heldere ring rondom de
podosoom kern, hetgeen suggereert dat er een fysische verandering
plaats vindt in deze ring structuur. 
FA formatie en het verlies van podosomen gaat gepaard met con-
tractie (het samentrekken van het cytoskelet) van de DCs. Contractie
van het cytoskelet wordt gegenereerd door het motoreiwit myosine II
in associatie met het actine cytoskelet. Van de drie vormen van myo-
sine II (A, B en C) komt hoofdzakelijk myosine IIA voor in DCs. Door
gebruik te maken van de myosine II remmer blebbistatine hebben we
het belang van myosine II(A) in PGE2-geïnduceerde podosoom-
dissolutie verder kunnen bevestigen (hoofdstuk 5). 
De vorm van de cel en de organisatie van het cytoskelet worden door
verschillende processen beïnvloed, en in belangrijke mate gere-
guleerd door de GTPases RhoA, Rac1 en CDC42. Daarom is de
betrokkenheid van deze GTPases bij de PGE2-geïnduceerde
effecten op podosomen onderzocht (hoofdstuk 5). Hieruit blijkt dat
activatie van RhoA end RhoA-gemedieerde contractie een essentiële
rol speelt bij PGE2-geïnduceerd podosoomverlies. Uit deze resulta-
ten blijkt dat PGE2 stimulatie , leidt tot cAMP verhoging, wat het ver-
lies van podosomen en ontstaan van FAs induceert. Deze effecten
zijn een direct gevolg van myosine II geïnduceerde contractie die
ontstaat door activatie van de RhoA-Rho kinase route (hoofdstuk 5).
Verder suggereren deze bevindingen dat podosomen en FAs
tegengesteld gereguleerd worden door de contractiele status van de
cel.
De regulatie van elementaire cellulaire functies, zoals differentiatie,
apoptose, adhesie en migratie, is afhankelijk van de balans tussen
krachten die gegenereerd worden door de ECM aan de buitenkant
van de cel en de krachten die ontstaan door myosine II geïnduceerde
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contractie in de cel. Integrines die georganiseerd zijn in adhesie
structuren vormen de verbinding tussen de omgeving van de cel en
het cytoskelet. Fysische aspecten van het substraat en de cellulaire
omgeving kunnen het ontstaan van krachten binnen in de cel beïn-
vloeden. In hoofdstuk 6 hebben we de effecten van deze fysische
aspecten op DC-adhesie en het ontstaan van podosomen onder-
zocht. Het vermogen van DCs om te hechten en om podosomen en
FAs te vormen op tweedimensionale substraten lijkt onafhankelijk
van het type substraat of het hydrofobe karakter ervan. Om de
effecten van topologie en omvang van het substraat oppervlak te
onderzoeken is gezocht naar een substraat waarop de DCs niet
kunnen hechten, maar dat zodanig behandeld kan worden dat de
DCs locaal wel kunnen hechten. Hydrogels blijken aan deze eigen-
schappen te voldoen. Eiwitten en zelf grotere deeltjes geïmmo-
biliseerd op deze hydrogels geven aanleiding tot DC-adhesie en
podosoom vorming. Hydrogels kunnen worden gebruikt in combi-
natie met microcontact printing, wat een meer gecontroleerde af-
meting en plaatsing van de eiwit-gecoate opervlakken toelaat. Het
gebruik van hydrogels in combinatie met microcontact printing lijkt
dan ook een goede methode om de rol van substraat grootte en af-
stand te onderzoeken (hoofdstuk 6). 
Ook is het effect van reliëfverschillen in het substraat op DC-adhesie
en podosoomvorming onderzocht gebruikmakend van substraten
met richels en anders gevormde hoogtestructuren. DCs vormen
specifiek podosomen op de randen van deze hoogtestructuren
(hoofdstuk 6). Dit suggereert dat de hoek van het substraat een
kromming van de celmembraan induceert wat resulteert in mecha-
nische stress die leidt tot locale podosoomformatie. De effecten van
reliëfverschillen op podosoomformatie suggereren dat podosomen
mechanosensoren kunnen zijn, net als FAs. De invloed van mecha-
nische effecten op podosoomvorming en -regulatie zou gevolgen
kunnen hebben op het gedrag van DCs in de verschillende weefsels
en tijdens het verlaten van de weefsels. Samenvattend tonen de
bevindingen in dit proefschrift aan dat adhesiestructuren (met name
podosomen) strikt gereguleerd worden tijden DC-maturatie. Deze
regulatie speelt een belangrijke rol bij de inductie van snelle migratie
vanuit de weefsels naar de lymfeklieren, een voorwaarde voor goede
T cel activatie.
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List of abbreviations
-/- knock out
Ab antibody
AFM atomic force microscopy
APC antigen presenting cell
BMDCs bone marrow-derived DCs
BSA bovine serum albumin
cAMP cyclic adenosine monophosphate  
CBA cytokine beads array 
COX cyclooxygenase
CTL cytotoxic T lymphocyte
DCs dendritic cells
DC-SIGN DC-specific ICAM-3 grabbing nonintegrin 
DEAE diethylaminoethyl
DNA desoxyribonucleic acid
ECM extracellular matrix
ELISA enzyme-linked immunosorbent assay
FAs focal adhesions
FCS fetal calf serum
FITC fluorescein isothiocyanate
FN fibronectin
g gram
GM-CSF Granulocyte Macrophage-Colony Stimulating Factor
GTP Guanosine triphosphate 
h hour
HLA human leukocyte antigen
ICAM intercellular adhesion molecule
iDCs immature DCs
IFN interferon 
IL interleukin
IRF IFN-regulatory factor
IRM Interference Reflection Microscopy
KLH keyhole limpet hemocyanin
l liter
LPS lipopolysaccharide
LTA lipoteichoic acid
MAL MyD88 adaptor-like
MCM monocyte conditioned medium
MDA-5 melanoma differentiation-associated gene 5
mDCs mature DCs
MFI mean fluorescent intensity
MHC major histocompatibility complex
List of abbreviations
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List of abbreviations
min minutes
MODCs monocyte-derived DCs
moi mode of infection
MyD88 myeloid differentiation primary response gene 88
myDCs myeloid DCs
MΦ macrophage
NF-κB nuclear factor κB
NK cell natural killer cell
NOD nucleotide-binding oligomerization domain
PAMPs pathogen associated molecular patterns
PBMCs peripheral blood mononuclear cells
PBS phosphate buffered saline
Pd pull down
pDCs plasmacytoid DCs
PDMA poly(dimethyl siloxane)
PE phycoerythrin
PEG poly(ethylene glycol)
PEN poly(ethylene naphthalate)
PGE2 prostaglandin E2
PGs prostaglandins
PKA protein kinase A
PLL poly-L-lysine
PMA phorbol 12-mystate 13-acetate
PMMA poly(methyl methacrylate)
polyI:C polyinosinic-polycytidylic acid
PRRs pattern recognition receptors
PS polystyrene
RIG retinoic acid-inducible gene
RNA ribonucleic acid
RT-PCR reverse transcriptase polymerase chain reaction
SD (s.d.) standard deviation
SEM (s.e.m.) standard error of the mean
Th T helper
TL total lysate
TLRs Toll-like receptors
TNFα Tumor Necrosis Factor α
TRAM TRIF-related adaptor molecule
TRIF TIR domain-containing adaptor-inducing IFN 
WASp Wiskott Aldrich Syndrome protein
WT wild-type
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alle hulp met computerissues. Ben en Frank de L bedankt voor alle
hulp (en creatieve naamgeving) met de confocaal. Joost te R
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Liesbeth Jacobs en Trees Jansen bedankt voor de cytokineme-
tingen. Leo Joosten bedankt voor de TRIF-deficiënte muizen.
Samen met een aantal andere TILlers heb ik een flinke tijd op de 6e
verdieping doorgebracht. Alessandra, Ben, Joost, Agnieszka,
Machteld, 'bezoeker' Inge en op het laatst Koen, ik vond dat we een
erg gezellig groepje hadden samen. 
Ook wil ik alle celbiologen bedanken voor de goede sfeer en leuke
borrels e.d., het was erg gezellig. Ik vond het erg leuk om mijn data
ook aan een celbiologisch publiek te kunnen presenteren. Bé,
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de Leica, alle liters mowiol en de gezelligheid. 
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